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Abstract 
Genetic regulation of the cellular and physiological response to hypertonic stress in 
C. elegans 
 
Sarel Johanna Urso, Ph.D. 
 





Virtually all cells must maintain osmotic homeostasis in order to survive.  Changes in 
extracellular osmolarity due to both physiological and pathophysiological conditions disrupt 
osmotic homeostasis and elicit rapid cellular responses.  In particular, increased extracellular 
osmolarity (hypertonic stress, HTS) causes a rapid decrease in cell volume leading to increased 
intracellular ionic strength.  One major pathway cells activate to counteract HTS involves the 
upregulation of genes that facilitate accumulation of small organic solutes called compatible 
osmolytes.  Compatible osmolytes restore cell volume, decrease intracellular ionic strength, and 
promote proper protein folding.  The mechanisms by which animals detect HTS and activate 
osmoprotective gene expression, including genes involved in osmolyte accumulation, remain 
poorly understood.  Similarly to humans, Caenorhabditis elegans responds to HTS by synthesizing 
compatible osmolytes from glucose metabolic products.  C. elegans synthesizes the compatible 
osmolyte glycerol by transcriptionally upregulating the enzyme that catalyzes the rate-limiting step 
in glycerol biosynthesis, glycerol-3-phosphate dehydrogenase (GPDH-1).  To understand how the 
hypertonic stress response (HTSR) is coordinated in animals, I conducted a genetic screen to 
identify mutants with no induction of osmolyte biosynthesis gene expression (Nio mutants).  In 
this screen I discovered ten loss-of-function (LOF) recessive single-gene mutants with impaired 
hypertonic induction of a gpdh-1 reporter.  In addition to a Nio phenotype, four of these mutants 
were unable to adapt to HTS.  The phenotype-causing mutations in two of these mutants were 
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distinct nonsense single nucleotide polymorphisms in the conserved O-GlcNAc transferase OGT-
1.  The phenotype-causing mutations in the other two mutants were LOF missense mutations in 
interacting components of the 3’ mRNA cleavage and polyadenylation complex.  Upon further 
characterization, I found that ogt-1 is required in an osmosensitive hypodermal cell signaling 
pathway for the post-transcriptional induction of gpdh-1.  Surprisingly, OGT-1 does not function 
through its well-studied enzymatic O-GlcNAcylation activity in this pathway.  Additionally, my 
data suggest that OGT-1 and the 3’ cleavage and polyadenylation complex function through 
separate cellular pathways to regulate the HTSR.  The results from my thesis project not only 
describe novel functions of conserved and well-studied proteins, but they also identify unusual 




  vi 
Table of Contents 
Preface ......................................................................................................................................... xvi 
List of Abbreviations ................................................................................................................. xix 
1.0 Introduction ............................................................................................................................. 1 
1.1 Cell volume regulation .................................................................................................... 2 
1.1.1 Determinants of cell membrane permeability .....................................................2 
1.1.2 Cells of all types respond to changes in extracellular solute concentration with 
the osmotic stress response ....................................................................................5 
1.1.2.1 The hypotonic stress response ................................................................ 6 
1.1.2.2 The hypertonic stress response ............................................................... 8 
1.2 Intracellular compatible osmolyte accumulation is a widespread mechanism cells use 
to adapt to hypertonic stress .......................................................................................... 9 
1.2.1 The chemical diversity of compatible osmolytes................................................11 
1.2.2 Compatible osmolytes function as chemical chaperones ..................................12 
1.3 Regulation of the osmotic stress response has been well characterized in bacteria, 
yeast, and plants............................................................................................................ 14 
1.3.1 Regulation of the osmotic stress response in bacteria .......................................15 
1.3.1.1 Hypertonicity induced gene expression in bacteria ............................ 16 
1.3.2 Regulation of the osmotic stress response in Saccharomyces cerevisiae ..........18 
1.3.2.1 The high osmolarity glycerol mitogen-activated protein kinase 
pathway in yeast ..................................................................................... 21 
1.3.3 Regulation of the osmotic stress response in plants ..........................................25 
 
  vii 
1.3.4 Conclusions ...........................................................................................................29 
1.4 Regulation of the osmotic stress response in mammals ............................................. 29 
1.4.1 The vasopressin – AQP2 axis and the renin – angiotensin – aldosterone axis 
regulate systemic plasma osmolarity in mammals ............................................30 
1.4.2 The cellular response to osmotic stress in mammals .........................................33 
1.4.2.1 Regulatory volume increase in mammals ............................................ 34 
1.4.2.2 Intracellular compatible osmolyte accumulation in mammals ......... 35 
1.4.2.3 NFAT5 regulates protective gene expression during hypertonic stress 
in mammals ............................................................................................ 36 
1.4.3 Physiological exposure of mammalian cells to osmotic stress ..........................40 
1.4.4 Pathophysiological exposure of mammalian cells to osmotic stress ................41 
1.4.5 Conclusions ...........................................................................................................44 
1.5 C. elegans provides a powerful in vivo model system to study genetic regulation of the 
hypertonic stress response ........................................................................................... 44 
1.5.1 The hypertonic stress response in C. elegans .....................................................51 
1.5.1.1 Compatible osmolyte accumulation in C. elegans during hypertonic 
stress ........................................................................................................ 52 
1.5.1.2 Osmotically regulated genes in C. elegans ........................................... 54 
1.5.1.3 Transcriptional regulation of the C. elegans hypertonic stress response
 ................................................................................................................. 55 
1.5.2 Conclusions ...........................................................................................................62 
1.6 The O-GlcNAc transferase OGT .................................................................................. 63 
1.6.1 Evolutionary conservation of OGT protein structure and function ................63 
 
  viii 
1.6.2 The cellular functions of OGT.............................................................................66 
1.6.2.1 The O-GlcNAcylation function of OGT ............................................... 66 
1.6.2.2 The proteolytic function of OGT .......................................................... 71 
1.6.2.3 The non-catalytic functions of OGT .................................................... 72 
1.6.3 The role of OGT in cellular processes ................................................................74 
1.6.3.1 OGT and insulin signaling .................................................................... 74 
1.6.3.2 OGT and the nervous system ................................................................ 75 
1.6.3.3 OGT and autophagy .............................................................................. 77 
1.6.3.4 OGT and cellular stress responses ....................................................... 78 
1.6.4 The essential function of OGT.............................................................................81 
1.6.5 Conclusions ...........................................................................................................83 
1.7 The 3’mRNA cleavage and polyadenylation complex ................................................ 84 
1.7.1 Mechanism of 3’ mRNA cleavage and polyadenylation ...................................86 
1.7.2 Alternative polyadenylation ................................................................................87 
1.7.3 Conclusions ...........................................................................................................91 
1.8 Conclusions ..................................................................................................................... 92 
2.0 Results .................................................................................................................................... 95 
2.1 Identification of mutant C. elegans with impaired induction of the hypertonic stress 
response through an unbiased, fluorescence based, forward genetic screen .......... 95 
2.2 The O-GlcNAc transferase OGT-1 is required post-transcriptionally for the 
hypertonic induction of GPDH-1 and physiological adaptation to hypertonic stress
 ...................................................................................................................................... 107 
 
  ix 
2.2.1 OGT-1 is required for osmosensitive GPDH-1-GFP protein expression, but not 
osmosensitive transcription in a sequence-independent manner ..................112 
2.2.2 Physiological and genetic adaptation to hypertonic stress requires ogt-1 .....120 
2.2.3 Non-canonical activity of ogt-1 in the hypodermis regulates gpdh-1 induction 
by hypertonic stress through a functionally conserved mechanism ..............125 
2.3 Interacting components of the 3’ mRNA cleavage and polyadenylation complex are 
required for the hypertonic induction of GPDH-1 and physiological adaptation to 
hypertonic stress ......................................................................................................... 132 
3.0 Discussion............................................................................................................................. 140 
3.1 Identification of mutant C. elegans with impaired induction of the hypertonic stress 
response through an unbiased fluorescence based forward genetic screen .......... 140 
3.1.1 Future directions ................................................................................................144 
3.2 The O-GlcNAc transferase OGT-1 is required post-transcriptionally for the 
hypertonic induction of GPDH-1 and physiological adaptation to hypertonic stress
 ...................................................................................................................................... 145 
3.2.1 Future directions ................................................................................................152 
3.3 Interacting components of the 3’ mRNA cleavage and polyadenylation complex are 
required for the hypertonic induction of GPDH-1 and physiological adaptation to 
hypertonic stress ......................................................................................................... 155 
3.3.1 Future directions ................................................................................................160 
3.4 Conclusions ................................................................................................................... 162 
4.0 Methods ................................................................................................................................ 166 
4.1 C. elegans strains and culture ..................................................................................... 166 
 
  x 
4.2 Genetic methods ........................................................................................................... 167 
4.2.1 ENU mutagenesis and mutant isolation ...........................................................167 
4.2.2 Backcrossing and single gene recessive determination ...................................168 
4.2.3 Complementation testing ...................................................................................168 
4.2.4 Whole genome sequencing .................................................................................169 
4.2.5 SNP and INDEL identification in mutants ......................................................169 
4.2.6 RNAi methods .....................................................................................................170 
4.3 COPAS biosort acquisition and analysis ................................................................... 170 
4.4 Molecular biology and transgenics ............................................................................. 171 
4.4.1 Reporter strains ..................................................................................................171 
4.4.2 Transgene rescue ................................................................................................172 
4.4.3 CRISPR/Cas9 genomic editing ..........................................................................172 
4.4.4 mRNA isolation, cDNA synthesis, and qPCR ..................................................173 
4.4.5 Western blots ......................................................................................................173 
4.5 Microscopy ................................................................................................................... 174 
4.6 Immunofluorescence .................................................................................................... 175 
4.7 C. elegans assays ........................................................................................................... 175 
4.7.1 Acute adaptation assay.......................................................................................175 
4.7.2 Chronic adaptation assay...................................................................................176 
4.7.3 Survival assays and OSR assays ........................................................................176 
4.8 Statistical analysis ........................................................................................................ 177 
Appendix A Supplementary Data............................................................................................ 178 
 
  xi 
Appendix A.1 Investigating the role of the PQR/AQR/URX neurons in the physiological 
hypertonic stress response ......................................................................................... 178 
Appendix A.2 Loss of gpdh-1 impairs growth during hypertonic stress ...................... 181 
Appendix A.3 ogt-1 is required for full induction of the transcriptional gpdh-1p::GFP 
(drIs4) and translational gpdh-1p::GPDH-1-GFP (kbIs6) reporters during 
hypertonic stress ......................................................................................................... 182 
Appendix A.4 Quantification of the hypertonic induction of gpdh-1p::GFP (drIs4) in a 
mixed age population of animals ............................................................................... 183 
Appendix A.5 Intracellular glycerol measurements in ogt-1, cpf-2, and symk-1 mutants
 ...................................................................................................................................... 186 
Appendix A.6 empty vector(RNAi) and ogt-1(RNAi) impact the acute adaptation of wild 
type animals ................................................................................................................ 188 
Appendix A.7 ogt-1 mutant acute adaptation assays with overexpressed transgenes . 189 
Appendix A.8 osm-8(dr9) mutants have reduced gpdh-1 RNA induction .................... 192 
Appendix A.9 Expression of hOGT cDNA with the myo2p::GFP marker does not rescue 
gpdh-1p::GFP induction in ogt-1 mutants ................................................................ 193 
Appendix A.10 HB101 E. coli impairs hypertonic gpdh-1p::GFP induction in wild type 
animals ......................................................................................................................... 195 
Appendix A.11 TPRs 1-6 are required for hypertonic induction of gpdh-1p::GFP and 
acute adaptation to hypertonic stress ....................................................................... 196 
Appendix A.12 The protein expression of OGT-1 may increase in response to hypertonic 
stress............................................................................................................................. 199 
Bibliography .............................................................................................................................. 201 
 
  xii 
List of Tables 
Table 2.1.1 The genetics of the nio genes are consistent with recessive single gene alleles .. 99 
Table 2.1.2 Genetic complemention of the nio alleles ............................................................ 100 
Table 2.1.3 Number of unique homozygous SNPS in each Nio mutant ............................... 105 
Table 2.1.4 nio gene candidates (SNPs) ................................................................................... 106 
Table 2.2.1 Genetic complementation of the ogt alleles ......................................................... 110 




  xiii 
List of Figures 
Figure 1.3.1 The high osmolarity glycerol (HOG) osmosensing pathway in yeast ............... 24 
Figure 2.1.1 gpdh-1 transcriptional and translational reporters are upregulated by HTS . 96 
Figure 2.1.2 Seven nio genes are required for the upregulation of the gpdh-1 transcriptional 
reporter by HTS .............................................................................................................. 98 
Figure 2.1.3 The majority of Nio mutants upregulate osmosensitive mRNAs, exhibit normal 
survival, and are able to acutely adapt to HTS .......................................................... 103 
Figure 2.2.1 The conserved O-GlcNAc transferase OGT-1 is required for the upregulation 
of the gpdh-1p::GFP transcriptional reporter by HTS. ............................................ 108 
Figure 2.2.2 ogt-1 is not required for the upregulation of transcriptional reporters by heat 
shock or ER stress or for the upregulation of the nlp-29p::GFP reporter by HTS. 111 
Figure 2.2.3 ogt-1 is not required for the upregulation of ORG mRNA transcripts by HTS
......................................................................................................................................... 114 
Figure 2.2.4 OGT-1 functions post-transcriptionally to regulate osmosensitive GPDH-1 
protein expression ......................................................................................................... 117 
Figure 2.2.5 OGT-1 regulates hypertonic induction of the gpdh-1 transcriptional reporter in 
a sequence independent manner .................................................................................. 120 
Figure 2.2.6 ogt-1 is required for physiological acute and chronic adaptation to HTS ...... 122 
Figure 2.2.7 ogt-1 is required for genetic adaptation to HTS ............................................... 124 
Figure 2.2.8 ogt-1 expression is required acutely in the hypodermis for hypertonic induction 
of gpdh-1p::GFP ............................................................................................................ 126 
 
  xiv 
Figure 2.2.9 Overexpression of human Ogt partially rescues hypertonic induction of gpdh-
1p::GFP .......................................................................................................................... 128 
Figure 2.2.10 OGT-1 functions through a non-catalytic mechanism to regulate hypertonic 
induction of gpdh-1p::GFP and adaptation to HTS................................................... 129 
Figure 2.2.11 The tetratricorepeat domain of OGT-1 is required for hypertonic induction of 
gpdh-1p::GFP and adaptation to HTS ........................................................................ 131 
Figure 2.3.1 The nio-3(dr16) and nio-7(dr23) mutants contain distinct LOF mutations in the 
CstF-64 homolog cpf-2 and the symplekin homolog symk-1 respectively that impair 
the HTSR ....................................................................................................................... 133 
Figure 2.3.2 cpf-2 and symk-1 are required for hypertonic induction of gpdh-1p::GFP .... 134 
Figure 2.3.3 cpf-2 and symk-1 are required for hypertonic induction of gpdh-1p::GPDH-1-
GFP................................................................................................................................. 136 
Figure 2.3.4 CPF-2 and OGT-1 form puncta during HTS that do not colocalize............... 138 
Figure 3.2.1 A non-catalytic function of ogt-1 is required to couple HTS induced 
transcription and translation to enable physiological adaptation to HTS............... 147 
Figure 3.4.1 HTSR pathways in C. elegans ............................................................................. 163 
Figure A.1 tax-2 expression in the PQR/AQR/URX neurons is not required for survival 
during HTS ................................................................................................................................ 180 
Figure A.2 gpdh-1 is required for growth in hypertonic conditions..................................... 182 
Figure A.3 ogt-1 is required for full induction of the gpdh-1p::GFP (drIs4) and gpdh-
1p::GPDH-1-GFP (kbIs6) reporters during HTS....................................................... 183 
Figure A.4 The dependence of gpdh-1p::GFP expression on animal developmental stage 185 
Figure A.5 Intracellular glycerol accumulation in ogt-1, cpf-2, and symk-1 mutants ........ 187 
 
  xv 
Figure A.6 Acute adaptation of WT animals treated with empty vector(RNAi) or ogt-1(RNAi)
......................................................................................................................................... 189 
Figure A.7 Acute adaptation assays with ogt-1 mutant rescue strains ................................ 191 
Figure A.8 ogt-1 is required for constitutive upregulation of osmosensitive mRNAs in an osm-
8 mutant ......................................................................................................................... 193 
Figure A.9 Expression of hOGT cDNA with the pharyngeal myo2p::GFP marker does not 
rescue hypertonic gpdh-1p::GFP induction in ogt-1 mutants ................................... 195 
Figure A.10 Hypertonic gpdh-1p::GFP induction is impaired in WT and ogt-1(dr20) mutant 
animals fed HB101 E. coli ............................................................................................ 196 
Figure A.11 TPRs 1-6 are required for hypertonic induction of gpdh-1p::GFP and acute 
adaptation to HTS ......................................................................................................... 198 
Figure A.12 The protein expression of OGT-1-GFP changes during hypertonic stress .... 200 
 
 
  xvi 
Preface 
Since the start of my journey into scientific research ten years ago, my experiences have 
been shaped by wonderful mentors and an amazing network of friends and family.  I consider 
myself very lucky and I am extremely grateful to everyone who made this dissertation possible. 
First and foremost, I would like to thank my doctoral advisor Dr. Todd Lamitina.  Todd is 
a brilliant scientist, driven researcher, and truly an exceptional mentor.  I am so lucky to have 
found the perfect lab for my graduate education.  I joined Todd’s lab with no experience in genetics 
or C. elegans, but thanks to countless hours spent discussing ideas, analyzing papers, and learning 
techniques with Todd, I am graduating as a well-rounded C. elegans geneticist and biologist.  
Todd’s love and energy for science are contagious.  Todd comes into lab every day genuinely 
excited about something, whether it be a new idea, a new discovery, or a recent baseball, running, 
or music - related accomplishment.  This excitement is refreshing and encouraging, but above all 
it is inspiring.  From Todd’s example I have learned how to be a curious, confident, and creative 
scientist and I will take these skills with me into the next steps of my career. 
Second, I would like to thank members of the broader University of Pittsburgh community 
for their academic support.  Thank you to my thesis committee made up of Drs. Arohan 
Subramanya, Arjumand Ghazi, Yang Hong and Karen Arndt for their valued advice on my project, 
bringing a variety of perspectives to my research, and guiding me towards developing a focused 
story.  This work benefited greatly from our biannual meetings.  Thank you to my Cell Biology 
and Molecular Physiology program directors, Drs. Michael Butterworth and Adam Kwiatkowski, 
for their feedback on presentations, career advice, and keeping me on track to finish my doctorate.  
 
  xvii 
Last, thank you to the Pittsburgh worm community, specifically the Yanowitz, Ghazi, and Gurkar 
labs, for sharing reagents, expertise, and good holiday party laughs with me. 
Third, I would like to thank the mentors who introduced me to science and paved the way 
for my journey into graduate school.  My scientific career started as a high school junior in Dr. 
Cynthia Haseltine’s lab at Washington State University.  Dr. Haseltine not only introduced me to 
research and common biological techniques, while guiding me through my own project, but her 
never-wavering enthusiasm and love for science also inspired me to pursue a career in science.  I 
continued my scientific pursuits at Oberlin College and was greatly influenced by my honor’s 
thesis advisor Dr. Lisa Ryno.  Through Dr. Ryno’s dedicated mentorship I learned how to 
contribute to a collaborative lab environment, troubleshoot, and most importantly how to tell a 
story through my research.   
Finally, I would like to thank my support network inside and outside the lab.  Thank you 
to my two fellow ‘Lamitina Lab Rats’, Dr. Paige Rudich and Carley Snoznik for being the best lab 
mates and friends I could have asked for.  It was an honor to work alongside such smart and hard-
working women.  Thank you to my fellow scientists and good friends, Julia Loose and Charlie 
Good, for our regular hikes and valuable scientific and non-scientific chats.  Last and most 
importantly, thank you to my family.  Thank you to my parents, Dr. David Loewus and Andrea 
Kirchner-Loewus, for encouraging me from the beginning to be an independent thinker and hard 
worker and for providing me with a strong foundation from which to pursue my dreams.  Thank 
you to my late grandparents, Drs. Frank and Mary Loewus for being my scientific role models and 
setting me up with my own subscription to The Scientist as a high schooler.  Above all, thank you 
to my husband and biggest supporter, Josh Urso, for his unwavering love and encouragement 
during all the highs and lows of graduate school. 
 
  xviii 
This dissertation was supported by a NIH R01GM135577 grant to Todd and a Research 
Advisory Council grant from the Children’s Hospital of Pittsburgh to me. 
 
  xix 
List of Abbreviations 
3’ UTR: 3’ untranslated region 
ABA: Abscisic acid 
ACE: Angiotensin-converting enzyme 
Akt: Protein kinase B 
AMPK: AMP-activated protein kinase 
APA complex: 3’ mRNA cleavage and polyadenylation complex 
APA: Alternative polyadenylation 
AQP2: Aquaporin 2 
AQP5: Aquaporin 5 
AQP7: Aquaporin 7 
AT1: Angiotensin II receptor type I  
ATM: Ataxia telangiectasia-mutated kinase 
BTG1: Betaine/GABA transporter 1 
CaMKIV: Calcium/calmodulin-dependent kinase 
ceOGT-1: C. elegans OGT-1 
CF IIm: Cleavage factor II 
CF Im: Cleavage factor I 
 
  xx 
CHO cells: Chinese hamster ovary cells 
CPSF: Cleavage and polyadenylation specificity factor 
CstF: Cleavage stimulation factor 
DMSP: Dimethylsulfoniopropionate 
DSE: Downstream element sequence 
ECF: Extracellular fluid 
ECM: Extracellular matrix 
eIF2α: Eukaryotic translation initiation factor 2 alpha 
eIF4F: Eukaryotic initiation factor 4F 
eIF4GI: Eukaryotic translation initiation factor 4 gamma 1 
ENac: Epithelial sodium channel 
ENU: N-ethyl-N-nitrosourea 
ER: Endoplasmic reticulum 
ev(RNAi): empty vector RNAi 
GFP: Green fluorescent protein 
GPC: Glycerophosphocholine 
GPD1: Glycerol-3-phosphate dehydrogenase (yeast) 
GPDH: Glycerol-3-phosphate dehydrogenase (C. elegans) 
HBP: Hexamine biosynthetic pathway 
 
  xxi 
HCF-1: Mammalian host cell factor 1 
HOG pathway: High osmolarity glycerol pathway (yeast) 
hOGT: H. sapians OGT 
HSPs: Heat shock proteins 
HTS: Hypertonic stress 
HTSR: Hypertonic stress response 
LOF: Loss-of-function 
LRRC8: Leucine-rich repeat containing 8A channel 
MAPK: Mitogen-activated protein kinase 
MEFs: Mouse embryonic fibroblasts 
MNCs: Magnocellular neurosecretory cells 
mOGT: Mitochondrial OGT 
MscL: Mechanosensitive channel large conductance 
MscS: Mechanosensitive channel small conductance 
NCED: 9-cis-expoxycartenoid dioxygenases 
ncOGT: Nucleocytoplasmic OGT 
NFAT5/TonEBP: Nuclear factor of activated T cells 5/ Tonicity-responsive enhancer 
binding protein 
NGM: Nematode growth media 
Nio: No induction of osmolyte biosynthesis gene expression 
 
  xxii 
NLS: Nuclear localization signal 
NPA motif: Asparagine-proline-alanine motif 
NTE: Neuropathy target esterase 
OLVTs: Organum vasculosum of the lamina terminalis cells 
ORE/TonE: Osmotic response element/tonicity enhancer element 
ORG: Osmotically regulated gene 
OSR: Osmotic stress resistance 
OSR1: Oxidative stress responsive kinase 1 
PABP: Poly(A)-binding protein  
PAP: Poly(A) polymerase 
PAS: Polyadenylation signal sequence 
PI3K-IA: Phosphoinositide 3-kinase IA 
PKA: Protein kinase A 
RAA: Renin-angiotensin-aldosterone  
RBPs: RNA binding proteins 
RNAi: RNA interference 
RR: Response regulator 
RRM: RNA-recognition motif 
RVD: Regulatory volume decrease 
 
  xxiii 
SHK: Sensor histidine kinase 
SMIT: Sodium myo-inositol transporter 
SNARE: Soluble N-ethylmaleimide–sensitive factor attachment protein receptor 
SNP: Single nucleotide polymorphism 
sOGT: Short isoform OGT 
SPAK: Ste20/SPS1-related proline/alanine-rich kinase 
SYMPK: Symplekin 
TAUT: Taurine transporter 
TMAO: Trimethylamine N-oxide 
TOF: time of flight 
TPR: Tetratricopeptide repeat  
TRPV1: Transient receptor potential vanilloid type-1 channel 
UPR: Unfolded protein response 
VRAC: Volume – regulated anion channel 
WNK1: Lysine deficient protein kinase 1 






  1 
1.0 Introduction 
Cell volume is among the most aggressively defended physiological set points.  Changes 
in cell volume affect cellular properties vital for proper cell function such as turgor pressure, 
membrane tension, and increased intracellular ionic strength [1].  Among the cellular functions 
directly affected by cell shrinkage or swelling are protein folding [2], enzymatic function [3, 4], 
membrane potential [5], and cytoskeletal architecture [6].  Abrupt changes in cell volume lead to 
cell death if proper protective mechanisms are not engaged [7-12].  Therefore, cells in every type 
of organism have evolved mechanisms to adapt to and counteract changes in cellular volume.  
Many, but not all, of these mechanisms are highly conserved.  While the physiological mechanisms 
used to adapt to cell volume changes have been extensively characterized in single and 
multicellular organisms, the regulatory pathways that are triggered by cell volume changes to 
initiate these adaptive mechanisms are poorly understood, especially in multicellular organisms.  
Using the in vivo model Caenorhabditis elegans, my project uses unbiased genetic methods to 
dissect the regulatory pathways governing the cellular and organismal responses to changes in cell 
volume caused by osmotic stress.  I discovered ten mutants with distinct loss of function (LOF) 
mutations in seven genes that have an impaired response to increased extracellular osmolarity 
(hypertonic stress, HTS).  Detailed characterization of four of these mutants revealed critical roles 
of the O-GlcNAc transferase OGT and the 3’ mRNA cleavage and polyadenylation complex in 
the hypertonic stress response (HTSR).  Intriguingly, I demonstrate that OGT functions through a 
non-canonical and post-transcriptional mechanism to regulate the HTSR.  My discoveries 
contribute novel insights to our understanding of the HTSR in multicellular organisms and suggest 
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that multiple pathways are required to successfully upregulate protective gene expression during 
HTS. 
1.1 Cell volume regulation 
Cell volume is directly influenced by water movement across the plasma membrane.  Cell 
membranes are several orders of magnitude more permeable to water than they are to ions [13, 
14].  This permeability allows water to move up ionic concentration gradients, a force termed 
osmosis.  Water therefore accumulates inside cells when extracellular ionic strength is decreased 
relative to intracellular ionic strength (hypotonic stress) and this results in cell swelling.  
Correspondingly, water leaves cells when extracellular ionic strength is increased relative to 
intracellular ionic strength (HTS) and this results in cell shrinkage.  Cells respond to hypertonic 
and hypotonic stress with specific mechanisms that restore cell volume. 
1.1.1 Determinants of cell membrane permeability 
The permeability of the cell plasma membrane to water is determined by two main factors: 
fluidity of the lipid bilayer [15] and the presence of water-permeable channels (aquaporins) in the 
plasma membrane [16].  Generally, the more fluid the lipid bilayer, the more permeable the 
membrane is to nonionic molecules like water and urea.  Plotting liposome fluidity against 
liposome permeability to water, urea, acetamide, and ammonia fits a single exponential function, 
implying that membrane permeability is dependent on membrane fluidity [15].  Properties of the 
lipid bilayer that increase its fluidity include decreased acyl chain saturation, decreased cholesterol 
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concentration, and decreased sphingomyelin concentration [15].  However, the positive correlation 
between membrane fluidity and permeability does not apply to ionic molecules such as salts [15].  
The permeability of membranes to these charged molecules depends on channel and transporter 
activity in the membrane.  Therefore, changing membrane fluidity is one way cells fine tune how 
rapidly nonionic molecules, most notably water, are able to move across the plasma membrane.   
In addition to membrane fluidity, the presence of aquaporins in the plasma membrane also 
directly influences membrane water permeability [16].  Aquaporins are protein channels that allow 
for the passive movement of water molecules across the plasma membrane [16].  Water molecules 
move through aquaporins in the direction of their osmotic gradient [16].  In addition to water, some 
aquaporins are also passively permeable to the metabolites glycerol and urea [17].   Cells can thus 
regulate their permeability to nonionic molecules, such as water, by modulating the concentration 
of aquaporins in the plasma membrane. 
Since the serendipitous discovery of the first aquaporin, Aquaporin 1, by Agre, et al. in 
1987 [18], 13 mammalian channels, many of which are conserved in other organisms, have been 
identified that are permeable to water, glycerol and/or urea [17].  The fundamental structure of an 
aquaporin consists of four subunits, each subunit containing two hemipores made up of three 
transmembrane domains with two conserved loops containing the asparagine-proline-alanine 
(NPA) motif [16, 19].  The NPA motif confers specificity to the aquaporin by forming hydrogen 
bonds with water, glycerol, and/or urea to facilitate their movement through the channel [16, 19].  
Although each aquaporin has a similar fundamental structure and function, the expression profile 
and physiological role of the 13 mammalian aquaporins varies across cell type [17]. 
Aquaporin 2 (AQP2) is expressed in the kidney renal collecting duct and plays an integral 
role in systemic osmotic homeostasis in mammals [20].  AQP2 is not constitutively localized in 
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the plasma membrane.  Instead, under basal conditions AQP2 is localized primarily in intracellular 
vesicles where it does not function in plasma membrane permeability [20].  It is only during 
systemic water depletion that AQP2 is exocytosed to the apical membrane where it increases 
plasma membrane permeability to water and thereby allows water to be reabsorbed from the urine 
to replenish systemic water levels [20].  Highlighting the importance of AQP2, mice with a loss 
of function mutation in AQP2 have severe urine concentrating defect at birth that results in 
dehydration and ultimately death within 5-6 days [21].  AQP2 is therefore an example of how 
regulation of aquaporin number in the plasma membrane can directly influence membrane water 
permeability to meet the organismal needs. 
Aquaporin 5 (AQP5) is another example of an aquaporin that plays a role in fluid 
homeostasis in mammals [22].  AQP5 functions primarily in the salivary glands to promote 
salivary secretion.  The parotid and sublingual acinar cells of AQP5 deficient mice have decreased 
permeability to water, which results in decreased salivary secretion due to a low efflux of water 
[22].   
While both AQP2 and AQP5 function primarily in water permeability, Aquaporin 7 
(AQP7) is both water and glycerol permeable and is critical for glycerol homeostasis in adipose 
cells where it facilitates the efflux of glycerol [23, 24].  Strikingly, knock down of AQP7 in mice 
causes adipocyte hypertrophy and a subsequent increase in body mass due to intracellular glycerol 
and triglyceride accumulation [25].  Therefore, depending on its structure and cell specificity, 
aquaporins play a variety of physiological roles in mammals critical for water and/or glycerol 
homeostasis.  The key function of aquaporins required for these physiological roles is the 
modulation of plasma membrane permeability. 
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Surprisingly, aquaporins are not required for osmotic homeostasis in all organisms.  The 
small nematode Caenorhabditis elegans has eight aquaporins, but they are not required for 
adaption to osmotic stress [26].  Simultaneous knockout of all four epithelial expressed and water-
permeant aquaporins in C. elegans leads to a slight increase in hypotonic stress sensitivity, but has 
no effect on HTS sensitivity or survival during either type of osmotic stress [26].  This result 
suggests that some organisms, including C. elegans, may have redundant mechanisms to alter 
membrane permeability or that aquaporin-mediated membrane permeability is not as important for 
C. elegans osmotic physiology. 
In conclusion, the permeability of the plasma membrane to water is determined primarily 
by lipid bilayer composition and aquaporin concentration.  The plasma membrane is significantly 
more permeable to water than it is to ionic molecules and this water permeability can be further 
increased by decreasing acyl chain saturation, cholesterol, and sphingolipid concentration and 
increasing aquaporin concentration in the lipid bilayer.  Cells fine tune their water permeability by 
limiting the localization of aquaporins in the plasma membrane, as seen with AQP2, to meet 
organismal needs.  Importantly, the permeability of the plasma membrane to water, but not ionic 
molecules, makes cells intrinsically sensitive to osmotic stress regardless of how lipid composition 
or aquaporin concentration are regulated. 
   
1.1.2 Cells of all types respond to changes in extracellular solute concentration with the 
osmotic stress response 
Cells are extremely sensitive to changes in osmotic homeostasis.  For example, some renal 
cells respond to osmotic perturbations of < 3% [27].  One important consequence of osmotic stress 
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is that it changes cell volume [28].  Maintenance of cell volume is required for proper cell function 
and thus cells have evolved mechanisms to sense even small changes in cell volume and activate 
protective pathways.  Osmotic stress can be categorized into two types: anisosmotic volume 
changes and isosmotic volume changes [29].  Anisosmotic volume changes are introduced by 
altered extracellular osmolarity; for example by increased extracellular salt concentration.  
Isosmotic volume changes are introduced by improper cell function; for example by inhibition of 
ion transporters such as the Na+/K+-ATPase [29].  Anisosmotic stress is the primary focus of my 
research project. 
1.1.2.1 The hypotonic stress response 
The fundamental mechanisms cells utilize to adapt to hypotonic stress are conserved across 
organisms.  Decreased extracellular solute concentration relative to intracellular solute 
concentration osmotically drives water into the cell causing cell swelling.  To counteract impaired 
cellular function due to increased cell volume, cells employ a conserved two-phase hypotonic 
stress response.  Within seconds of hypotonic stress, cells activate the K+-Cl- transporter, ClC-2 
Cl- channel, and a volume – regulated anion channel (VRAC) to passively efflux K+ ions, Cl- ions, 
and nonionic molecules called compatible osmolytes from the cell [29, 30].  These transporters are 
stored in submembrane cytoplasmic vesicles that are quickly activated by exocytosis to the plasma 
membrane [29, 30].  The rapid efflux of solutes osmotically draws water out of the cell in a process 
called regulatory volume decrease (RVD) and this restores normal cell volume.   
The molecular identity of VRAC has long remained mysterious.  It has been known for 
over forty years that in addition to ion efflux, compatible osmolyte efflux also contributes 
significantly to RVD, but the volume sensitive channel (VRAC) through which compatible 
osmolyte efflux occurs has remained unknown [31, 32].  In the late 1990s compatible osmolyte 
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efflux was proposed to occur through an anion channel distinct from the volume activated ClC-2 
Cl- channel [33-35].  It was not until 2014 that an essential component of VRAC was identified: 
the leucine-rich repeat containing 8A channel (LRRC8) [36].  Knockdown of LRRC8 slows ionic 
and compatible osmolyte efflux from cells and prevents cells from undergoing RVD during 
hypotonic stress, suggesting that LRRC8 is a required component of VRAC [36].  However, it is 
still not understood how LRRC8 is activated by increased cell volume. 
In addition to the immediate RVD that occurs in response to hypotonic stress, cells also 
employ a second slower phase of adaptation to hypotonic stress.  In this second phase of adaption, 
cells inhibit the accumulation of intracellular compatible osmolytes by downregulating the 
transcription of compatible osmolyte biosynthetic enzymes and compatible osmolyte transporters 
[33].  By decreasing the intracellular accumulation of compatible osmolytes, cells decrease 
intracellular osmolarity to match the decreased extracellular osmolarity and thus restore normal 
water content and cell volume. 
Hypotonic stress is induced either anisosmotically by decreased extracellular osmolarity or 
isosmotically by impaired cell function.  Anisosmotic hypotonic stress occurs when the water 
content of the extracellular fluid is increased or the solute concentration of the extracellular fluid 
is decreased.  Isosmotic hypotonic stress occurs when the ion transport into or out of the cell is 
activated or inhibited respectively [29].  For example, activation of the epithelial sodium channel 
ENaC increases sodium transport into the cell causing cell swelling [37].  Correspondingly, 
inhibition of the Na+/K+-ATPase decreases sodium transport out of the cell also causing cell 
swelling [38].  Both anisosmotic and isosmotic hypotonic stress activate the two-phased adaptation 
pathways discussed above. 
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1.1.2.2 The hypertonic stress response  
HTS is the opposite of hypotonic stress and is characterized by increased extracellular 
relative to intracellular solute concentration.  HTS results in rapid cell shrinkage and increased 
intracellular ionic strength [28].  To avoid the cellular toxicity associated with HTS - induced cell 
shrinkage, cells employ a two-phase adaptative response [7, 8].  Similarly to the hypotonic stress 
response, within seconds of HTS cells influx sodium and chloride through the Na+-K+-2Cl- 
cotransporter [39], Na+/ H+ exchanger [40], and Cl-/HCO3- exchanger [29, 41, 42].  Increased 
intracellular ion concentration osmotically drives water into the cell to counteract cell shrinkage.  
Intracellular sodium is quickly replaced by intracellular potassium through sodium-induced 
activation of the Na+/K+-ATPase [41, 43].  The second, slower phase of the HTSR involves the 
accumulation of compatible osmolytes [44].  In this phase, the transcription of compatible 
osmolyte biosynthesis genes and/or compatible osmolyte transporters is increased over the minutes 
and hours following HTS [45].  Compatible osmolytes eventually replace the intracellular ions that 
were accumulated during the first phase of the HTSR so that cell volume and intracellular ionic 
strength are restored to homeostatic setpoints [41, 46].    
Regulation of the HTSR in metazoans is poorly understood.  The ion transporters that 
mediate rapid ion influx during HTS are regulated primarily by phosphorylation and several of the 
required kinases have been identified, as is discussed in subsequent sections [47, 48].  However, 
it is unknown whether these kinases themselves are the osmosensing proteins (osmosensors) or 
whether other osmosensors exist that activate these kinases during HTS.  Similarly, one 
transcription factor that upregulates compatible osmolyte accumulation gene transcription in the 
second phase of the HTSR has been identified in mammals, but it remains poorly understood how 
this transcription factor itself is activated [49].  Furthermore, this transcription factor is only found 
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in mammals.  Whether or not other conserved mechanisms for regulation of osmosensitive gene 
expression exist is not known.  The objective of my thesis project is to re-examine the functional 
requirements for a conserved aspect of the HTSR by taking an unbiased forward genetic approach 
in the multicellular animal model C. elegans.  While this type of approach has defined HTSR 
mechanisms in unicellular organisms and plants, I am the first to apply such approaches in an 
animal model. 
1.2 Intracellular compatible osmolyte accumulation is a widespread mechanism cells use to 
adapt to hypertonic stress 
Intracellular compatible osmolyte accumulation is an essential component of the HTSR.  
Compatible osmolytes are small organic molecules whose intracellular concentration tracks the 
extracellular solute concentration to maintain appropriate intracellular water content [44].  Most 
compatible osmolytes have a net neutral charge at physiological pH and do not interact with 
charged cell metabolites or components [44].  Unlike inorganic ion accumulation, intracellular 
compatible osmolyte accumulation, even at molar concentrations, does not interfere with 
enzymatic activity or protein folding [3, 4, 50].  The second phase of the HTSR, in which 
intracellular ions are replaced by compatible osmolytes, is therefore critical for sustained 
adaptation to HTS because high intracellular ion concentration is detrimental to the function and 
folding of proteins required for proper cell function [4].  
In virtually all organisms, compatible osmolytes are intracellularly accumulated by 
transcriptional upregulation of biosynthetic enzymes or transporter proteins that mediate their 
influx [44].  Different organisms and even distinct cell types within a single organism have varying 
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preferences for compatible osmolyte accumulation [51].  Several bacteria, for example Escherichia 
coli, first accumulate compatible osmolytes from their environment by upregulating the 
corresponding transporters.  However, if their environment lacks the necessary compatible 
osmolytes, these bacteria upregulate biosynthetic enzymes to make their own [52].  Yeast and 
plants, on the other hand, accumulate compatible osmolytes primarily by upregulating biosynthetic 
enzymes regardless of the compatible osmolyte content of their environment [52, 53].  In 
mammals, some cells upregulate biosynthesis enzymes, while others upregulate transporters to 
accumulate compatible osmolytes [52].  A key readout for the HTSR that I use in my thesis project 
is the genetic upregulation of osmolyte biosynthetic enzyme upregulation in C. elegans.   
Even though compatible osmolytes are accumulated to extremely high concentrations 
inside cells without negatively affecting cellular functions, most compatible osmolytes are not 
completely inert [44].  In addition to protecting cells against HTS, compatible osmolytes in plants 
function as antioxidants to scavenge free radicals [54, 55].  In marine invertebrates living in 
hydrothermal vents and cold seeps, compatible osmolytes, such as hypotaurine and thiotaurine, 
function in sulphide/sulphate detoxication to protect cells from high sulfur levels [56, 57].  In these 
same deep sea marine organisms, another compatible osmolyte, trimethylamine N-oxide (TMAO) 
stabilizes proteins to counteract protein damage due to hydrostatic pressure [58].  Finally, 
compatible osmolytes also function in defense.  Unicellular algae accumulate the compatible 
osmolyte dimethylsulfoniopropionate (DMSP) during HTS.  DMSP not only protects unicellular 
algae from HTS, but also from predators.  Cell lysis activates cleavage of DMSP into the gas 
dimethyl sulfide (DMS), which deters predators [59, 60].  Therefore, while compatible osmolytes 
are essential for the HTSR, they also benefit cells in other ways.    
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1.2.1 The chemical diversity of compatible osmolytes 
There is significant chemical diversity among compatible osmolytes.  Generally 
compatible osmolytes can be grouped into four categories: polyols (e.g. glycerol, sucrose, inositol, 
and sorbitol), free amino acids and amino acid derivatives (e.g. taurine, beta-alanine, glycine, 
proline), urea and methylamines (e.g. trimethylamine N-oxide (TMAO), betaine, sacrosine), and 
small carbohydrates (e.g. trehalose) [44, 51].  Urea alone is denaturing, but simultaneous 
accumulation of urea and TMAO in a 2:1 urea:TMAO ratio, such as in marine organisms, 
counteracts the denaturing effects of urea and allows it to function as a compatible osmolyte [44, 
51].  The majority of compatible osmolytes are utilized in multiple organisms.  Betaine is used as 
a compatible osmolyte in all kingdoms of life.  Similarly, taurine is accumulated in most marine 
and mammalian organisms.  In contrast, urea is not widely used as a compatible osmolyte, except 
in cartilaginous fish, where it is accumulated with TMAO [51, 55].  A single organism can also 
accumulate multiple types of compatible osmolytes.  The mammalian kidney alone accumulates 
myo-inositol, sorbitol, glycerophosphorylcholine (GPC), glycine betaine, and taurine [55].  While 
there is striking chemical diversity in compatible osmolytes, they all share the property that they 
can be accumulate to molar concentrations in cells to maintain osmotic homeostasis.    
One explanation for the chemical diversity of compatible osmolytes is that they evolved 
with organisms to be compatible with specific enzymes.  However, it has since been demonstrated 
that the compatibility of osmolytes is general and not specific towards enzymes of particular cell 
types or species.  The hypertonic growth of E. coli depleted of its preferred compatible osmolytes 
betaine and proline can be rescued by a variety of compatible osmolytes not naturally used by E. 
coli [61].  Similarly, in cultured mammalian kidney cells that preferentially synthesize sorbitol 
during HTS, cell growth due to inhibition of sorbitol synthesis can be rescued with glycine betaine 
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[62].  Therefore, compatible osmolytes likely evolved chemical diversity not because they only 
function in specific cell types, but because different cells and organisms have different diets, 
metabolisms, and environments that make some compatible osmolytes more accessible than others 
[51]. 
1.2.2 Compatible osmolytes function as chemical chaperones    
In addition to tracking extracellular solute concentration and restoring cell volume 
homeostasis, compatible osmolytes also function as chemical chaperones to promote proper 
protein folding.  The first experiments to demonstrate this showed that compatible osmolytes 
glycerol and TMAO protect proteins from thermal denaturation [63, 64] and reduce the rate of 
scrapie prion formation [65].  It has since been demonstrated that compatible osmolytes stabilize 
proteins by interacting unfavorably with the peptide backbone.  This unfavorable interaction 
causes proteins to fold more tightly to shield the peptide backbone from interactions with 
compatible osmolyte molecules.  In this way, compatible osmolytes increase the Gibbs free energy 
required to shift a protein from the folded to unfolded state and this enhances the relative stability 
of the folded state [66].  In contrast to compatible osmolytes, inorganic ions interact favorably with 
the protein backbone and promote protein denaturation [51].  Therefore, accumulation of 
compatible osmolytes during HTS not only restores cell volume, but also promotes protein 
homeostasis. 
Compatible osmolytes can be categorized into four groups based on their protein stabilizing 
properties as measured by the biophysical Tanford’s transfer model [67].  First, there are 
compatible osmolytes, such as sorbitol and sucrose that stabilize proteins.  Even though these 
compatible osmolytes interact favorably with amino acid side chains, which alone is denaturing, 
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their unfavorable interaction with the peptide backbone is stronger.  Therefore proteins exclude 
these compatible osmolytes from their peptide backbones by folding and the Gibbs free energy 
required to unfold the protein is increased [67].  Second, there are compatible osmolytes that only 
moderately stabilize proteins because their unfavorable interactions with the peptide backbone 
barely outcompete their favorable interactions with amino acid side chains.  Examples of 
osmolytes that fall into this second category include glycerol, glycine betaine, and proline [67].  
Third, there is one compatible osmolyte that is denaturing on its own: urea.  Nonpolar amino acid 
side chains and the peptide backbone interact with urea to promote protein unfolding [67].  Finally, 
there are counteracting compatible osmolytes.  The most notable examples of these are TMAO 
and urea, which are found to promote protein folding in cartilaginous fish when in a 2:1 urea: 
TMAO ratio.  TMAO offsets the favorable interactions between urea and the protein backbone so 
that protein folding is promoted.  In the absence of urea, TMAO precipitates proteins because it 
“overstabilizes” protein folding [67].  Therefore, TMAO requires the presence of a counteracting 
solute like urea to be beneficial.  Trehalose is another example of an “overstabilizing” solute and 
can function with the counteracting solute urea to promote protein homeostasis [55, 68].  In 
conclusion, although compatible osmolytes act as chemical chaperones to different degrees, most 
contribute to protein homeostasis when accumulated to high concentrations, such as during HTS. 
Chemical chaperones are distinct from protein chaperones in three ways.  First, protein 
chaperones bind misfolded proteins in an energetic (ATP-dependent) or regulated process and aid 
in their folding, whereas chemical chaperones promote protein folding by their passive (non-
energetic) exclusion from proteins [69].  Second, protein chaperones are catalytic, allowing them 
to be present in substantially lower concentrations than chemical chaperones and still maintain 
protein homeostasis.  Third, the driving forces for chemical chaperones on protein folding are 
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continuous.  In contrast, protein chaperones act temporarily on proteins and once their interaction 
with the protein is lost, the driving forces for protein misfolding continue to persist [69].  Chemical 
chaperones and protein chaperones therefore both function in protein homeostasis, but the 
mechanisms through which they operate are distinct. 
1.3 Regulation of the osmotic stress response has been well characterized in bacteria, yeast, 
and plants. 
Over the last fifty years, detailed pathways regulating the HTSR in bacteria, yeast, and 
plants have been elucidated primarily through genetic methods.  Specifically, unbiased forward 
genetic screens have been instrumental in the characterization of these pathways.  Forward genetic 
screens are powerful because they allow the organism to reveal what is required for a pathway in 
a physiologically relevant context.  Driven by the success of this approach in other organisms, my 
thesis project takes advantage of the power of unbiased genetic screens and the genetic 
manipulability of C. elegans to characterize the HTSR in an animal system for the first time. 
Despite the evolutionary distance between bacteria, yeast, and plants, all utilize two-
component signal transduction systems to modulate gene expression during HTS.  The prototypical 
two component transduction system consists of a sensor histidine kinase (SHK) and a response 
regulator (RR).  A stimulus is sensed by the input domain of the SHK and this causes auto-
phosphorylation of its histidine kinase catalytic domain.  The phosphoryl group is then transferred 
to the receiver domain of the RR to activate its nuclear translocation and subsequent gene 
regulation [70].  While this is the basic organization of a two-component signal transduction 
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system, more complex variations commonly exist, such as in the HTSR, as is highlighted in the 
subsequent sections. 
1.3.1 Regulation of the osmotic stress response in bacteria 
The bacterial hypo- and hypertonic stress responses are made up of the same general 
themes as that of other organisms.  Bacteria respond to hypotonic stress by rapidly effluxing 
cytoplasmic solutes to relieve cell swelling .  Among the effluxed cytoplasmic solutes are ions and 
the compatible osmolytes proline, glycine betaine, and trehalose [71, 72].  This efflux occurs 
through two mechanosensitive channels: mechanosensitive channel small conductance (MscS) and 
mechanosensitive channel large conductance (MscL) [73-75].  Multiple members of the MscS 
family are expressed in bacteria, archaea, fungi, and plants, while only a single member of the 
MscL family is expressed in bacteria and fungi [76].  Proteins related to MscS are predicted to 
exist in mammals as well [77].  MscS and MscL are large channels that are permeable to molecules 
less than 1000 Da, including proline, potassium, glutamate, trehalose, and ATP [76].  Both 
channels are necessary for an effective hypotonic stress response in bacteria, as loss of their activity 
results in increased sensitivity to hypotonicity and retention of cytoplasmic solutes like potassium 
[75]. 
To date, more is known about the regulation of MscL than MscS.  MscL exists in a closed 
conformation in the plasma membrane under basal conditions [78].  Data from liposomes suggests 
that MscL is activated directly by changes in the lipid bilayer and its activation does not require 
additional proteins [74].  The open conformation of MscL is promoted by both the thinning of the 
lipid bilayer and the increased curvature of the lipid bilayer due to asymmetry in lipid composition 
[79].  However, it is hypothesized that increased curvature of the lipid bilayer is the primary driving 
 
  16 
force for MscL opening because in liposomes, increased bilayer curvature traps MscL in the open 
state, whereas thinning of the lipid bilayer alone is not sufficient to have this effect [79].  MscL 
thus directly senses biophysical changes in the cell caused by hypotonic stress and is itself an 
osmosensor. 
Like the bacterial hypotonic stress response, the bacterial HTSR follows the same themes 
as that of other organisms.  Bacteria respond to HTS with a rapid initial response followed by a 
slower sustainable response.  Cell shrinkage induced by HTS causes the immediate intracellular 
accumulation of potassium via activation of ion transporters to restore cell volume [80].  To 
prevent a shift in membrane potential caused by positively charged potassium, cells synthesize the 
counter-ion glutamate [80].  Within two hours of HTS, intracellular potassium glutamate is 
replaced by intracellular compatible osmolytes.  Specifically, bacteria increase uptake of proline 
and betaine from their environment by upregulating the corresponding transporters [81, 82].  
However, if their environment does not contain proline or betaine, bacteria accumulate 
intracellular trehalose via synthesis [80].  Accumulation of these compatible osmolytes restores 
bacterial cell volume without increasing intracellular ionic strength and thereby provides a 
sustainable adaptive response. 
1.3.1.1 Hypertonicity induced gene expression in bacteria  
Transcriptional regulation is an essential aspect of the HTSR in bacteria.  Osmotically 
induced gene expression is the primary way compatible osmolyte accumulation is regulated during 
the second phase of the HTSR, but it also plays an important role in the initial phase of potassium 
accumulation.  Bacteria have four potassium transporter systems, Kdp, TrkA, TrkD, and TrkF that 
facilitate potassium accumulation during HTSR [83].  Three of the four transporter systems, TrkA, 
TrkD, and TrkF are primarily regulated post-transcriptionally during HTSR to facilitate a rapid 
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influx of potassium [83].  However, the Kdp potassium transport system is genetically regulated 
during HTSR and serves as a backup system if satisfactory potassium levels are not reached by the 
other transport systems [83, 84].  Expression of the Kdp operon (kdpFABC)  is dependent on two 
factors: intracellular potassium levels and a two component signal transduction system [85-89].  
kdp expression is inhibited by increased potassium to prevent its activation in conditions of 
adequate intracellular potassium concentration [85].  The two component signal transduction 
system that also regulates expression of kdpFABC is made of an inner membrane-localized SHK, 
KdpD, and a DNA binding cytosolic RR, KdpE [86].  Both kdpD and kdpE are localized on an 
operon adjacent to the kdpFABC operon [87].  During conditions of HTS and low intracellular 
potassium concentration, KdpD is activated via autophosphorylation to subsequently 
phosphorylate KdpE [88].  Phosphorylated KdpE binds the regulatory sequence upstream of 
kdpFABC to induce its transcription and thereby increase Kdp transporter protein concentration at 
the plasma membrane to facilitate potassium influx [89].  In this way, the Kdp transporter system 
is genetically activated by HTS and fine-tuned by intracellular potassium concentration. 
 In the second phase of the HTSR, bacteria accumulate the compatible osmolytes proline 
and betaine through osmotically regulated gene expression [81, 82].  HTS increases the expression 
of proP and proU, which encode two betaine/proline transport systems [90, 91].  Increased 
intracellular proline and betaine in turn repress transcriptional induction of proP and proU in a 
negative feedback loop [85].  The transcription of proP during HTS is regulated by its P1 promoter 
[92].  During isosmotic conditions, the cAMP receptor protein CRP (CRP-cAMP) binds the ProP 
P1 promoter to repress its transcription [93, 94].  Intracellular potassium glutamate accumulation 
during HTS destabilizes the association between CRP-cAMP and the ProP P1 promoter, allowing 
for its transient transcription [93, 94].  Similarly to ProP, ProU transcription is induced by 
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increased intracellular potassium glutamate concentration during HTS [95-97].  However, unlike 
ProP, ProU can be upregulated in a cell-free, protein-free system by addition of only potassium 
glutamate, suggesting potassium glutamate itself is able to increase proU transcription without any 
protein factors [96].  ProP and ProU genetic upregulation are the primary ways bacteria accumulate 
proline and betaine when these two compatible osmolytes exist in their environment. 
A final example of osmosensitive gene expression in bacteria is the OmpF and OmpC porin 
system.  Both OmpF and OmpC are trimers that form pores in the outer membrane and allow 
passive diffusion of small hydrophilic molecules less than 650 kDa in size [98, 99].  ompC and 
ompF are upregulated during hypertonic and hypotonic stress respectively, but their precise roles 
in these osmotic stress responses remain unknown [100-102].  Despite their unknown 
physiological role, the two component signal transduction system that regulates ompF and ompC 
transcription during osmotic stress has been well characterized.  During HTS, the inner membrane 
localized SHK, EnvZ, undergoes autophosphorylation and subsequently phosphorylates the 
cytoplasmic RR OmpR [103].  Phosphorylation of OmpR causes it to bind the upstream regulatory 
regions of ompC and ompF [104, 105].  OmpR activates the transcription of ompC and represses 
the transcription of ompF [101, 102].  Therefore, OmpC levels are increased during HTS and 
OmpF levels are increased during hypotonic stress.  The OmpC/OmpF system in bacteria is an 
example of how one signal transduction pathway is harnessed to simultaneously regulate two 
proteins in opposing ways. 
1.3.2 Regulation of the osmotic stress response in Saccharomyces cerevisiae  
Of all organisms, the osmotic stress response has been the most thoroughly characterized 
in Saccharomyces cerevisiae (yeast).  Yeast genetics, specifically the power of forward genetic 
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screens, has provided a powerful platform to characterize the regulatory pathways controlling ion 
and compatible osmolyte accumulation and efflux [106-111].  Additionally, yeast utilize one 
compatible osmolyte during osmotic stress - glycerol - which provides a quantifiable readout of 
the stress response [53].   
The hypotonic stress response in yeast has two phases.  In the acute response, cell swelling 
is reversed by efflux of the compatible osmolyte glycerol from the cell via the Fps1p 
aquaglyceroporin [112].  Within three minutes of hypotonic stress, 50% of intracellular glycerol 
is effluxed from wild type (WT) cells.  In contrast fps1p𝛥 mutants take over two hours to remove 
this same amount of glycerol [112].  Furthermore, fps1p𝛥 mutants are unable to survive levels of 
hypotonic stress that 100% of WT yeast are able to tolerate [112].  Therefore, glycerol efflux, 
specifically through the Fps1p aquaglyceroporin, is essential for the initial phase of the hypotonic 
stress response in yeast. 
In addition to compatible osmolyte efflux, yeast respond to hypotonic stress with a slower, 
more sustained response in which they repair cell wall damage caused by cell swelling.  
Specifically, hypotonic stress upregulates och1, which encodes a cis-Golgi localized 
mannosyltransferase [113].  Och1 is required for N-linked glycosylation of secreted and 
transmembrane proteins, a process vital for cell wall maintenance [113].  Failure to maintain cell 
wall integrity is detrimental to subsequent hypotonic challenges as highlighted by pkc1𝛥 mutants, 
which are sensitive to hypotonicity due to an impaired cell wall [114].  Overexpression of the Och1 
pathway in the pkc1𝛥 mutant rescues its hypotonic sensitivity, further suggesting that maintenance 
of cell wall integrity is a critical defense against hypotonic stress [114, 115]. 
Like the hypotonic stress response, the HTSR in yeast is composed of two phases.  In the 
seconds immediately following HTS, yeast increase intracellular ion concentration to counteract 
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cell shrinkage.  Unlike bacteria, which accumulate ions by activating plasma membrane ion 
channels, yeast activate the vacuolar Na+/H+ exchanger Nhx1.  Nhx1 transports sodium into the 
vacuole to maintain cellular water content, without exposing cytoplasmic proteins to high ionic 
strength [116].  Consequently, nhx1𝛥 mutants are slow growing in the initial phase after HTS 
because they are unable to rapidly reverse cell shrinkage [116].  Yeast mutants with a defective 
vacuole also have increased sensitivity to acute HTS, highlighting the importance of the vacuole 
in initial intracellular ion accumulation [107]. 
Another mechanism yeast use to prevent intracellular ion concentration from getting 
destructively high, is to activate the plasma membrane Nha1 Na+/H+ antiporter and Tok1 potassium 
channel [117].  Nha1 and Tok1 mediate the efflux of sodium and potassium respectively to lower 
cytoplasmic ionic strength.  Both these permeability pathways are activated via phosphorylation 
by the p38 MAPK homolog and master osmotic regulator Hog1 [117].  In conclusion, like in 
bacteria, the initial phase of the HTSR in yeast is made up of intracellular ion accumulation, but 
these ions accumulate primarily in the vacuole instead of the cytoplasm.  Yeast fine tune 
cytoplasmic ion concentration via the vacuolar Nhx1 exchanger and the plasma membrane Nha1 
antiporter and Tok1 channel. 
In the hours following HTS, yeast initiate a second phase of the HTSR that facilitates long-
term cellular adaptation.  These adaptive responses depend on transient modulation of gene 
expression.  Over 300 mRNAs are differentially regulated by HTS in yeast.  Among these genes 
are cell cycle progression genes and osmolyte accumulation genes [118-120].  In response to HTS, 
yeast downregulate the cell cycle regulators cln1, cln2, and clb5 and upregulate cln3 to temporarily 
delay the cell cycle in the G1 stage.  Resumption of the cell cycle occurs when cell volume and 
ionic strength are restored to homeostatic set points by intracellular compatible osmolyte 
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accumulation [121].  Specifically, yeast upregulate the glycerol biosynthetic enzyme glycerol-3-
phosphate dehydrogenase (GPD1) to facilitate intracellular accumulation of the glucose metabolite 
glycerol [122].  Genes that increase glycerol synthesis capacity such as glucose transporters and 
glucose metabolic enzymes are also upregulated, but to a lesser extent than GPD1 [118].  
Furthermore, to prevent glycerol efflux during HTS, the aquaglyceroporin Fps1p is closed [112, 
123].  Glycerol accumulation in yeast is essential for survival in hypertonic conditions [122]. 
1.3.2.1 The high osmolarity glycerol mitogen-activated protein kinase pathway in yeast 
ORG expression critical for the yeast HTSR is regulated by the p38 MAPK yeast homolog 
Hog1 [124].  Hog1 was identified almost three decades ago through an unbiased forward genetic 
screen in yeast [106].  This forward genetic screen identified mutants that failed to grow in high 
osmolarity media due to impaired glycerol accumulation.  Both hog1𝛥 and its downstream target 
pbs2𝛥 (originally named hog4𝛥) mutants were picked up in the screen [106].  Not only did this 
genetic screen identify Hog1 as an essential regulator of the HTSR in yeast, but it also defined a 
new class of conserved kinases, the p38 MAPKs.  The discovery of Hog1 led to dozens of 
subsequent forward genetic screens that were ultimately used to characterize the rest of the Hog1 
regulatory pathway and the HTSR (Fig 1.3.1) [106-111]. Therefore, unbiased genetic methods in 
yeast not only led to the characterization a novel osmosensing pathway, but also to the 
identification of a new class of conserved kinases, p38 MAPKs, which are now known to be 
involved in many important cellular processes outside of the HTSR.   
Hog1 regulates ORGs by interacting with several structurally unrelated transcription 
factors [125-128].  For example, upregulation of the glycerol biosynthetic enzyme GPD1 during 
HTS requires a physical interaction between phosphorylated Hog1 and the transcription factor 
Hot1 [128].  Hot1 recruits activated Hog1 to the promoters of osmolyte biosynthetic enzymes such 
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as GPD1 [128].  The recruitment of Hog1 to ORG promoters by osmotically regulated 
transcription factors and the corresponding upregulation of ORGs such as GPD1 is required for 
adaptation to HTS in yeast [108].   
The MAPK pathway that regulates Hog1 has been extensively characterized in yeast.  
Hog1 is regulated by two redundant signaling pathways that converge on Pbs2, a MAPKK and 
direct activator of Hog1 (Fig 1.3.1) [106, 110, 129, 130].  The first branch regulating Hog1 
activation is a complex two component signal transduction system made up of the transmembrane 
hybrid histidine kinase Sln1, the cytoplasmic proteins Ypd1 and Ssk1, and the redundant conserved 
MAPKKKs Ssk2/Ssk22.  During basal isosmotic conditions, Sln1 is activated to undergo 
autophosphorylation [111].  Activated Sln1 transfers a phosphoryl group to the nucleocytoplasmic 
protein Ypd1, which consequently phosphorylates Ssk1 to inactivate it [111].  During HTS, Sln1 
is never activated, causing the active, unphosphorylated, form of Ssk1 to accumulate [110].  
Double dephosphorylated dimers of Ssk1 phosphorylate the redundant MTK1 homologs and 
MAPKKKs Ssk2 and Ssk22, which phosphorylate the MKK homolog and MAPKK Pbs2 [109, 
131].  Phosphorylated Pbs2 in turn binds, phosphorylates, and activates Hog1 [130]. 
In addition to regulating HTS induced gene expression through Hog1, Sln1 also regulates 
hypotonic stress induced gene expression through the transcription factor Skn7 [113].  Intracellular 
accumulation of glycerol by inhibition of the aquaglyceroporin Fps1p activates Sln1 
autophosphorylation and subsequent phosphorylation of Ypd1 [132].  In addition to Ssk1, Ydp1 
has another phosphorylation target: the nuclear transcription factor Skn7 [133].  Phosphorylation 
of Skn7 by Ypd1 activates hypotonic gene expression, such as upregulation of OCH1, the 
mannosyltransferase required for cell wall biosynthesis [113].  Therefore, yeast use the Sln1 - 
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Ypd1 pathway to regulate both Hog1 activation during HTS and Skn7 activation during hypotonic 
stress. 
In addition to the Sln1 pathway, Hog1 activation during HTS is also regulated by the Sho1 
branch, which is redundant to the Sln1 pathway (Fig 1.3.1).  The transmembrane proteins Msb2, 
Hkr1, and Sho1 act as putative osmosensors in this branch of the pathway [134].  Msb2 and Hkr1 
are functionally redundant mucin-like proteins [134].  Sho1 is a scaffolding protein that is also 
considered an osmosensor because it can activate Hog1 in the absence of Msb2 and Hkr1 [135].  
Msb2, Hkr1, and Sho1 sense HTS and recruit the small GTPase Cdc42 to the plasma membrane 
and activate it [136].  The activation of Cdc42 is also dependent on the integral membrane protein 
Opy2 [137].  Activated Cdc42 binds and activates the p21-activated kinases Ste20/Cla4 [138, 139].  
The Cdc42-Ste20/Cla4 complex and Opy2 in turn bind and recruit the MAPKKK Ste11 and its 
complexed protein Ste50 to the plasma membrane via binding to the cytoplasmic domain of Sho1 
[138, 140].  The interaction of all of these proteins at the plasma membrane allows Ste20/Cla4 to 
phosphorylate and activate the MAPKKK Ste11 [141].  Activated Ste11 phosphorylates the 
MAPKK Pbs2, which also binds the cytoplasmic domain of Sho1 [138].  Finally, activated Pbs2 
phosphorylates and activates Hog1 [106, 130].  Therefore, the Sln1 and Sho1 branches converge 
on the MAPKK Pbs2 to activate the MAPK Hog1 (Fig 1.3.1). 
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Figure 1.3.1 The high osmolarity glycerol (HOG) osmosensing pathway in yeast 
The redundant Sho1 and Sln1 MAP kinase pathways converge on Pbs2 to regulate the expression of osmoprotective 
genes in yeast.   
 
Hog1 is phosphorylated by Pbs2 at two sites to activate it and induce its translocation into 
the nucleus, where it regulates gene expression [142, 143].  Both the phosphorylation of Hog1 and 
its catalytic activity are required for its nuclear translocation [144].  In addition to regulating gene 
expression in the nucleus, phosphorylated Hog1 also functions in the cytoplasm to activate the 
Nha1 and Tok1 ion transporters, which mediate efflux of excess sodium and potassium [117].  
After osmotic balance is reestablished, either by a return to isosmotic conditions or by sufficient 
intracellular accumulation of glycerol, Hog1 activity returns to basal levels because the Sln1/Sho1 
pathways are no longer activated and Hog1 is exported from the nucleus [143].  Furthermore, to 
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bring the system back to its original state, Hog1 is dephosphorylated by the type 2C Ser/Thr 
phosphatase family members Ptc1, Ptc2, and Ptc3 and by the protein tyrosine phosphatase family 
members Ptp2 and Ptp3 [145, 146].  The return of Hog1 back to its original state primes it to 
respond to dynamic osmotic conditions. 
The successful identification and characterization of the Hog1 osmosensing pathway in 
yeast illustrates how valuable unbiased forward genetic methods are for dissecting intricate stress 
response pathways.  However, it is still unclear if Hog1-like proteins and homologous signaling 
mechanisms are utilized in animals during hypertonic stress.  In my project, I harness the same 
unbiased genetic methods used to characterize the yeast Hog1 pathway to identify HTSR signaling 
pathways in the multicellular animal C. elegans.  Just as the discovery of Hog1 was not only 
important to the yeast HTSR, but also to the characterization p38 MAPKs, my research may yield 
protein functions and paradigms important to areas of biology outside of the animal HTSR. 
1.3.3 Regulation of the osmotic stress response in plants 
Conditions that plants face commonly in nature, such as drought and increased soil salinity, 
induce osmotic stress that is detrimental to plant survival [147].  Plants have therefore evolved 
elaborate adaptive responses to osmotic stress.  Unlike bacteria and yeast, the multicellularity of 
plants allows them to compartmentalize the osmotic stress response to distinct tissues [148].  
Although this compartmentalization contributes to the complexity of the osmotic stress response 
in plants, the fundamental processes plants use are similar to bacteria and yeast. 
During hypotonic stress, caused for example by increased rain, plants counteract cell 
swelling in an analogous way to bacteria.  Like bacteria, plants express homologs of MscS that 
facilitate the efflux of solutes during hypotonic stress [149].  Knockout of MscS channels in 
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Arabidopsis results in persistent cell swelling that can be rescued by increasing extracellular 
osmolarity [150]. 
Plants also exhibit similarity with other organisms, specifically yeast, in the mechanisms 
they use to respond to HTS.  Immediately following HTS, Arabidopsis thaliana sequesters sodium 
in the vacuole via the Na+/H+ antiporter AtNHX1.  AtNHX1 is a functional homologue of Nhx1 
in yeast and is expressed in the root, shoot, leaf, and flower tissues of Arabidopsis [151].  Vacuolar 
sodium sequestration increases intracellular ion concentration and thus water content without 
exposing cytoplasmic proteins to high ionic strength.  Overexpression of AtNHX1 in Arabidopsis 
confers resistance to HTS, supporting its role in the HTSR [151].  Like yeast, plants also efflux 
sodium from the cytoplasm to fine tune intracellular ion concentration during HTS.  SOS1 is the 
plasma membrane localized Na+/H+ antiporter through which sodium is extruded.  SOS1 is 
genetically upregulated in root and shoot tissue during HTS and mutations that affect its function 
lead to HTS sensitivity [152].  Within a few hours of HTS, plants, like all organisms, accumulate 
compatible osmolytes to maintain cell volume.  Due to the diversity of plant metabolisms and 
environmental conditions, plants use a variety of compatible osmolytes including proline, glycine 
betaine, mannitol, glucose, and fructose [153-155]. 
Osmolyte accumulation is genetically regulated in plants.  There are several signaling 
pathways that regulate hypertonic induced gene expression including osmolyte accumulation 
genes [156].  Most, but not all, of these signaling pathways are dependent on the stress-signaling 
hormone abscisic acid (ABA) [156, 157].  ABA is accumulated by plants in all tissues during HTS 
in response to decreased cell volume and turgor pressure [158, 159].  However, the proteins that 
sense these cell changes and activate ABA accumulation have not been identified.   
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ABA is synthesized by aldehyde oxidases, but none of the aldehyde oxidases have 
increased activity or protein levels during HTS [160].  Instead, an upstream cleavage step carried 
out by 9-cis-expoxycartenoid dioxygenases (NCED) is the rate-limiting step in ABA synthesis 
[161].  NCED3 is transcriptionally upregulated within fifteen minutes of plant dehydration [162, 
163].  Correspondingly, overexpression of NCED3 in Arabidopsis increases ABA abundance and 
HTS tolerance [162].  After osmotic homeostasis is achieved, ABA is catabolized to an inactive 
form by oxidation or conjugation.  A key part of this catabolism pathway includes the ABA 8’-
hydroxylases CYP707As [164].  CYP707A3 is transcriptionally upregulated within thirty minutes 
of the reestablishment of osmotic homeostasis and knockout of CPY707A3 results in the retainment 
of high ABA levels after recovery from HTS [165].  Retainment of ABA in cpy707a3 mutants 
likely makes them less sensitive to subsequent HTS [165].  Dynamic ABA accumulation is 
therefore required for osmotically regulated gene expression in plants and facilitates survival 
during HTS [166]. 
AREB/ABF transcription factors are activated during HTS in an ABA dependent manner.  
AREB/ABF transcription factors regulate the expression of many ORGs, including the 
upregulation of compatible osmolyte accumulation genes [167].  Knockout or inactivation of 
AREB/ABF transcription factors results in defective ABA accumulation, osmotically induced 
gene expression, proline accumulation, and growth during HTS [167, 168].  ABA activates 
AREB/ABF transcription factors through a well-characterized pathway.  ABA binds the 
PYR/PYL/RCAR family of steroidogenic acute regulatory protein–related lipid–transfer (START) 
domain-containing soluble receptors [169].  When bound to ABA, these receptors inhibit protein 
phosphatase 2Cs (PP2Cs).  PP2Cs normally inhibit SNF1-related protein kinase 2s (SnRK2s), but 
because ABA inhibits PP2Cs, SnRK2s become activated during HTS [169-171].  Active SnRK2s 
 
  28 
in turn phosphorylate and activate AREB/ABF transcription factors, which bind G-box-like-cis-
acting elements called ABA-responsive elements (ABREs) in the promoters of target genes [172, 
173]. 
Not all osmotically induced genes have ABREs.   Some genes, like the osmotically 
protective BURP domain (named for its four members: BNM2, USP, RD22, and PG1β) protein 
RD22, are upregulated in an ABA-dependent, AREB/ABF-independent manner [174].  RD22 is 
upregulated by the basic helix-loop-helix (bHLH)-related MYC2 and MYB-related MYB2 
transcription factors via MYC and MYB recognition sites in its promoter [174].  Overexpression 
of MYC2 and MYB2 increases RD22 expression to facilitate the maintenance of chlorophyll 
integrity during HTS [174, 175].  In addition to ABA-dependent gene expression, the MYC2 
transcription factor regulates several other plant hormone signaling pathways, such as those 
involved in plant defense and development [176].   
Although most hypertonicity induced gene expression in plants is ABA dependent, there 
are also key ABA-independent pathways [156].  The CBF/DREB1/DREB2 transcription factors 
are activated during HTS in plants in an ABA-independent manner to regulate osmotically induced 
gene expression [177].  These transcription factors bind C-repeat (CRT)/dehydration-responsive 
elements (DREs) in genes to upregulate them [178].  Overexpression of CBF/DREB1/DREB2 
transcription factors results in increased drought (HTS) tolerance, suggesting that the upregulation 
of key osmoprotective genes are dependent on this pathway [179].  
Additionally, a yeast-like two component signal transduction system has been identified in 
plants that activates hypertonicity induced gene expression.  AtHK1 was identified in Arabidopsis 
as a transmembrane hybrid histidine kinase similar to Sln1 in yeast [180].  Like Sln1, AtHK1 is in 
an active state during isosmotic conditions and in an inactive state during hypertonic conditions 
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[180].  In fact, AtHK1 can activate Hog1 in sln1𝛥 sho1𝛥 mutant yeast, supporting it functional 
conservation with Sln1 [180].  AtHK1 may function upstream of AREB/ABF and 
CBF/DREB1/DREB2 transcription factors, because AtHK1 mutants fail to activate these 
transcription factors and the upregulation of their downstream gene targets to the same extent as 
WT plants [181]. 
1.3.4 Conclusions 
In conclusion, regulation of the osmotic stress response in bacteria, yeast, and plants has 
been extensively genetically characterized over the last several decades.  Such genetic analyses 
are more challenging to execute in most animals, including mammals.  Therefore, genetic 
dissection of these osmotically induced pathways in animals has remained largely incomplete.  The 
objective of my research project is to fill this gap in knowledge using the genetically amenable 
small animal C. elegans to identify key components of HTSR regulatory pathways.  Similar to the 
examples just discussed for bacteria, yeast, and plants, my research uses unbiased genetic 
screening approaches to characterize proteins, mechanisms, and eventually pathways required for 
activation of the metazoan HTSR. 
1.4 Regulation of the osmotic stress response in mammals 
Like bacteria, yeast, and plants, mammals respond to osmotic stress with a cellular adaptive 
response to counteract cell volume and intracellular ionic strength changes.  However, unlike these 
other organisms, mammals regulate their extracellular fluid (ECF) osmolarity systemically in 
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addition to cellularly.  Mammals maintain their ECF osmolarity within a tight range.  Although 
there is slight variation among species, all mammals have an ECF osmolarity around 300 mosmol 
kg-1 under normal conditions [182].  Even small deviations (< 10%) in osmolarity can have 
detrimental consequences to sensitive tissues like the brain [183].  Simple acts such as strenuous 
exercise in the heat or increased sodium intake can acutely increase plasma osmolarity 1-3% [184, 
185].  Therefore, mammals have evolved sophisticated mechanisms to systemically regulate 
osmolarity.  Moreover, mammalian tissues are capable of responding to osmotic stress at the 
cellular level.  These cellular osmotic stress responses are most relevant to tissues that experience 
physiological osmotic fluctuations, such as the kidney, and during diseases that affect systemic or 
tissue osmolarity, such as hyper- and hyponatremia.  The following section will focus on systemic 
osmoregulation in mammals, while the subsequent section with focus on cellular osmoregulation 
in mammals.  The two primary pathways regulating systemic plasma osmolarity in mammals are 
the vasopressin – AQP2 and renin-angiotensin-aldosterone signaling axes.  
1.4.1  The vasopressin – AQP2 axis and the renin – angiotensin – aldosterone axis regulate 
systemic plasma osmolarity in mammals  
Mammals sense systemic plasma osmolarity in two areas of the brain: the organum 
vasculosum of the lamina terminalis cells (OVLTs) in the AV3V region and the magnocellular 
neurosecretory cells (MNCs) in the supraoptic nucleus of the hypothalamus [185-187].  OLVTs 
and MNCs are unique among mammalian cells because they are the only cells that do not counter 
osmotically-induced changes in cell volume with adaptive mechanisms.  Instead the volume of 
these cells changes proportionally to the ECF osmolarity and this allows them to sense systemic 
osmotic changes [188, 189].  Specifically, decreased cell volume leads to increased nonselective 
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cation channel conductance, membrane depolarization and activation of OLVTs and MNCs [187, 
189-192].  Cell volume changes and not intracellular ionic strength changes activate OLVTs and 
MNCs because decreasing OLVT or MNC cell volume with suction or negative pressure is 
sufficient to activate these neurons [189, 193].   
The transient receptor potential vanilloid type-1 (TRPV1) channel is proposed to be the 
osmosensing entity in OLVTs and MNCs.  When the TRPV1 channel is knocked out or 
inactivated, the volume of OLVTs and MNCs still decreases with increasing ECF osmolarity, but 
nonselective cation conductance, membrane potential, and action potential firing rate are not 
increased in these cells [189, 190, 194].  Thus the TRPV1 channel is required for OLVT and MNC 
activation.  In particular an intact microtubule-TRPV1 interaction is required for hypertonic 
activation of MNCs [195].  Activated OLVTs and MNCs facilitate water reabsorption in the kidney 
via the hormone vasopressin to correct systemic hypertonic plasma [196-199]. 
The antidiuretic hormone, vasopressin, is synthesized in MNCs [196-199].  There are at 
least three stimuli that modulate the synthesis of vasopressin.  First, as discussed above MNCs 
directly sense increases in ECF osmolarity and synthesize vasopressin in response to cell shrinkage 
[187, 198, 199].  Second, the osmosensitive OLVT neurons can activate MNCs.  OLVT neuronal 
axons project into the supraoptic nucleus and increase the firing rate of MNCs when they become 
activated by increased ECF osmolarity [200].  Third, astrocytes surrounding MNCs release the 
compatible osmolyte taurine in an osmolarity dependent manner [201].  Taurine binds inhibitory 
glycine receptors on MNCs to inactivate them.  Hypertonic ECF inhibits taurine release from these 
astrocytes and this promotes the activation of MNCs [201, 202]. 
After vasopressin synthesis, MNCs package vasopressin molecules into large dense core 
vesicles that are subsequently transported to axon terminals [198].  These MNC axon terminals 
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project into the posterior pituitary, allowing vesicles filled with vasopressin to be exocytosed into 
fenestrated capillaries [203-205].  Exocytosis of vasopressin is calcium dependent and driven by 
MNC action potentials initiated in the soma [206].  Following release into the blood stream, 
vasopressin binds V2 G-protein coupled receptors on the basolateral side of principal cells in the 
renal collecting duct of the kidney [207, 208].  Binding of vasopressin to V2 receptors leads to 
adenylyl cyclase activation, increased cyclic AMP concentration and activation of protein kinase 
A (PKA) [20, 207, 209].  Activated PKA phosphorylates AQP2 and increases its translocation to 
the apical membrane [20, 209].  Increased AQP2 at the apical membrane in turn increases water 
reabsorption by the collecting duct to correct systemic hypertonic ECF [20]. 
In contrast to the vasopressin – AQP2 axis, which is activated by increased systemic ECF 
osmolarity, the renin-angiotensin-aldosterone (RAA) signaling axis is activated by decreased 
plasma volume [210].  The RAA signaling axis responds to decreased plasma volume and 
functions to increase sodium reabsorption in the collecting duct of the kidney via the hormone 
aldosterone and regulators angiotensin I and II [211].  Low salt intake activates the proteolytic 
cleavage of angiotensinogen by the enzyme renin to form angiotensin I [212, 213].  Renin is 
synthesized, stored, and secreted from juxtaglomerular cells of the kidney and angiotensinogen is 
secreted into circulation by liver cells [214].  Angiotensin I is subsequently converted to 
angiotensin II by angiotensin-converting enzyme (ACE).  ACE is secreted into circulation by both 
kidney and lung cells [215].  Angiotensin II binds type I receptors (AT1) in the zona glomerulosa 
of the adrenal gland to stimulate aldosterone secretion [216-220].  To promote sodium reabsorption 
in the kidney, aldosterone binds the mineralocorticoid receptor (MR) in the cortical collecting duct 
of the kidney [221].  Binding of aldosterone to MR increases the number of epithelial sodium 
channels (ENaC) in the apical membrane of principal renal collecting duct cells and increases 
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ENaC transcription [222-224].  ENaC facilitates sodium reabsorption in the kidney [223].  In this 
way, aldosterone increases plasma volume and ECF osmolarity in response to systemic hypotonic 
stress. 
1.4.2 The cellular response to osmotic stress in mammals 
Even though mammals tightly regulate systemic ECF osmolarity, all mammalian cells, 
with the exception of OLVTs and MNCs, have the capacity to respond to osmotic stress at the 
cellular level.  This cellular response allows mammalian cells to survive during diseases in which 
systemic osmoregulatory mechanisms are unable to reestablish osmotic homeostasis, such as 
during hypernatremia, or in tissues that require drastic osmotic fluctuations for normal function, 
such as in the kidney.  Similarly to bacteria, yeast, and plants, the cellular HTSR in mammals 
consists of an initial regulatory volume increase phase followed by a slower osmolyte 
accumulation phase.  Although the transcription factor Nuclear Factor of Activated T Cells 5 
(NFAT5)/Tonicity-Responsive Enhancer Binding protein (TonEBP) has been identified as a 
master regulator of the HTS response in mammals, the osmosensing pathways upstream of 
NFAT5, including the osmosensor that activates NFAT5, has not been fully characterized [49, 
225].  Furthermore, NFAT5 is not conserved in all metazoans, which indicates there may be more 
ancient NFAT5-independent HTSR regulatory mechanisms.  Therefore, much about the precise 
signaling pathways that sense and initiate ORG expression in animals still remain elusive.  My 
thesis project seeks to fill these gaps in knowledge by studying ORG expression in C. elegans.  
Since C. elegans do not express a homolog of NFAT5, it provides a platform from which to 
investigate NFAT5-independent mechanisms regulating ORG expression.  Additionally, C. 
elegans provides powerful genetic means to identify conserved osmosensitive signaling pathways 
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upstream of NFAT5-dependent or -independent gene expression.  Through the use of C. elegans, 
my objective is to characterize conserved regulatory mechanisms governing the HTSR in animals.  
1.4.2.1 Regulatory volume increase in mammals   
The initial response to HTS in mammalian cells, like in other organisms, is a rapid influx 
of ions to counteract cell shrinkage.  Within thirty seconds of HTS induction by 500 mM sorbitol 
or sodium chloride, mammalian cells activate the lysine deficient protein kinase 1 (WNK1) by 
autophosphorylation [226].  WNK1 subsequently phosphorylates the Ste20/SPS1-related 
proline/alanine-rich kinase (SPAK) and the oxidative stress responsive kinase 1 (OSR1) [227, 
228].  Activated SPAK and OSR1 phosphorylate the Na-K-Cl cotransporter NKCC1, which 
mediates the influx of sodium to correct cell shrinkage [47, 48, 229]. 
WNK1 activation peaks around two minutes following HTS and is sustained for up to 
eighty minutes [226].  Although the specific mechanisms by which HTS activates WNK1 are not 
well understood, two key observations have provided clues about its regulation.  First, WNK1 
activation has been shown to occur independently of the three canonical mammalian MAPK 
signaling pathways, classical MAPK (ERK), C-Jun N-terminal kinase (JNK), and p38, which 
commonly regulate stress responsive signaling pathways [226].  Second, HTS causes diffuse 
cytoplasmic WNK1 to condense into reversible membraneless liquid droplets [230].  These 
condensates may colocalize with clathrin and the trans-Golgi network [226].  Formation of these 
phase separated WNK1 structures trigger activation of the WNK1/SPAK/OSR1/NKCC1 pathway 
[230].  Furthermore, optogenetic experiments have demonstrated that it is specifically molecular 
crowding caused by HTS induced cell shrinkage that promotes WNK1 puncta formation [230].  
Therefore, WNK1 is intrinsically sensitive to HTS and may itself serve as the osmosensor required 
to activate NKCC1 and correct cell shrinkage.  
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In addition to mammals, the WNK1 pathway is required for acute cell volume recovery in 
other organisms, such as C. elegans [231].  C. elegans have a single SPAK-like protein, GCK-3, 
which is required for acute volume recovery and survival during HTS.  gck-3 mutants exhibit 
greater shrinkage and reduced volume recovery during HTS compared to WT animals [231].  
Furthermore, GCK-3 interacts physically with WNK-1 in C. elegans and wnk-1 mutants have a 
qualitatively similar HTS sensitivity as gck-3 mutants.  Genetic epistasis experiments indicate that 
WNK-1 and GCK-3 function in the same HTSR pathway in C. elegans, like they do in mammals 
[231].  The evolutionary conservation of the hypertonicity induced WNK1 pathway highlights the 
importance of acute volume recovery in the HTSR.  
1.4.2.2 Intracellular compatible osmolyte accumulation in mammals 
Within a few hours of HTS, intracellular ions accumulated during the acute phase of the 
HTSR are replaced with compatible osmolytes [232].  As discussed previously, the intracellular 
accumulation of compatible osmolytes protects cells against HTS - induced shrinkage, without 
increasing intracellular ionic strength.  Therefore compatible osmolytes enable a long-term 
adaptive strategy for cells in hypertonic environments.  In mammals, each cell type accumulates a 
different combination of compatible osmolytes during HTS.  For example, renal medullary cells 
accumulate sorbitol, glycine betaine, myo-inositol, taurine, and glycerophosphocholine (GPC) 
[233].  The brain accumulates myo-inositol, glutamate, glutamine, taurine, and creatine [32].  Liver 
endothelial cells accumulate glycine betaine, myo-inositol, and taurine [234].  Since compatible 
osmolytes are often interchangeable in their protection during HTS, it is not completely understood 
why different mammalian cells accumulate different compatible osmolytes.  One hypothesis is that 
a cell’s metabolism and/or extracellular matrix (ECM) composition determine which compatible 
osmolytes it uses [51]. 
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Five of the most common compatible osmolytes found in mammals are sorbitol, betaine, 
myo-inositol, taurine, and GPC.  Sorbitol is accumulated intracellularly during HTS via increased 
synthesis.  HTS activates upregulation of aldose reductase, which catalyzes the rate-limiting step 
of sorbitol synthesis from glucose [235, 236].  In contrast to sorbitol, myo-inositol is accumulated 
intracellularly via increased transport from the ECF.  The source of this myo-inositol is either diet 
or lipid degradation pathways [237].  HTS increases transcription of the sodium myo-inositol 
transporter (SMIT), which couples import of myo-inositol to the concentration gradient of sodium 
[236, 238, 239].  Like myo-inositol, taurine and betaine are accumulated intracellularly via 
transport from the ECF.  The primary source of both these compatible osmolytes is dietary [240, 
241].  HTS increases transcription of the taurine transporter (TAUT) and the betaine/GABA 
transporter 1 (BTG1), which couple taurine and betaine import to the sodium and chloride 
concentration gradients respectively [236, 242-245].  Finally, GPC is accumulated intracellularly 
by both increased synthesis and decreased breakdown of phosphatidylcholine.  HTS increases 
transcription of the enzyme that synthesizes GPC, neuropathy target esterase (NTE), and decreases 
transcription of the enzyme that breaks down GPC, GPC-choline-phosphodiesterase (GDPD5) to 
cumulatively increase GPC accumulation [52, 246-248].  Importantly, the genetic regulation of all 
these osmolyte accumulation genes is regulated by the transcription factor NFAT5 [49, 236, 243]. 
1.4.2.3 NFAT5 regulates protective gene expression during hypertonic stress in mammals 
NFAT5, part of the Rel family of transcriptional activators, is a master regulator of 
osmotically regulate gene (ORG) expression in mammals [225].  Mammalian kidney cells, 
specifically those in the inner medulla of the kidney are routinely exposed to ECF osmolarities of 
almost six times normal plasma osmolarity [249].  NFAT5 plays a critical role in kidney cells to 
regulate the expression of over one hundred ORGs, including compatible osmolyte accumulation 
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genes, under physiological conditions [236].  Importantly, NFAT5 is expressed and functions in 
most cell types, not just those of the kidney [250].  Many tissues can experience changes in the 
osmolarity of their micro-environment and therefore require NFAT5 -dependent hypertonic 
adaptive pathways [251]. 
NFAT5 is required both in vitro and in vivo for ORG upregulation [49, 252].  Knockout of 
NFAT5 in cell culture impairs the upregulation of ORGs, including osmolyte accumulation genes 
[236].  Correspondingly, in response to HTS, WT cells increase NFAT5 protein levels four-fold 
and increase NFAT5 nuclear accumulation ten-fold to upregulate ORG expression [250].  Under 
isotonic conditions NFAT5 is equally distributed in the cytoplasm and nucleus [250].  Supporting 
the in vitro NFAT5 observations, NFAT5 is activated in the inner medulla of the mouse kidney 
during dehydration [253].  Unlike in cell culture, in vivo activation of NFAT5 consists only of 
NFAT5 nuclear enrichment and not of increased NFAT5 protein expression [253].  Homozygous 
NFAT5 null mice exhibit decreased upregulation of ORGs, including compatible osmolyte 
accumulation genes, during dehydration-induced HTS [49].  This decreased ORG upregulation 
manifests itself physiologically by primarily affecting the kidney because this tissue experiences 
large osmotic variations.  NFAT5 null mice have kidney hypoplasia, altered medullary 
morphology, and increased apoptosis of inner medullary cells [49].  NFAT5 is therefore a critical 
architect of the HTSR in mammalian cells. 
Compatible osmolyte accumulation genes make up an important portion of NFAT5-
dependent ORGs.  As mentioned previously, NFAT5 regulates the hypertonicity-induced 
expression of enzymes responsible for compatible osmolyte accumulation such as aldose 
reductase, SMIT, TAUT, and NTE.  However, NFAT5 also regulates dozens of other genes 
induced by HTS  [236].  It is the cumulative effect of all these genes that protects cells from HTS.  
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Several heat shock proteins (HSPs), such as HSP70, αB-crystallin, a HSP40 called HLJ1, and 
HSP110 members Osp94 and HSP105B are upregulated as part of the HTSR in an NFAT5-
dependent manner [254-258].  These heat shock proteins collectively function to protect cells from 
protein damage caused by high intracellular ionic strength.  Also among the genes that NFAT5 
induces the transcription of is AQP2.  Whereas vasopressin is required for acute activation of 
AQP2 in systemic osmoregulation, NFAT5 is required for increased AQP2 expression after 
twenty-four hours of HTS to maintain water reabsorption in the collecting duct [259].  
Interestingly, there are also several genes that are upregulated in an NFAT5-independent manner 
during HTS.   The mechanism by which these genes are upregulated is not known [236]. 
NFAT5 target genes have at least one DNA motif called an osmotic response element 
(ORE) or tonicity enhancer element (TonE) in their promoter [260, 261].  The sequence of the 
consensus ORE/TonE is (A/C/G/T)GGAAA(A/T) (A/G/T)(A/C/T)(A/C)C(A/C/G/T) [261].  
Binding of NFAT5 to OREs/TonEs does not require phosphorylation because NFAT5 treated with 
calf intestinal phosphatase binds ORE/TonE DNA elements in binding assays [262]. 
As with all transcription factors, NFAT5 functions in the nucleus to activate ORG 
upregulation.  Even though binding of NFAT5 to OREs/TonEs does not require phosphorylation, 
nuclear translocation of NFAT5 is regulated by hypertonicity-induced phosphorylation.  The 
kinetics of NFAT5 phosphorylation during HTS correlate temporally with NFAT nuclear 
localization [262].  Since NFAT5 is too big to diffuse in and out of the nucleus, nuclear 
translocation of NFAT5 requires an N-terminal nuclear localization signal and an auxiliary export 
domain [263].  One way phosphorylation of NFAT5 may facilitate its nuclear localization is by 
exposing these nuclear localization domains to nuclear import machinery.   
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Ataxia telangiectasia-mutated kinase (ATM) is partially required for the nuclear 
translocation of NFAT5 [264].  However it is unclear whether ATM directly phosphorylates 
NFAT5 because consensus ATM phosphorylation sites have not been identified in the portion of 
NFAT5 required for ATM regulation [264].  Nevertheless, cells without ATM have reduced 
nuclear enrichment of NFAT5, suggesting that ATM directly or indirectly regulates NFAT5 
nuclear enrichment [264].  Since NFAT5 nuclear localization is not completely eliminated in ATM 
null cells, other unknown factor(s) are also required for NFAT nuclear translocation [264]. 
In addition to phosphorylation and nuclear localization, activation of NFAT5’s three 
transactivation domains stimulates ORG upregulation.  The transactivation domains of NFAT5 
mediate interactions between NFAT5 and its activators to induce gene expression.  As ECF 
hypertonicity increases, the activity of one of NFAT5’s three transactivation domains increases 
and this is dependent on several regulators [265].  Although these regulators are each required for 
full activation of NFAT5, none of them is alone sufficient to activate NFAT5 [266].  Furthermore, 
there is a lack of direct evidence that many of these regulators interact with NFAT5 [267].  
Therefore, although the role of NFAT5 in the mammalian HTSR has been studied for over twenty 
years, a comprehensive genetic characterization of the regulatory pathways upstream of NFAT5, 
if such pathways exist, has remained elusive. 
There are at least five kinases that have been implicated in NFAT5 regulation via its 
transactivation domain.  Inhibition of the cAMP-dependent PKA,  p38 MAPK, Src tyrosine kinase 
Fyn, ATM, or phosphoinositide 3-kinase IA (PI3K-IA) decreases the transactivation activity of 
NFAT5 and upregulation of ORGs during the HTSR [265, 268-270].  All five of these kinases are 
activated by HTS, suggesting they may act upstream of NFAT5 [124, 265, 270-272].  However, 
only PKA and ATM have been shown via coimmunoprecipitation to physically interact with 
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NFAT5 either directly or indirectly [269].  Furthermore, ATM and PI3K-IA are the only two 
kinases that have been suggested to function together to regulate hypertonic activation of NFAT5.  
Knockout of PI3K-IA decreases NFAT5 activation in an ATM dependent manner [270].  
Therefore it is likely that multiple parallel pathways involving these kinases regulate NFAT5 
activation during the HTSR. 
While study of NFAT5 activity has proven to be an important tool for characterizing 
regulation of the HTSR in mammals, it has not led to a detailed understanding of the pathway.  
Despite decades of study, significant work is still required to dissect apart the pathways regulating 
NFAT5 activity, understand the requirement for seemingly redundant pathways, and identify the 
osmosensor(s) that activate these pathways.  These studies may be limited due to possible genetic 
redundancy, NFAT5-independent pathways, and the absence of in vivo context in cell culture.  My 
project seeks to address these limitations and study regulation of the HTSR using a fundamentally 
different approach that does not rely on NFAT5 activity.  Instead, I use unbiased genetic 
approaches in C. elegans to characterize pathways regulating the HTSR.  Such approaches allow 
for investigation of the HTSR in an in vivo context and have the potential to offer new perspectives 
on the HTSR [273].    
1.4.3 Physiological exposure of mammalian cells to osmotic stress 
All mammalian cells, with the exception of osmosensing neurons, are able to detect HTS 
and initiate protective ORG expression [250, 251, 267].  However, due to systemic 
osmoregulation, only some cells are routinely exposed to HTS under physiological conditions 
[251, 267].  Cells in the inner medulla of the kidney are exposed to the most drastic osmotic 
fluctuations in mammals.  Cells at the tip of the renal inner medulla are commonly exposed to 
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osmolarities of up to 1,744 mosmol kg-1, in contrast the plasma osmolarity of about 300 mosmol 
kg-1 [249].  Hypertonic ECF in the inner medulla is a normal part of kidney physiology, as it drives 
water reabsorption in the collecting duct during antidiuresis.  Depending on the state of diuresis, 
kidney cells are therefore routinely exposed to large fluctuations in ECF osmolarity and must 
modulate expression of protective genes, including osmolyte accumulation genes to survive and 
adapt [41]. 
Other mammalian cells that are exposed to HTS under physiological conditions include 
cells in lymphoid tissues and the liver [251].  Both liver and lymphoid tissues have high metabolic 
activities and cell densities, two factors that increase hypertonicity of the ECF [251].  Cells in the 
thymus and spleen can be exposed to ECF osmolarities of up to 330 mosmol kg-1 [251].  Partial 
loss of NFAT5 activity impairs lymphocyte function supporting a critical role of NFAT5 in the 
adaptation of lymphocytes to hypertonic environments [251]. 
1.4.4 Pathophysiological exposure of mammalian cells to osmotic stress 
Mammalian cells are also exposed to osmotic stress during disease.  In certain mammalian 
diseases, such as hypernatremia, hyponatremia, and ischemia reperfusion injury, systemic 
regulation of ECF osmolarity and the cellular HTSR are insufficient to avoid acute cellular and 
tissue damage due to osmotic stress.  Hypernatremia is a condition in which plasma osmolarity is 
hypertonic due to a net water loss or sodium gain [274].  Chronic hypernatremia is caused 
gradually over several days and is most common in infants and elderly people because they miss 
or are unable to communicate early symptoms [274, 275].  Diarrhea and thirst 
impairment/dehydration are the most common causes of hypernatremia in infants and the elderly 
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respectively.  However, hypernatremia can also be a side effect of other diseases such as Cushing’s 
syndrome, Guillain-Barre syndrome, and diabetes insipidus [274]. 
The symptoms of hypernatremia correlate in severity with how quickly plasma osmolarity 
is changed.  The brain is the most susceptible organ to hypernatremia because hypernatremia 
causes brain shrinkage [274, 276, 277].  Although brain cells adapt quickly to HTS by 
accumulating compatible osmolytes, rapid and drastic increases in hypertonicity, as seen in 
hypernatremia, can overwhelm these adaptive responses [274, 276].  Correspondingly, most 
symptoms of hypernatremia are neurological [274, 277].  These symptoms start with lethargy and 
irritability and progress to muscle rigidity, tremors, seizures and eventually death if plasma 
hypertonicity is not corrected [274].  The treatment for hypernatremia is a slow administration of 
hypotonic fluids.  Hypotonic fluids decrease plasma hypertonicity.  However, because compatible 
osmolytes accumulated intracellularly in the brain take up to two days to return to normal levels, 
rapid administration of hypotonic fluids can cause cerebral edema, which leads to convulsions, 
coma and even death [275, 278].  Therefore, hypernatremia, especially in severe cases in which 
plasma osmolarity exceeds 377 mosmol kg-1, requires slow, monitored correction [277]. 
In contrast to hypernatremia, hyponatremia is characterized by hypotonic plasma due to 
excess water intake or reduced sodium intake [279].  Hyponatremia is the most common cause of 
brain swelling [279].  It is most frequently caused by psychotic polydipsia (excessive water intake 
that is most common in psychiatric patients), renal failure, use of thiazide diuretics, osmotic 
diuresis, and inappropriate secretion of vasopressin due to a head trauma, brain tumor, or 
cerebrovascular accident [279].  The first symptoms of hyponatremia are brain swelling, 
depression of sensorium, and seizures [280].  Acute hyponatremia results in death in over half of 
cases because ECF hypotonicity progresses quicker than the ability of the brain to mount an 
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adaptive response [280].  However, chronic, slow onset, hyponatremia rarely leads to death or 
symptoms, because brain cells have time to efflux ions and compatible osmolytes to reestablish 
osmotic homeostasis [32, 280].  Following the same principles of hypernatremia, hyponatremia is 
corrected via the slow infusion of hypertonic saline [281].  If hypertonic saline is administered too 
rapidly, brain dehydration resulting in demyelinating brain lesions and a 40% death rate occurs 
[282].  Therefore, like hypernatremia, hyponatremia requires a deliberate, slow correction to 
appropriately leverage the osmotic stress response to restore homeostasis. 
Finally, another common cause of osmotic stress in mammals is ischemia reperfusion 
injury.  Ischemia reperfusion injury is caused by insufficient blood supply to an organ, most 
commonly the heart, kidneys, lung, and brain [283].  Strokes and myocardial infarction are 
examples of conditions that cause ischemia reperfusion injury [283]. Unlike hypernatremia and 
hyponatremia, which are caused by anisosmotic osmotic changes, ischemia reperfusion injury is 
caused by isosmotic cell volume changes.  Insufficient blood supply to an organ causes a switch 
from aerobic to anaerobic metabolism in the affected tissues and this leads to Na+/K+-ATPase 
failure due to decreased ATP production [284, 285].  Failure of the Na+/K+-ATPase triggers a loss 
in the transmembrane ionic gradient because sodium is no longer pumped out of the cells.  The net 
result is increased intracellular sodium concentration, which results in hypotonic stress-induced 
cell swelling [286]. 
The swelling of endothelial cells during ischemia blocks small blood vessels and causes 
“no-reflow” after reperfusion of the affected tissue.  Thus, even when blood supply to the affected 
tissue is fixed, blood is still unable to access cells in the tissue because of endothelial cell swelling 
[287].  Ischemia reperfusion injury can be avoided by exposing affected cells to acute HTS to 
decrease cell swelling.  This is most effectively done with mannitol or glucose injections [288]. 
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1.4.5 Conclusions 
Mammalian organisms, unlike bacteria, yeast, and plants, maintain a systemic plasma 
osmolarity of about 300 mosmol kg-1 via the vasopressin and aldosterone hormone signaling 
pathways.  However, individual mammalian cells still maintain the ability to respond and adapt to 
osmotic stress and this is critical for their survival.  Cells such as those in the kidney, lymphoid 
tissues, and liver are routinely exposed to HTS and all cells are exposed to osmotic stress during 
diseases in which systemic osmotic regulation is insufficient to maintain ECF osmolarity.  While 
the transcription factor NFAT5 has emerged as a key regulator of the cellular HTSR in mammals, 
much remains unknown about its regulation.  Specifically, it remains elusive how mammalian cells 
sense HTS, how these osmosensitive signals are transmitted to the kinases upstream of NFAT5, 
and if there are NFAT5-independent mechanisms cells use to regulate ORG expression.  My thesis 
project will address these unknowns using the invertebrate animal C. elegans.  
1.5 C. elegans provides a powerful in vivo model system to study genetic regulation of the 
hypertonic stress response 
C. elegans is a multicellular transparent small nematode that was first cultivated for 
laboratory research by Sydney Brenner in the 1970s [289].  Brenner was interested in mapping out 
the structure of the nervous system and chose C. elegans as an animal model because of its 
relatively simple nervous system and genetic manipulability [289].  Since Brenner’s introduction 
of C. elegans to the scientific community, this model organism has proved instrumental in the 
discovery of diverse conserved cellular pathways.  Discoveries using C. elegans have been 
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recognized with three separate Nobel Prizes.  First, in the 2002 Nobel Prize, Brenner was 
recognized for establishing C. elegans as a model system [289], John E. Sulston was recognized 
for creating a cell linage map [290, 291], and H. Robert Horvitz was recognized for describing a 
conserved pathway regulating programmed cell death [292-294].  The identification of the cell 
death pathway has since played a key role in understanding human diseases, such as 
neurodegenerative disease, in which programmed cell death pathways are aberrantly activated 
[295].  Second, in 2006 Andrew Z. Fire and Craig C. Mello were awarded the Nobel Prize for their 
discovery of RNA interference (RNAi) [296].  RNAi has since become an important tool, not only 
in basic research, but in therapeutics as well [297].  Finally, Martin Chalfie was acknowledged 
with the 2008 Nobel Prize in Chemistry for his development of green fluorescent protein (GFP) as 
a genetic tool.  Chalfie used C. elegans to demonstrate that GFP could be used to visualize neuronal 
gene expression in live cells [298].  These Nobel Prize winning discoveries, combined with 
countless other discoveries in C. elegans, illustrate the value of this small nematode in science.  
Multiple experimental attributes make C. elegans uniquely suited to answer genetic 
questions, particularly those related to understanding stress response pathways such as the HTSR.  
The first and perhaps greatest advantage of C. elegans is its optical transparency throughout its 
entire lifecycle.  This transparency allows scientists to view all C. elegans cells under the 
microscope in living animals without perturbing the ECM, cell interactions, or tissue integrity.  
Furthermore, fluorescently tagged proteins in these cells can be viewed at single cell and 
subcellular resolution.  The optical transparency of C. elegans made the high-throughput genetic 
screen that was the basis for my thesis project possible.  Using the COPAS Biosort I sorted 
thousands of living C. elegans based on the expression of a GFP tagged gene in the hypodermis 
without dissecting or perturbing the cells.  I was able to not only detect GFP in the hypodermis of 
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living animals, but also sort out animals based on GFP intensity.  Another benefit of using an 
optically transparent model organism is that fluorescently tagged protein localization can be 
visualized in living animals through imaging.  In my thesis project, I utilized this advantage to 
determine the localization of proteins required for the HTSR. 
A second advantage of C. elegans is its hermaphroditic genetics.  C. elegans produces 
germline oocytes and sperm cells, allowing it to self-fertilize once it reaches adulthood [289].  In 
its self-reproductive lifespan of about six days a C. elegans produces 200-300 self-offspring [299].  
Because of its hermaphroditic mode of reproduction, each of these offspring is genetically 
representative of the maternal genotype.  In combination with standard genetic tools, such as 
genetic balancers and markers, this mode of reproduction enables simple maintenance and 
identification of heterozygous and homozygous mutations within a population of animals.  
However, male C. elegans can also arise through errors of meiosis and mate with hermaphrodites 
to produce 50% male offspring [289].  The existence of males allows mutations to be moved into 
and out of different genetic backgrounds through standard genetic crossing methods.  The ability 
of C. elegans to both self- and cross- fertilize made it possible for me to isolate clonal populations 
of C. elegans from a single animal in the forward genetic screen that was the basis for my thesis 
project.  These characteristics also made it possible to rapidly determine if my isolated mutants 
exhibited Mendelian segregation properties consistent with single gene recessive phenotype-
causing mutations. 
A third advantage of C. elegans is its compact genome.  The genome of C. elegans, which 
was completed in 1998, consists of roughly 20,000 protein coding genes and about 1,300 non-
protein coding genes in just over 100 million base pairs of DNA [300-302].  Included in the non-
protein coding genes are 590 transfer RNAs, 275 ribosomal RNAs, 140 trans-spliced leader RNAs, 
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120 miRNAs, 70 spliceosomal RNAs, and 30 snoRNAs [302].  Even though humans and C. 
elegans have a similar number of protein-coding genes, C. elegans package their genes in thirty-
fold less DNA [300].  The compact nature of the C. elegans genome makes whole genome 
sequencing relatively quick and inexpensive.  Additionally, about 80% of protein-coding C. 
elegans genes have human homologs, suggesting that many aspects of this organism’s physiology 
are conserved across evolution [303]. The compact and stable nature of the C. elegans genome, 
along with inexpensive whole-genome resequencing allowed me to efficiently sequence the 
genomes of over a dozen HTSR defective mutants and identify mutations in genes involved in the 
HTSR. 
Finally, a fourth advantage of C. elegans is its multicellularity.  An adult hermaphroditic 
C. elegans develops from an embryo to an adult with 959 somatic cells in just over three days at 
the standard cultivation temperature of 20°C [304, 305].  Adult animals contain neurons, glial, 
muscle, intestinal, and hypodermal cells that are very similar to their counterparts in mammals 
[306].  The outer layer of these adult animals is a collagen-rich cuticle made of hundreds of ECM 
proteins [307].  This structure provides protection against harmful pathogens, leverage for muscle 
contraction and motility, and sensors for detection of stressors [308-310].  Therefore, unlike single 
cell model systems such as yeast, C. elegans provides a platform from which to characterize 
intercellular signaling pathways, such as paracrine and endocrine signaling events, in the context 
of the native ECM.  This platform was critical to my thesis project because it allowed me to study 
the involvement of multiple cell types in the HTSR and do so in the context of the ECM, which 
plays an important functional role in the HTSR.  
Unbiased genetic screens in C. elegans have been instrumental for understanding the 
regulation of key conserved physiological stress responsive pathways [311-314].  Most of these 
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screens utilize a common phenotypic strategy.  First, they identify key transcriptional targets that 
are upregulated by the stressor.  Second, they generate transgenic animals that express GFP under 
control of a stress-inducible promoter.  Finally, they screen for mutants or RNAi knockdowns that 
either constitutively activate or inhibit stress-inducible expression of the reporter based on GFP 
expression.  While conceptually simple, these types of in vivo high-throughput screening 
approaches are only possible in C. elegans due to its optical transparency. 
The conserved pathways regulating the oxidative stress response transcriptional regulator,  
SKN-1 (Nrf homolog), have been extensively characterized through unbiased genetic strategies in 
C. elegans.  SKN-1 is required for both the upregulation of phase II detoxification genes during 
xenobiotic and oxidative stresses and for the upregulation of proteasomal subunits during 
proteasomal disruption [315, 316].  Additionally, knockdown of skn-1 decreases lifespan, 
suggesting that SKN-1 dependent gene expression mediates longevity [315].  Fluorescent reporter 
– based genetic screens have been instrumental in understanding how SKN-1 is regulated during 
control and stress conditions.  The phase two detoxification gene gst-4 is specifically and robustly 
upregulated during oxidative stress in a SKN-1 dependent manner, making it an ideal reporter 
candidate for a genetic screen [311].  Indeed, an RNAi screen using a gst-4p::GFP reporter 
identified several genes that constitutively activate reporter expression during control conditions 
[311].  Upon further examination of these genes, SKN-1 target gene expression and nuclear 
localization were found to be negatively regulated by a proteasomal degradation pathway 
involving the WD40 protein WDR-23 [311].  This result suggests that SKN-1 is constitutively 
localized to the nucleus, but it is unable to accumulate during control conditions due to a WDR-
23 dependent proteasomal degradation pathway.  Therefore, a C. elegans RNAi screen was the 
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first to identify proteasomal degradation as a method of SKN-1 regulation and it paved the way 
for characterization of conserved pathways in other organisms. 
Furthermore, another RNAi screen using the SKN-1 dependent phase II detoxification gene 
reporter, gcs-1p::GFP, led to the discovery that genes involved in translation and ribosomal 
assembly also negatively regulate SKN-1 dependent gene transcription [312].  RNAi knockdown 
of translation initiation factors in the eukaryotic initiation factor 4F (eIF4F) and pre-initiation 
complexes resulted in constitutive SKN-1 dependent gene expression and increased lifespan in a  
SKN-1 dependent manner [312].  The results from this RNAi were not only the first to suggest 
that SKN-1 mediates lifespan extension in animals with inhibited translation, but they also 
revealed the complexity of SKN-1 regulation.  
Finally, in addition to these RNAi based screens, forward mutagenesis screens have also 
been instrumental towards characterizing SKN-1 regulation.  The proteasomal subunit gene rpt-3 
is upregulated in a SKN-1 dependent manner during proteasomal disruption [313].  Therefore, in 
C. elegans with genetically disrupted proteasomes, rpt-3::GFP is constitutively expressed.  
Animals constitutively expressing rpt-3::GFP were used in a forward mutagenesis based genetic 
screen to identify mutants with impaired rpt-3::GFP induction.  This genetic screen revealed a 
critical role of the ER in SKN-1 regulation [313].  An ER-associated isoform of SKN-1 and ER-
mediated post-translational modifications of SKN-1 are required for SKN-1 dependent 
transcriptional responses during proteasomal disruption [313].  This genetic screen not only 
identified a novel form of SKN-1 regulation, but it also uncovered potential therapeutic targets 
upstream of SKN-1/Nrf that could be used in cancers resistant to proteasomal inhibitors. 
Similarly to the oxidative stress response, genetic screening approaches in C. elegans have 
also played a critical role in defining the Ire1 branch of the endoplasmic reticulum (ER) unfolded 
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protein response (UPR) [314].  The heat shock protein gene hsp-4 is strongly upregulated by ER 
stress in an ire-1 dependent manner in C. elegans [314].  This robust and specific upregulation 
makes hsp-4p::GFP an excellent reporter for forward genetic screens.  A forward genetic screen 
in mutants that constitutively upregulated hsp-4p::GFP led to the discovery that the X-box binding 
protein -1 (XBP-1) is required for the IRE-1 dependent UPR transcriptional response [314].  IRE-
1 was subsequently shown to cleave XBP-1 into its active form during ER stress in both C. elegans 
and mammals [314].  Therefore, as is often the case with genetic screens in C. elegans, this hsp-
4p::GFP fluorescence based forward genetic screen was critical towards identifying a conserved 
physiological pathway and it led to a broader understanding of this pathway not only in C. elegans, 
but in mammals as well. 
The oxidative and ER stress response illustrate the power of unbiased genetic screening 
strategies in C. elegans for understanding the regulation of physiological stress-responsive 
signaling pathways.  Often these unbiased genetic screens reveal unexpected novel signaling 
mechanisms that would have taken longer to uncover using traditional biochemical or cell 
biological methods.  My thesis project applies genetic screens, similar to those used to characterize 
these oxidative and ER stress responses, to the HTSR in C. elegans in order to identify signaling 
pathways regulating ORG expression.  By taking an unbiased screening approach, I identified 
surprising and unexpected new genes and pathways required for the HTSR.  My thesis focuses on 
two such pathways, one involving the O-GlcNAc transferase OGT-1 and one involving the 
3’mRNA cleavage and polyadenylation complex. 
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1.5.1 The hypertonic stress response in C. elegans 
HTS is induced in C. elegans by increasing the osmolarity of its environment. True 
isotonicity for C. elegans is not known. However, most studies of the C. elegans HTSR consider 
standard Nematode Growth Media (NGM), which contains ~50 mM NaCl and has an osmolarity 
of ~170 mOsm, to be isotonic [317].  HTS is typically elicited by raising NaCl concentrations.  
HTS causes at least three distinct organismal phenotypes in C. elegans, depending on the relative 
increase and duration of exposure.  First, acute HTS (>500 mM NaCl) can lead to death of the 
organism within 24 hours [318].  Second, acute exposure to non-lethal HTS (i.e. adaptation, 200 
mM NaCl) allows animals to subsequently survive a normally lethal HTS for naïve animals [318].  
Third, chronic exposure to non-lethal HTS (250 mM NaCl) elicits adaptive mechanisms that 
enable growth and development over multiple generations [319]. Specific and sometimes 
overlapping molecular mechanisms mediate each of these organismal responses. 
Immediately upon exposure to HTS, the body cavity of C. elegans shrinks as water leaves 
[318].  This HTS - induced cell shrinkage activates the conserved ‘With No Lysine’ protein kinase 
1 (WNK-1) pathway [231].  The WNK-1 cell volume recovery pathway is the initial cellular 
response to HTS that mediates the influx of ions (and osmotically obliged water) into the cell to 
quickly restore cell volume.  In mammals, cell shrinkage activates auto-phosphorylation of WNK-
1 [226, 320].  Phosphorylated WNK-1 subsequently phosphorylates and activates SPAK and 
OSR1 [227, 228].  Finally, SPAK and OSR1 phosphorylate and activate the Na – K – Cl 
cotransporter NKCC1, which mediates the influx of sodium and water to correct cell shrinkage 
[47, 48, 229].  The WNK-1 pathway is also activated in C. elegans following HTS [231].  Although 
the WNK-1 pathway acutely restores cell volume, the activation of WNK-1 targets increases 
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intracellular ionic strength due to the influx of sodium ions.  Increased intracellular ionic strength 
interferes with many cellular processes such as protein folding and enzyme activity [3, 4].  While 
the WNK1 pathway is important for the acute phase of the HTSR, other pathways appear to 
mediate long-term aspects of the HTSR that replace inorganic ions with compatible solutes. 
1.5.1.1 Compatible osmolyte accumulation in C. elegans during hypertonic stress  
Glycerol is the primary compatible osmolyte used by laboratory-reared C. elegans to 
adapt to HTS [318].  This is similar to yeast, which also utilize glycerol [53].  Although mammals 
do not utilize glycerol as an osmolyte, they do take a similar metabolic approach to osmolyte 
production by breaking down glucose to produce sorbitol [235].  In this respect, C. elegans may 
represent an evolutionary intermediate in terms of mechanisms of HTS adaptation. Intracellular 
glycerol concentration tracks extracellular osmolarity and accumulates on the order of hours in C. 
elegans [317, 318].  When C. elegans acclimated to a hypertonic environment is transferred back 
to normal growth conditions, glycerol levels drop due to glycerol efflux [318].  Therefore, glycerol 
accumulation in C. elegans is dynamic.   
C. elegans biosynthesizes glycerol via transcriptional upregulation of a glycerol-3-
phosphate dehydrogenase homolog (gpdh) [318].  GPDH catalyzes the rate-limiting step in 
glycerol biosynthesis [321].  Therefore, upregulation of gpdh enhances the rate of glycerol 
production.  There are two classes of eukaryotic GPDH enzymes, a cytosolic NADH-dependent 
form and a mitochondrial FAD-dependent form.  NADH – and FAD – dependent GPDHs together 
make up the ‘glycerol – phosphate shuttle’ that is critical for cellular glucose metabolism [322, 
323].  NADH – dependent GPDH reduces dihydroxyacetone (DAP) to glycerol-3-phosphate (G3P) 
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while oxidizing NADH to NAD, and FAD – dependent GPDH oxidizes G3P to DAP while 
reducing FAD to FADH2 [323].  Only NADH – dependent GPDH is involved in the HTSR [318].   
There are two NADH-dependent gpdh genes in the C. elegans genome encoded by gpdh-
1 and gpdh-2 [317, 318].  During the HTSR, gpdh-2 exhibits little to no upregulation [317]. This 
contrasts with gpdh-1, which is upregulated > 20 - 50 – fold within the first three hours of HTS 
exposure [319, 324].  Notably, loss of gpdh-1 does not significantly reduce steady state whole 
animal glycerol levels in response to HTS, although the rate of glycerol accumulation is slowed 
[317].  gpdh-1 mutants do exhibit a mild defect in their ability to acutely adapt to HTS, showing 
that gpdh-1 does play a functionally significant role the HTSR [319].  However, animals lacking 
both gpdh-1 and gpdh-2 exhibit a ~50% reduction in steady-state glycerol levels [317].  This 
suggests that gpdh-2 can function redundantly with gpdh-1 in HTS-induced glycerol production.  
It also suggests the existence of gpdh-independent mechanisms for glycerol production. 
A transcriptional reporter for gpdh-2 is constitutively expressed in the intestine, 
hypodermis, and excretory cell and is not substantially upregulated by HTS [317].  On the other 
hand, a gpdh-1 transcriptional reporter is virtually undetectable under control conditions but is 
strongly induced in the hypodermis and intestine during HTS [317].  This reporter is specifically 
induced by HTS since it is not induced by other cellular stressors, such as heat shock, ER stress, 
or oxidative stress.  Interestingly, the gpdh-1 reporter is not activated in other tissues, such as the 
muscle, neurons, or germline [317].  This suggests a model in which the hypodermis and intestine, 
which are environmentally exposed epithelial tissues that are the first to encounter HTS, are the 
primary sites of glycerol production.  Glycerol is then shunted out of the basolateral membrane 
into the pseudocoelomic space, where it can be accumulated by non-glycerol producing cells, such 
as muscle and neurons, via passive uptake mechanisms.  In support of such a model, glycerol 
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permeant aquaglyceroporins are localized to the basolateral epithelial membrane, while water 
permeant aquaporins are present on the apical membrane [26].  This could provide a permeability 
pathway for the efflux of glycerol out of the intestine as well as an influx pathway for osmotically 
driven water movement. 
1.5.1.2 Osmotically regulated genes in C. elegans 
gpdh-1 is one of 324 ORGs in C. elegans [324].  Several of these upregulated ORGs 
suggest there may be other interesting physiological mechanisms involved in the C. elegans HTSR.  
For example, the H+-coupled myo-inositol transporter hmit-1.1 is upregulated >100-fold by HTS.  
The kinetics of hmit-1.1 upregulation differ from those of gpdh-1 in that hmit-1.1 upregulation 
peaks at later timepoints than gpdh-1 [324].  While myo-inositol is a major osmolyte in mammalian 
cells and is accumulated via transcriptional upregulation SMIT [238, 239], there is no evidence 
that C. elegans accumulate myo-inositol under laboratory conditions [318].  However, myo-
inositol is a major breakdown product of plant organic material, which is present in many, if not 
all, of the sites where C. elegans are known to inhabit [325-327].  Therefore, the upregulation of 
hmit-1.1 may indicate that C. elegans in the wild can utilize myo-inositol as an osmolyte in addition 
to glycerol, but that it is unable to use myo-inositol in the laboratory since it is absent from the 
cultivation conditions. 
Many genes upregulated by HTS are also upregulated during bacterial and fungal infection 
in C. elegans.  This does not include gpdh-1 or hmit-1.1, which appear to be exclusively 
upregulated by HTS.  Instead, many of these co-regulated genes are components of the C. elegans 
innate immune response, such as members of the neuropeptide-like protein (nlp) and caenicin (cnc) 
gene families [324].  Some pathogens, such as the fungal pathogen Drechmeria coniospora, 
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physically penetrate the cuticle as part of the infection process [308, 328].  Since both pathogens 
and the HTS impinge on the specialized C. elegans ECM that forms the cuticle, this supports the 
hypothesis that upregulation of some ORGs may be triggered via hypertonicity- or pathogen-
induced disruptions in the cuticle.  Consistent with this hypothesis, several mutants affecting 
structural components of the cuticle, including many collagen-encoding dpy genes (i.e. dpy-7, -8, 
-9, and -10), constitutively activate the C. elegans HTSR [310, 317, 324].  One possible 
interpretation of these genetic findings is that the cuticle is a water impermeant cell wall-like 
structure that slows the movement of water out of the underlying tissues during HTS.  However, 
the cuticle is permeable to many small molecule dyes [329], suggesting that smaller molecules, 
such as water, can move through this structure with relative ease, although such permeability could 
be dynamically regulated by HTS.  Moreover, enhancing cuticle permeability does not alter the 
HTS phenotype of C. elegans mutants [329].  Another possible hypothesis that is consistent with 
such observations is that the cuticle functions as a mechanical osmosensor whose shape, tension, 
and/or connections to the underlying hypodermis are influenced by changes in the hypodermal 
tissue volume.  Whether or not HTS itself leads to specific disruption of the cuticle and how such 
disruptions might couple to signaling pathways that activate ORGs is not yet known. 
1.5.1.3 Transcriptional regulation of the C. elegans hypertonic stress response 
For over a decade, our lab has taken advantage of the strong and specific upregulation of 
gpdh-1 and the power of unbiased genetic screens in C. elegans to characterize the genetic 
pathways regulating the HTSR, specifically ORG expression [317, 329].  The first screen for 
regulators of the HTSR utilized genome-wide RNAi screening to identify genes that when 
inhibited caused upregulation of a gpdh-1p::GFP reporter under isotonic conditions [317].  This 
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screen identified over one hundred genes negatively regulating gpdh-1 and other ORG expression 
[317].  Surprisingly, most of the genes identified in this screen fell into two classes. 
The first class of osmotic regulators included protein homeostasis genes involved in RNA 
processing, protein synthesis, protein folding, and protein degradation [317].  One hypothesis to 
explain this discovery is that cells sense HTS and upregulate gpdh-1 expression through detection 
of stress- induced protein damage.  While protein damage can be replicated by inhibition of protein 
homeostasis genes, other stressors, such as heat shock, also cause protein damage but nevertheless 
fail to upregulate gpdh-1 expression [317].  This suggests that HTS causes a type of protein damage 
that differs from other types of protein damage and specifically activates the HTSR without 
activating other stress response pathways.  In support of this hypothesis is the observation that 
HTS causes a model protein (polyQ) to form aggregates [330, 331].  These polyQ aggregates differ 
from aggregates caused by other stressors in both C. elegans and mammalian cells in their 
morphology, solubility, and ubiquitination characteristics, suggesting they are a unique aggregate 
species [330, 331].  Additional studies show that endosomal sorting pathways and lysosomes clear 
existing protein damage to facilitate survival and adaptation during HTS [332].  However, when 
genes involved in degradation are inhibited, protein damage accumulates and C. elegans can no 
longer survive or adapt to HTS [332].  These data clearly reveal an important role for maintenance 
of the proteome in the regulation of the C. elegans HTSR. 
In a mechanism likely related to HTSR-induced accumulation of damaged proteins, 
regulation of protein translation also has a critical role in the HTSR [333, 334].  Global protein 
translation is inhibited ~50% by mild HTS (200 mM NaCl) [334].  Moreover, pharmacological 
inhibitors of translation lead to a mild upregulation of gpdh-1 mRNA even in the absence of HTS, 
suggesting a direct signaling link between HTS-induced translation inhibition and regulation of 
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the ORG gpdh-1 [334].  HTS-induced translational inhibition requires phosphorylation of 
eukaryotic translation initiation factor 2 alpha (eIF2α) by the kinase GCN-2 and its accessory 
protein GCN-1 and loss of gcn-1 or gcn-2 reduces HTS-induced gpdh-1 expression by ~50% [334].  
GCN-1/2 appear to act in the same pathway as WNK-1 (Section 1.5.1) since gcn-1 mutants are 
non-additive with wnk-1 knockdown [334].  How this pathway for HTS-induced translational 
inhibition is linked to transcriptional regulation of gpdh-1 is currently unknown. 
The second large class of genes that negatively regulate gpdh-1 gene expression and the 
HTSR are genes encoding secreted extracellular proteins [317].  These extracellular proteins are 
synthesized by the hypodermis and secreted from the apical membrane to generate the specialized 
C. elegans ECM called the cuticle [307].  This ECM is shed and resynthesized during each of the 
four larval molts that occur in C. elegans development [309].  The precise organization and 
makeup of the cuticle differs between these developmental stages.  However, by adulthood the 
cuticle contains hundreds of ring-like annular furrows that form circumferential-oriented 
ingressions along the length of the animals [309].  One of the most abundant structural components 
of the cuticle are collagen proteins, which are encoded by many genes in C. elegans [335].  
Mutations in several of these collagen genes lead to alterations in body shape [336, 337].  
Interestingly, mutations in collagen genes that disrupt specifically the annular furrow (dpy-2, -7, -
8, -9, and -10) [310] activate gpdh-1 expression under isotonic conditions and cause the 
accumulation of massive amounts of glycerol [310, 317].  As a result, these mutants retain motility 
in extremely hypertonic environments (500 mM NaCl), whereas WT animals rapidly paralyze 
[310, 317].  This suggests that the annular furrow plays an important role in the C. elegans HTSR.  
However, animals with LOF mutations in other secreted proteins, such as the mucin-like protein 
OSM-8, the notch ligands OSM-7 and OSM-11, and the novel secreted protein OSR-1 exhibit 
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qualitatively normal furrows, but also activate gpdh-1 expression, accumulate glycerol, and are 
osmotic stress resistant [317, 324, 329, 338-340].  One possibility is that these non-furrow 
disrupting ECM proteins act to couple furrow-based osmosensing to the underlying hypodermis 
through detection of HTS-induced structural changes.  Direct tests of this mechanically-based 
osmosensing model are still needed. 
The genetic origins of several HTSR-regulated extracellular genes reveal connections 
between whole-animal HTS adaptation and behavioral responses that allow C. elegans to avoid 
hypertonic environments.  osm-7, -8, and -11 were isolated in a forward genetic screen for osmotic 
avoidance abnormal (osm) mutants [341].  While wild-type animals crawl away from hypertonic 
stimuli, osm mutants fail to avoid these stimuli.  Hypertonic avoidance behavior depends on the 
ciliated ASH sensory amphid neurons [342].  There are three classes of osm genes that differ based 
on their effects on the ASH neuron.  The first and second class of osm genes function cell 
autonomously in the ASH neurons to regulate cilia formation and cell signaling respectively [343, 
344].  In contrast, the third class of osm genes, which includes osm-7, -8, and -11 is not expressed 
in the ASH neurons and mutations in these genes do not affect the ASH neurons.  Instead, these 
genes are expressed in the hypodermis, where they function to inhibit the expression of gpdh-1 
and glycerol accumulation [329, 338].  The hypodermal expression of these class three osm genes 
suggests that an unidentified paracrine factor(s) signals from the hypodermis to the ASH neurons 
during HTS to modulate behavior.  One possibility is that this paracrine factor is glycerol itself  
because glycerol could blunt amphid neuron volume changes upon hypertonic exposure when 
present at high levels.  In addition, there is some evidence that retrograde signaling occurs, i.e. that 
ASH neurons signal to osmosensitive tissues to modify the HTSR.  The class two osm gene, osm-
9, encodes a transient receptor potential channel, TRPV, that is expressed in ASH neurons to 
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facilitate ASH-dependent signaling [343].  Surprisingly, osm-9 mutants are not only behaviorally 
osm, but they also constitutively upregulate the ORG aqp-8 in osmosensitive tissues [345] and 
have improved acute survival during HTS due to decreased protein damage [346].  Therefore, 
unidentified paracrine factors signal from the ASH neurons to the osmosensitive tissues of osm-9 
mutants to modulate cellular physiology.  The osm paradigm provides a unique opportunity to 
investigate how hypodermis-based physiological information is integrated to modulate neuronal-
based behavior and vice versa.  It also highlights the importance of investigating the HTSR at the 
organismal level, where behavior and physiology can be studied together. 
The class three gene osm-8 has been studied in significant molecular detail to understand 
its role in the HTSR.  osm-8 encodes a small hypodermally – secreted mucin protein [329].  Like 
the other class three osm mutants, osm-8 mutants constitutively induce ORGs, including gpdh-1, 
accumulate large amounts of glycerol during control conditions, and are resistant to normally lethal 
levels of HTS [329].  To identify genes that may function downstream of the secreted osm-8 gene 
to transduce signals from outside the cell to the nucleus, our lab performed an unbiased RNAi 
screen for suppressors of osm-8 mutants. Inhibition of the multi-pass transmembrane patched – 
related protein 23 (ptr-23) completely suppressed many osm-8 phenotypes, including constitutive 
gpdh-1 induction, glycerol accumulation, and the osmotic stress resistance (OSR) phenotype 
[329].  However, ptr-23 did not suppress the induction of all ORGs, since many innate immunity 
genes upregulated in osm-8 mutants were similarly upregulated in osm-8; ptr-23 double mutants 
[329]. Therefore, a subset of ORGs must be regulated in a ptr-23 – independent manner. 
Furthermore, ptr-23;osm-8 double mutants still induce the gpdh-1 reporter during HTS, suggesting 
that the HTSR does not exclusively require ptr-23 [329]. These two observations indicate that 
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there are multiple redundant pathways regulating the HTSR and at least one of them is independent 
of ptr-23.  
While unbiased genetic screens have revealed valuable information about the HTSR, the 
specific signaling pathways that control upregulation of gpdh-1 and/or other ORGs have not yet 
been identified.  In yeast and mammals, MAPK – dependent signaling pathways are known to 
regulate HTS – dependent transcription.  The p38 MAPK activates hypertonic induction of the 
mammalian transcription factor NFAT5/TonEBP [347, 348] and the p38 MAPK homolog, HOG1, 
regulates the transcription of ORGs during HTS in yeast [106].  Despite the roles of MAPK 
signaling in the yeast and mammalian HTSR, there is little evidence that MAPK signaling is 
involved in the C. elegans HTSR.  MAPK signaling components have thus far not been isolated 
in genetic screens for regulators of the HTSR, although we note that such screens have not yet 
reached saturation [317, 329].  Moreover, knockdown of p38 signaling pathway components in 
osm-7 and osm-11 mutants has no effect on acute or chronic OSR [338].  Similarly, p38 MAPK 
signaling is not involved in induction of the ORG, nlp-29, by HTS despite being required for 
induction of nlp-29 during fungal infection [349]. However, MAPK signaling is involved in the 
chronic survival of osr-1 mutants on HTS [340] and the survival of WT animals during desiccation 
[350].  Therefore, MAPKs may be involved in the C. elegans HTSR, but they are unlikely to be a 
major contributor to the transcriptional upregulation of ORGs during HTS. 
In mammals, the rel family transcription factor NFAT5 is directly responsible for the 
transcriptional upregulation of many genes by HTS [236].  However, the C. elegans genome does 
not contain rel family transcription factors.  While the tonicity-responsive transcription factor in 
C. elegans is currently unknown, promoter analysis of C. elegans ORGs has provided some 
candidates.  The promoters of C. elegans ORGs are highly enriched for GATA-type transcription 
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factor binding sites [324].  RNAi screening identified the GATA erythroid-like factors ELT-2 and 
ELT-3 as being required for HTS-induced upregulation of a gpdh-1 transcriptional reporter [324].  
elt-2 is expressed in the intestine and mediates intestinal upregulation of gpdh-1, while elt-3 is 
expressed in the hypodermis and is required for hypodermal upregulation of gpdh-1 [324].  Both 
these transcription factors function downstream of the ECM proteins that negatively regulate the 
HTSR, but it is unknown if they are required for all HTSR pathways [324].  An alternative 
hypothesis is that elt-2 and elt-3 are required for intestinal and hypodermal differentiation and 
development but are not the physiological targets of the HTSR [351, 352].  Future studies using 
CRISPR/Cas9 to tag native alleles of elt-2 and elt-3 followed by cell biological and biochemical 
analysis in the presence and absence of HTS are needed to determine if HTS leads to changes in 
the localization and/or activity of elt-2/3, as has been shown for other stress-responsive 
transcription factors [315, 353]. 
In conclusion, protein homeostasis and extracellular proteins inhibit HTSR-induced 
transcriptional responses.  While it is tempting to speculate that increased protein damage 
functions as the illusive “osmosensor” during HTS, it is unlikely to be the primary way cells sense 
HTS because it is prominent only at extremely high levels of HTS [330, 331].  Another hypothesis 
is that cells sense HTS through changes in ECM structure.  The annular furrow in the ECM has 
been linked to the HTSR, but it remains unknown if changes in its structure during HTS trigger 
the HTSR .  Finally, in addition to understanding how cells sense HTS, a transcription factor(s) 
specific to ORG induction remains to be identified.  ELT-2 and ELT-3 are required for intestinal 
and hypodermal ORG induction respectively.  However, since they are also generally required for 
transcription in these tissues, it is unknown whether they themselves are activated in a specific 
way by HTS or function with other HTS – specific factors [351, 352].  Continued unbiased genetic 
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screening efforts, which is the greatest strength of the C. elegans model system, should help to 
identify HTSR relevant transcription factors, signaling pathways, and other proteins involved in 
signaling the transcriptional response to HTS. 
1.5.2 Conclusions 
Our lab was the first to harness the power of genetic screens in C. elegans to characterize 
the HTSR.  Transcriptionally, the HTSR is under strong negative regulation.  Regulation of protein 
homeostasis genes, which oppose protein damage and synthesis, negatively regulate the HTSR 
transcriptional response through gcn-1/2 and gck-3/wnk-1 signaling pathways.  Extracellular 
proteins inhibit gpdh-1 transcriptional induction under isotonic conditions through a pathway 
involving a transmembrane protein and GATA-type transcription factors.  Additional independent 
pathways also regulate the transcription of other ORGs.  Therefore, genetic screens performed to 
date have revealed the existence of at least two transcriptional HTSR pathways in C. elegans [273]. 
In my thesis project, I build on our previous success of using unbiased genetic screens to 
understand negative regulation of the HTSR in C. elegans by using the same fundamental 
strategies to understand the positive regulation of this stress response.  Using gpdh-1p::GFP 
fluorescent reporter expression as a read-out for the HTSR, I conducted a forward genetic screen 
for mutants that have an impaired HTSR.  My unbiased genetic screen led to the discovery of three 
unexpected genes affecting two biological pathways.  One gene is the sole C. elegans homolog of 
the conserved O-GlcNAc transferase OGT and the other two genes are interacting proteins within 
the 3’ mRNA cleavage and polyadenylation complex.  Neither of these pathways have previously 
been linked to the HTSR.  Understanding how these genes contribute to the HTSR is the goal of 
my thesis project and will contribute fundamentally new insights into this stress response pathway. 
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1.6 The O-GlcNAc transferase OGT  
Post-translational modifications play key roles in cellular processes such as stress 
responses.  One recently discovered post-translational modification is the addition of a single ring 
sugar motif, ß-linked N-acetylglucosamine (O-GlcNAc), to serine and threonine residues of 
intracellular proteins [354].  O-GlcNAcylation was first described in 1984 following a 
serendipitous discovery in lymphocytes and it was subsequently observed to be abundant in the 
nucleus and cytoplasm of a variety of cell types [355-358].  Similarly to other post-translational 
modifications, O-GlcNAcylation modifies the function, localization, and stability of proteins 
[354].  In 1997, the sole enzyme that O-GlcNAcylates proteins, O-GlcNAc transferase (OGT), was 
cloned in mammals and C. elegans [359, 360].  Shortly after, the sole enzyme that removes O-
GlcNAc, O-GlcNAcase (OGA), was discovered and cloned [361].  OGT and OGA are 
ubiquitously expressed in the somatic tissues of all metazoans and are absent from yeast genomes 
[360-362].  Together these two enzymes regulate O-GlcNAc homeostasis, which is important to a 
variety of cellular processes including metabolism, stress responses, and proteostasis [354].   
1.6.1 Evolutionary conservation of OGT protein structure and function 
The structure of OGT is highly conserved among metazoans with up to 80% identity 
between organisms [359].  OGT is made up of an N-terminal tetratricopeptide repeat (TPR) 
domain, a nuclear localization signal (NLS), and C-terminal catalytic domain [360, 363].  C. 
elegans and human OGT shares 89% identity in the TPR domain and 74% identity in the catalytic 
domain [319]. 
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The N-terminal TPR domain of OGT is made up of 12.5 repeats, each with 34 amino acids, 
that mediate the recognition and binding of O-GlcNAcylation substrates to OGT [364-366].  
Together these repeats are arranged in anti-parallel α-helices that form two flexible right-handed 
superhelices with substrate-interacting asparagine residues lining the inner protein binding groove 
[367].  The large surface area and conformational flexibility of the TPR domain facilitates 
interactions with a wide range of substrates.  In addition to substrate recognition, the TPR domain 
is required for OGT trimerization [368].  While trimerization is not required for O-GlcNAcylation 
activity, trimerization increases the affinity of OGT for its O-GlcNAc donor uridine diphosphate 
N-acetylglucosamine (UDP-GlcNAc) [368].  This suggests that multimerization regulates OGT 
activity.  Deletion analysis demonstrates that TPRs 2 - 6 are sufficient to mediate binding of OGT 
to substrates [366], but all TPRs are required for OGT trimerization [368].   
Another important domain within OGT is the NLS.  OGT is localized in both the nucleus 
and cytoplasm and it therefore must be shuttled between these two cellular compartments [359].  
In the cytoplasm, OGT modifies hundreds of enzymes and structural proteins to modulate cellular 
pathways such as those involved in metabolism, protein expression, and cell stress responses [354].  
In the nucleus, OGT has two broad functions.  It modifies nuclear pore proteins to modulate nuclear 
envelope permeability and it modifies transcription and chromatin factors to regulate gene 
expression [369].  The O-GlcNAc modification is associated with the chromatin of hundreds of 
gene promoters and is required for proper transcriptional regulation of these genes [370].  OGT 
has been shown to recruit transcriptional repressors to gene promoters through both O-
GlcNAcylation-dependent and -independent mechanisms [371].  Additionally, within the nucleus, 
there is interplay between O-GlcNAcylation and phosphorylation of the C-terminal domain (CTD) 
of RNA Polymerase II (RNAP II).  O-GlcNAcylation of RNAP II is required for assembly of the 
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preinitiation transcriptional complex and knockdown of ogt decreases transcription about 50% 
[372].   
The nuclear localization of OGT is facilitated by a three amino acid NLS motif, DFP (aa 
451-453), located within the TPR domain [363].  In addition to the NLS, nuclear localization of 
OGT requires O-GlcNAcylation of Ser389 in the TPR domain [363].  It is hypothesized that O-
GlcNAcylation at this residue causes a conformational change in OGT that exposes the NLS to 
importin α5, which interacts with OGT via the DFP motif to transport OGT into the nucleus [363].   
Finally, located at the C-terminal end of OGT is the catalytic glycosyltransferase domain.  
This domain binds UDP-GlcNAc and the substrate to catalyze the addition of O-GlcNAc [373].  
A strict OGT substrate binding motif has not been identified, but many of its substrates have amino 
acids that promote an extended conformation, like proline, flanking the O-GlcNAcylated residue 
[373].  Structurally, the catalytic domain is made up of Rossmann-like folds (a layered sandwich-
like tertiary structure made up of alternating α-helices and ß-sheets) and α-helices with His498 
acting as the catalytic base [373].  The Rossmann-like folds function to bind nucleotides such as 
UDP-GlcNAc [374].  The catalytic domain alone is sufficient to O-GlcNAcylate synthetic peptides 
in vitro [365], but the TPR domain is required in vivo [319].    
The single mammalian ogt gene encodes four isoforms of OGT that vary only in the length 
of their TPR domains [359, 364].  The canonical nucleocytoplasmic isoform of OGT (ncOGT), 
isoform 3, has 12.5 TPRs and regulates global cellular O-GlcNAcylation [364].  A second 
nucleocytoplasmic isoform, isoform 1, is identical to isoform 3 except that it has ten fewer amino 
acids in its TPR domain.  Isoforms 1 and 3 function interchangeably.  Additionally, there is a 
shorter mitochondrially localized isoform of OGT (mOGT) that contains TPRs 5 – 12.5 and an N-
terminal mitochondrial targeting sequence [364].  TPRs 5 - 7 of mOGT are sufficient for substrate 
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binding [365].  Consistent with its mitochondrial localization, mOGT regulates mitochondrial 
membrane structure and function via O-GlcNAcylation of mitochondrially-encoded proteins 
[375].  Finally, the shortest isoform of OGT (sOGT) is nucleocytoplasmic and contains TPRs 11 
– 12.5.  The function(s) of sOGT remains largely unknown, but evidence suggests that it negatively 
regulates ncOGT O-GlcNAcylation activity by directly interacting with ncOGT [376].  In contrast 
to mammals, only one isoform of OGT have been experimentally verified in C. elegans.  C. elegans 
OGT-1 is nucleocytoplasmic and has high homology to mammalian ncOGT isoforms 1 and 3 
[360]. 
1.6.2 The cellular functions of OGT 
Although O-GlcNAcylation was the first discovered function of OGT and has long been 
considered the primary function of OGT, research in the last twenty years has revealed additional 
catalytic and non-catalytic functions of OGT.  My thesis project describes a novel non-catalytic 
role of OGT in the HTSR.  Using unbiased genetic approaches in C. elegans, I discovered a critical 
role of OGT in regulating protein expression of the osmolyte biosynthetic enzyme GPDH-1 during 
HTS.  Surprisingly, the function of OGT in the HTSR does not depend on the catalytic activity of 
OGT, but it does depend on the presence of the protein – protein interacting tetratricopeptide repeat 
(TPR) domain.  Therefore, my thesis project demonstrates that OGT engages in important 
molecular functions outside of its well described roles in post-translational O-GlcNAcylation. 
1.6.2.1 The O-GlcNAcylation function of OGT 
OGT was first discovered because of its O-GlcNAcylation activity [355].  Unlike canonical 
glycosylation, which occurs in the secretory pathway, OGT glycosylates thousands of intracellular 
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nuclear, cytoplasmic, and mitochondrial proteins [354].  OGT is the only protein that catalyzes the 
addition of the single ring sugar motif, O-GlcNAc, to serine and threonine residues of proteins 
[359].  Correspondingly, only one enzyme, OGA, catalyzes the removal of O-GlcNAc from 
proteins [361].  Together OGT and OGA establish a dynamic O-GlcNAcylation environment 
within cells. 
The source of O-GlcNAc in cells is UDP-GlcNAc [377].  The catalytic domain of OGT 
binds UDP-GlcNAc to facilitate the addition of O-GlcNAc to proteins and the energetically 
favorable release of UDP [373].  UDP-GlcNAc is synthesized from glucose, amino acids, fats, and 
nucleotides by the hexamine biosynthetic pathway (HBP) [378].  About 2 – 5% of intracellular 
glucose enters the HBP and becomes O-GlcNAc [379].  O-GlcNAc synthesis, and the HBP as a 
whole, is therefore sensitive to the nutrient and metabolic status of the cell.  In fact, diets high in 
fat and sugar have been shown to increase global O-GlcNAcylation without affecting OGT or 
OGA protein levels [380]. 
O-GlcNAcylation is regulated in several different ways.  As alluded to above, the first way 
O-GlcNAcylation is regulated is by the nutrient status of the cell.  Hyperglycemic conditions 
increase flux through the HBP, leading to a greater intracellular concentration of UDP-GlcNAc 
[354].  Increased intracellular UDP-GlcNAc in turn results in higher OGT activity and affinity of 
OGT for its substrates [368].  Paradoxically, glucose deprivation also increases O-GlcNAcylation 
[381].  This increase in O-GlcNAcylation is due not to increased flux through the HBP, but to the 
transcriptional upregulation of OGT by the AMP-activated protein kinase (AMPK).  Glucose 
deprivation activates AMPK to increase OGT transcript and protein levels [382].  One hypothesis 
is that increased O-GlcNAcylation in these glucose poor conditions protects proteins from 
degradation, as has been shown in other contexts [383].  Therefore, O-GlcNAcylation is regulated 
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both through intracellular UDP-GlcNAc levels and OGT transcription, depending on the nutrient 
status of the cell.  However, these are not the only factors regulating the catalytic function of OGT. 
O-GlcNAcylation activity is also regulated through post-translational modification of 
OGT.  OGT is phosphorylated under several different conditions to increase its O-GlcNAcylation 
activity.  Calcium/calmodulin – dependent protein kinase (CaMKIV) phosphorylates and activates 
OGT during potassium chloride – induced neuronal depolarization [384].  OGT activation in these 
neurons is required for Ca2+ – dependent gene induction, such as the upregulation of genes 
involved in nerve tissue remodeling and neuronal plasticity [384].  Another kinase that 
phosphorylates and activates OGT is the circadian rhythm regulator glycogen synthase kinase 3β 
(GSK3β) [385].  GSK3β activity oscillates in a circadian pattern, thereby causing the activity of 
its targets, such as OGT, to oscillate with circadian time as well [385].  O-GlcNAcylation of 
mammalian clock proteins plays a critical role in the timing and length of each circadian phase 
[385].  Finally, AMPK also phosphorylates OGT to regulate its nuclear localization and global 
substrate selectivity during stress conditions such as glucose deprivation [386].  Together these 
examples show that phosphorylation is one way that cells regulate OGT function. 
In addition to phosphorylation, OGT activity is also modulated via O-GlcNAcylation.  
Multiple sites on OGT are O-GlcNAcylated to regulate its nuclear localization and substrate 
selectivity [387].  O-GlcNAcylation of Ser389 in the TPR domain of OGT exposes the NLS and 
is required for the nuclear localization of OGT [363].  Furthermore, O-GlcNAcylation of the short 
isoform of OGT at Thr12 and Ser56 changes the substrate selectivity of sOGT and the latter 
promotes cell proliferation and cell cycle progression [388].  Therefore, the catalytic activity of 
OGT itself plays an autoregulatory role in confining OGT to specific cellular localizations and 
substrates. 
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The final way in which O-GlcNAcylation is regulated is via protein – protein interactions.  
A p38 MAPK interaction with the C-terminus of OGT is required for activation of OGT in low 
glucose conditions [382].  This interaction with p38 is independent of phosphorylation, as OGT is 
not a phosphorylation target of p38 [382].  The interaction between p38 and OGT is required for 
the O-GlcNAcylation of specific substrates, such as Neurofilament H, but not for the binding of 
OGT to these substrates [382].  Two other proteins that regulate O-GlcNAcylation via direct 
interactions with OGT are the targeting regulatory subunit of the PP1-beta serine/threonine 
phosphatase (MYPT1) and the transcriptional coactivating arginine methyltransferase CARM1 
[389].  Both these proteins change the substrate selectivity of OGT without changing its intrinsic 
catalytic activity.  It is hypothesized that MYPT1 and CARM1 enable OGT substrate specificity 
by acting as adaptor proteins between OGT and particular substrates [389].  However the nature 
of these substrates remains to be characterized.  
Since OGT modifies Ser and Thr residues of target substrates, the O-GlcNAc modification 
can compete with phosphorylation for modification of the same residue or influence modification 
of adjacent residues.  The crosstalk between these two PTMs is complicated and specific to the 
target protein.  At a global level, increasing O-GlcNAcylation decreases phosphorylation at some 
sites, while increasing it at others [390].  In many cases, O-GlcNAcylation and phosphorylation 
are not mutually exclusive.  For example, neurofilament proteins are simultaneously 
phosphorylated and O-GlcNAcylated in the same protein domains [391].   
However, cross-talk between O-GlcNAcylation and phosphorylation does occur when 
there is steric hindrance, modification of the same residue, or O-GlcNAcylation of the kinase.  For 
example, the CTD of RNAP II is dynamically O-GlcNAcylated at Thr4 and phosphorylated at 
Ser2 and Ser5 [392, 393].  However, O-GlcNAcylation is not detected on phosphorylated RNAP 
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II and vice versa due to steric hindrance between the added phosphates and O-GlcNAc [393].  O-
GlcNAcylation of the RNAP II CTD is required for proper assembly of the preinitiation complex 
and subsequent gene transcription [372].   Additionally, the same residue on a protein can be the 
target of both phosphorylation and O-GlcNAcylation.  Thr58 on the protooncogene c-Myc can be 
phosphorylated or O-GlcNAcylated depending on the nutrient status of the cell [394, 395].  During 
serum starvation, Thr58 is O-GlcNAcylated and during serum stimulation Thr58 is 
phosphorylated.  Therefore, mutually exclusive phosphorylation and O-GlcNAcylation can act as 
a rheostat for the nutrient status of the cell [395].  Finally, O-GlcNAcylation influences 
phosphorylation when the kinase itself is O-GlcNAcylated to modify its activity.  This occurs with 
CaMKIV, which is O-GlcNAcylated at a position that directly blocks its catalytic activity and 
prevents it from phosphorylating substrates [396].  Phosphorylation of CaMKIV in turn prevents 
this inhibitory O-GlcNAcylation and allows it to remain active[396].  
In conclusion, the O-GlcNAcylation activity of OGT integrates inputs, such as the nutrient 
status of the cell and circadian rhythm, to modulate a variety of cellular signaling pathways.  
Although progress has been made in understanding the mechanisms of OGT regulation and the 
cross talk between O-GlcNAcylation and phosphorylation, much is still not understood about this 
widespread PTM.  In particular, there is still much to learn about how one enzyme can achieve 
specificity to thousands of substrates, how the activities of OGT and OGA influence one another, 
and how the methods of OGT regulation are integrated together.  Continued research on this unique 
form of glycosylation from a biochemical, genetic, and physiological perspective will be useful to 
answering these questions.  
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1.6.2.2 The proteolytic function of OGT 
In addition to the reversible O-GlcNAc PTM, OGT also catalyzes a non-reversible 
proteolytic event.  It binds and proteolytically cleaves one known target, the mammalian host cell 
factor 1 (HCF-1) [397, 398].  HCF-1 is synthesized as a large precursor protein and must be 
cleaved at six central amino acid repeats (HCF-1PRO) by OGT to be activated in mammals [399].  
Once cleaved, the N - and C – terminal HCF-1 subunits remain non-covalently associated and 
promote passage through the Gl and M phase of the cell cycle respectively [399-401].  
Interestingly, OGT is only required to cleave HCF-1 in mammals.  Drosophila utilize another 
enzyme, Taspase1, to cleave HCF-1 [402] and HCF-1 in C. elegans is expressed in its active form 
and thus does not need to be cleaved [403].  
OGT uses the same active site for HCF-1 proteolysis as it uses for canonical O-
GlcNAcylation [404].  In fact, OGT proteolytically cleaves HCF-1 via the non-canonical O-
GlcNAcylation of a glutamate in HCF-1 [404].  This O-GlcNAcylated glutamate creates a high 
energy pyroglutamate species that causes spontaneous amide hydrolysis of HCF-1 [405].  In 
support of this model, the addition of uncleavable UDP-5SGlcNAc to cells inhibits HCF-1 
cleavage [404].   
While the proteolytic activity of OGT is important in mammalian biology, it appears to be 
obsolete in invertebrates such as C. elegans.  Therefore, the proteolytic activity of OGT is likely 
not involved in the HTSR.  In mammals, the proteolytic and O-GlcNAcylation activity of OGT 
can be inhibited by a single amino acid change in the C-terminal catalytic domain (K842M) [406].  
Even though OGT does not cleave HCF-1 in C. elegans, this residue is in a highly conserved region 
of OGT and can be mutated in C. elegans OGT-1 (K957M) to completely inhibit any potential 
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OGT-1 proteolytic activity [319].  In my thesis project we use this amino acid change to 
demonstrate that OGT proteolytic activity is not required in the HTSR. 
1.6.2.3 The non-catalytic functions of OGT 
Finally, in addition to its catalytic activities, OGT also has non-catalytic functions.  These 
non-catalytic functions of OGT have only recently been described and the exact non-catalytic 
mechanism(s) remain poorly understood [371, 407, 408].  However, it has been hypothesized that 
OGT may act as a scaffolding and/or adaptor protein via its N-terminal TPR domain.  In fact, it 
has been demonstrated that the TPR domain of OGT is sufficient to repress transcription in 
mammalian cells via an interaction with the corepressor mSin3A.  The first six TPRs of OGT 
recruit mSin3A to promoters to repress transcription in both histone deacetylase dependent and 
independent pathways [371].  Therefore, the catalytic activity of OGT is not required for mSin3A 
gene transcriptional repression. 
OGT has also been shown to function non-catalytically in mammalian cell adhesion.  
Specifically, OGT inhibits the formation of the E-cadherin/catenin complex in H1299 cells by 
binding and inhibiting p120, which stabilizes the complex [407].  Although it was not explicitly 
tested, inhibition of the E-cadherin/catenin complex by OGT is hypothesized to decrease E-
cadherin/catenin mediated cell adhesion and thus promote metastasis in cancer cells [407].  
Interestingly, WT and catalytically impaired OGT (OGT H558A) inhibit this E-cadherin/catenin 
complex to the same extent suggesting that the catalytic activity of OGT is not required for this 
OGT function [407].  However, it remains unknown if the TPR domain is required for this 
interaction.  Experiments with a truncated TPR domain would help to address this question.  
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Additionally, the physiological consequences of this noncatalytic role of OGT still need to be 
addressed. 
Another described non-catalytic function of OGT is in the GABAergic motor neurons of 
C. elegans [408].  OGT forms a complex with the HECT family ubiquitin ligase EEL-1 to facilitate 
proper neuronal function [408].  Overexpression of catalytically impaired or dead OGT-1 (H612A 
or K957M respectively) in ogt-1 mutants rescues the impaired GABAergic motor neuron function, 
demonstrating that the catalytic activity of OGT is dispensable for this phenotype [408].  As with 
the function of OGT in cell adhesion, it is not known if OGT functions in the GABAergic neurons 
through a mSin3A – like mechanism that requires only the TPR domain. 
Although several examples of non-catalytic OGT function have been described, there is 
very little mechanistic insight into this newly discovered function of OGT.  The most is known 
about the role of OGT in transcriptional repression, where it acts as an adaptor protein via its first 
six TPRs to recruit mSin3A to the promoter of genes.  Whether OGT acts as an adaptor protein 
via its TPR domain in cell adhesion and GABAergic neurons remains to be explored.  In my thesis 
research, through unbiased genetic screens, we discovered another non-catalytic function of OGT.  
The TPR, but not catalytic activity, of OGT is required for ORG protein expression in the HTSR.  
The requirement of the TPR domain suggests that OGT may function as an adaptor – like protein 
in the HTSR similar to its function in mSin3A - mediated transcriptional repression.  However, 
continued genetic and biochemical experiments are required to more thoroughly mechanistically 
characterize the role of OGT in the HTSR. 
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1.6.3 The role of OGT in cellular processes 
Due to its wide variety of substrates, OGT is involved in numerous aspects of cell biology 
and physiology including insulin signaling, neurobiology, autophagy, and cellular stress responses.  
The majority of these cellular processes require the O-GlcNAcylation activity of OGT, but it is 
important to note that in several of the studies a complete OGT knockout, which ablates all OGT 
functions, was used .  Therefore, in many cases, the described cellular roles of OGT could be due 
to either catalytic or non-catalytic OGT functions.  However, my thesis project describes a new 
role of OGT in cell physiology that does not require its catalytic activity.  The diverse involvement 
of OGT in cell signaling highlights the multi-faceted nature of this enzyme and its importance in 
cellular function. 
1.6.3.1 OGT and insulin signaling 
In mammals, elevated O-GlcNAcylation due to increased flux through the HBP, inhibition 
of OGA, or overexpression of Ogt suppresses insulin signaling [409-411].  Specifically, O-
GlcNAcylation of protein kinase B (Akt) inhibits its phosphorylation and activation by the PDK1 
kinase in adipocyte cell culture and mice [410, 412].  Since phosphorylated Akt activates glucose 
uptake, O-GlcNAcylation of Akt inhibits glucose uptake and results in insulin resistance [410, 
412].  Additionally, knockout of ogt-1 suppresses the Dauer phenotype in C. elegans containing 
loss of function mutations in the IGFR homolog DAF-2 and increases glycogen stores in WT C. 
elegans, suggesting that OGT-1 also suppresses insulin signaling in C. elegans [413].   
In addition to Akt, several other components of the insulin signaling pathway, including 
Foxo1 and Irs1, are also O-GlcNAcylated [410, 414, 415].  Like Akt, O-GlcNAcylation of these 
proteins affects their phosphorylation status and inactivates them [410, 414, 415].  Physiologically, 
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OGT acts in a negative feedback pathway to dampen insulin signaling.  Insulin stimulates the PI3 
kinase to produce PIP3 at the plasma membrane which recruits OGT to the plasma membrane via 
a unique C-terminal phosphoinositide binding domain [416].  Once at the plasma membrane, OGT 
O-GlcNAcylates components of the insulin signaling pathway to inhibit insulin-stimulated glucose 
uptake [416]. 
Unlike in mammals and C. elegans, where OGT suppresses insulin signaling, O-
GlcNAcylation in Drosophila appears to activate insulin signaling.  In particular, O-
GlcNAcylation of Akt in Drosophila enhances its phosphorylation and thus activation [417].  
These contradictory results highlight the complex and species specific interplay between O-
GlcNAcylation and insulin signaling.  Additionally, an important consideration with all of these 
studies connecting OGT to insulin signaling is that although O-GlcNAcylation was measured and 
correlated with these pathways, none of these studies explicitly tested whether catalytically dead, 
but otherwise functional, OGT could operate in these pathways.  A demonstration that catalytically 
dead OGT is unable to modulate insulin signaling would strengthen the argument that the O-
GlcNAcylation activity of OGT mediates this cellular pathway. 
1.6.3.2 OGT and the nervous system 
Research primarily in C. elegans has demonstrated the importance of OGT in the nervous 
system.  Knockout of ogt-1 in C. elegans increases neuronal axon regeneration after neuronal laser 
ablation by promoting a switch from mitochondrial oxidative phosphorylation to glycolysis [418].  
Interestingly, knockout of oga-1, which correspondingly results in increased O-GlcNAcylation, 
also increases neuronal axon regeneration but through a distinct mechanism that involves 
modulation of mitochondrial dynamics [418].  The effects of ogt-1 and oga-1 knockdown on 
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neuronal regeneration are dependent on AKT and SGK1 insulin signaling pathways respectively 
[418].  While the roles of OGT-1 and OGA-1 in neuronal regeneration are presumed to be via their 
O-GlcNAcylation and O-GlcNAcase activities respectively, this has not been explicitly 
demonstrated by either identifying O-GlcNAcylated targets or testing catalytically inhibited ogt-1 
mutants. 
In addition to neuron regeneration, OGT is involved in cognitive function in both C. 
elegans and mammals.  In C. elegans, OGT-1 functions in primary sensory neurons to regulate a 
type of learning called habituation [419].  Habituation describes the phenomenon whereby the 
response of an organism to repeated stimuli decreases over time.  OGT-1 inhibits habituation at 
short interstimulus intervals and promotes habituation at long interstimulus intervals [419].  The 
molecular mechanisms through which OGT-1 operates to regulate habituation remain unknown.  
In mice, Ogt knockout in the hippocampus causes premature aging phenotypes and impairs 
learning and memory [420].  Correspondingly, overexpression of Ogt in the hippocampus of older 
mice partially rescues age related cognitive decline [420].  O-GlcNAcylation in the hippocampus 
decreases as animals age, suggesting that the O-GlcNAcylation activity of OGT may mediate the 
learning and memory phenotypes in ogt knockout and aging mice [420].  However, the catalytic 
involvement of OGT in hippocampal function has not been explicitly demonstrated and therefore 
it cannot be ruled out that another non-catalytic function of OGT mediates memory and learning 
in mice. 
Finally as described in Section 1.6.2.3, OGT-1 is required for proper GABAergic motor 
neuron function in C. elegans through an interaction with the ubiquitin ligase EEL-1 that does not 
require the catalytic O-GlcNAcylation activity of OGT-1 [408].  As these several examples 
indicate, OGT is required in a wide range of neuronal processes.  However, the mechanistic details 
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of how OGT functions in the nervous system are largely undescribed.  In particular, it is often 
assumed that the O-GlcNAcylation function of OGT is the critical function.  However, OGT 
knockout models remove all OGT functions and therefore they cannot be used to attribute 
phenotypes to O-GlcNAcylation defects.  Instead, inhibition of the catalytic activity of OGT using 
biochemical or genetic CRISPR/Cas9 approaches should be used to dissect apart the roles of OGT 
in the nervous system.   
1.6.3.3 OGT and autophagy 
In C. elegans, Drosophila, and mammals, OGT inhibits autophagy.  ogt-1 mutant C. 
elegans have increased starvation-induced autophagy and clearance of proteotoxic proteins [421]. 
Knockdown of ogt in Drosophila increases the number of autophagic structures, while ogt 
overexpression correspondingly decreases autophagesome and autolysosome number basally and 
following starvation [422].  Furthermore, in Drosophila, ogt overexpression decreases the 
expression of autophagy-related proteins, suggesting that OGT may regulate autophagy at the 
transcriptional level [422].  In contrast, in C. elegans and mammalian cells there is substantial 
evidence that OGT directly O-GlcNAcylates autophagy proteins to regulate autophagic flux [423].  
Specifically, OGT inhibits the maturation of autophagosome into autolysosomes by O-
GlcNAcylating the soluble N-ethylmaleimide–sensitive factor attachment protein receptor 
(SNARE) complex [423].  The SNARE complex mediates the fusion of autophagosomes with 
lysosomes to create the autolysosome.  However, O-GlcNAcylation of one of its components, 
SNAP-29, inhibits SNARE complex formation and thus autophagy [423].  During conditions that 
promote autophagy, such as starvation, O-GlcNAcylation of SNAP-29 is decreased [423].  While 
four O-GlcNAcylated residues on SNAP-29 have been mapped out and mutation of these O-
GlcNAcylated residues has been shown to decrease SNARE complex assembly and promote 
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autophagy, it has not been explicitly shown that catalytically-dead OGT is unable to inhibit 
autophagy [423].  Such an experiment is needed to unequivocally support the hypothesis that the 
O-GlcNAcylation activity of OGT is required to regulate autophagy. 
1.6.3.4 OGT and cellular stress responses 
Finally, OGT regulates several cellular stress responses via its O-GlcNAcylation activity.  
The fast and dynamic nature of O-GlcNAcylation is well suited to facilitate rapid activation and 
suppression of these pathways in response to changes in cellular conditions.  In particular, distinct 
roles for OGT in the cellular responses to oxidative stress, heat shock, ER stress, and infection 
have been described.  First, OGT-1 functions in the oxidative stress response in C. elegans by O-
GlcNAcylating the oxidative stress response master regulator and nuclear factor-erythroid-related-
factor (Nrf) homolog SKN-1 [424].  O-GlcNAcylation of SKN-1 at Ser470 and Thr493 increases 
during oxidative stress and promotes its nuclear localization by sterically inhibiting SKN-1 
phosphorylation at Ser483 by GSK-3 [424].  Ser483 phosphorylation by GSK-3 functions under 
basal conditions to inhibit SKN-1 nuclear accumulation [425]. 
OGT has also been implicated in the heat shock response in mammalian cells.  However, 
there is conflicting data about the mechanisms by which OGT functions in this response.  Most 
recently, a post-transcriptional role of OGT in the heat shock response has been described in mouse 
embryonic fibroblasts (MEFs).  In this study, knockout of Ogt in MEFs decreased chaperone (e.g. 
Hsp70 and Hsp25) protein induction during heat shock, but had no effect on the mRNA induction 
of these chaperones [426].  OGT regulates this heat shock chaperone protein induction by O-
GlcNAcylating eukaryotic translation initiation factor 4 gamma 1 (eIF4GI) at Ser68 [426].  O-
GlcNAcylation of eIF4GI at this residue dissociates it from poly(A)-binding protein 1 (PABP1), 
which functions in stress granules to bring the 5’ and 3’ ends of RNA together to facilitate cap-
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dependent translation [426].  Dissociation of eIF4GI and PABP1 thereby dissolves the stress 
granules and releases stress-induced mRNAs trapped in the stress granules to facilitate the 
selective translation of stress – induced mRNAs, such as those encoding Hsp70 and Hsp25 [426].  
However, earlier studies conflict with a post-transcriptional role of OGT in the heat shock 
stress response.  One study found that OGT was required for the transcriptional upregulation of 
eighteen molecular chaperones during heat stress in MEFs [427].  OGT facilitates the induction of 
these chaperones by stimulating the phosphorylation of GSK-3, which in turn inhibits it and 
prevents it from phosphorylating HSF-1 at Ser303 [427].  Phosphorylation of HSF-1 at this site is 
inhibitory for the downstream induction of chaperones and therefore inhibiting this 
phosphorylation correspondingly activates chaperone transcriptional induction [427].  
Furthermore, another study found that knockout of Ogt in Chinese hamster ovary (CHO) cells 
decreased their survival during heat stress, but had no effect on heat shock chaperone protein 
induction, including Hsp70 [428].  Instead, knockout of OGT increased protein aggregation during 
heat stress, which decreased cell survival [428].   
While there are conflicting data about how OGT regulates the heat shock response, it is 
clear that OGT is required for mammalian cells to mount a normal response to and survive heat 
shock.  In particular, there is consensus that the O-GlcNAcylation activity of OGT is required in 
this response, although this has not been thoroughly tested using a catalytic dead version of OGT.  
However, whether OGT acts through a transcriptional, post-transcriptional, protein homeostasis, 
or combined mechanism remains unclear.  A multi-faceted involvement of OGT in the heat shock 
response likely explains these seemingly contradictory results. 
As with the heat shock response, there is also evidence that OGT post-transcriptionally 
regulates the ER UPR [429].  During ER stress in mammalian cells OGT O-GlcNAcylates eIF2α 
 
  80 
at three residues [429].  The O-GlcNAcylation of eIF2α inhibits its phosphorylation at Ser51.  
Since phosphorylation of eIF2α promotes the selective translation of stress-induced pro-apoptotic 
mRNAs like C/EBP homologous protein (CHOP), O-GlcNAcylation inhibits the translation of 
these pro-apoptotic factors and thus protects cells from apoptosis during ER stress [429]. 
Finally, OGT has been implicated in the innate immune response during bacterial infection 
in C. elegans [430].  ogt-1 mutants have decreased survival during exposure to Staphylococcus 
aureus, but interestingly not during exposure to Pseudomonas aeruginosa [430].  Therefore OGT-
1 is required for pathogen specific innate immunity.  OGT-1 does not function in this innate 
immune response through a p38 MAPK pathway, even though p38 MAPK signaling is integral to 
the innate immune response to S. aureus [430].  Rather, OGT facilitates the survival of C. elegans 
during exposure to S. aureus through a pathway with the innate immunity regulator and C. elegans 
β-catenin homolog BAR-1 [430]. 
In conclusion, OGT is involved in several different cellular stress responses including the 
oxidative stress response, the heat shock response, the ER stress response, and pathogen infection.  
The involvement of OGT in all these stress responses is presumed to be via its O-GlcNAcylation 
activity.  This has been tested in all cases except for the pathogen response by mutating OGT 
substrate residues to prevent their O-GlcNAcylation.  Work from my thesis project adds to the list 
of stress responses in which OGT is involved.  I found that OGT is critical to the HTSR.  OGT is 
required for both organismal adaptation to HTS and the upregulation of the protective compatible 
osmolyte accumulation protein GPDH-1.  As in the case of the heat shock and ER stress response, 
I present evidence that OGT functions through a post-transcriptional mechanism to regulate this 
protective protein upregulation.  However, unlike the stress responses OGT has previously been 
implicated in, I demonstrate that the O-GlcNAcylation activity of OGT is dispensable for the 
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HTSR.  This suggests that OGT functions through a unique mechanism, different from that of the 
other stress responses, to regulate the HTSR.   
1.6.4 The essential function of OGT 
Ogt is an essential gene in almost all metazoans.  C. elegans is the only organism that 
expresses ogt, but that does not require OGT for cellular viability [413].  Expression of Ogt is 
required for the completion of embryogenesis in Drosophila [431] and for cell division and cell 
cycle progression in mammalian cells [432].  Knockout of Ogt in replicating mammalian cells 
causes cell death [433].  Furthermore, even though postmitotic mammalian cells are able to survive 
without Ogt, their function is significantly impaired.  Mice with neuronal specific Ogt knockout 
survive ten days, but have compromised locomotion and neuronal defects [432].  Likewise, 
knockout of Ogt in mice cardiomyocytes from the start of development leads to increased fibrosis, 
apoptosis, and hypertrophy, altered gene expression, and increased cell stress activation in the 
heart [434].  The heart function in these animals is so poor that only 12% survive to 4 weeks old.  
Additionally, conditional knockout of Ogt in adult cardiomyocytes has no short term effects, but 
within a month results in cardiomyopathy [434].  Therefore, even in non-replicating cells, OGT is 
required for proper cell function. 
It is largely unknown whether O-GlcNAcylation, proteolysis of HCF-1, or a non-catalytic 
function of OGT is essential in mammalian cells.  If O-GlcNAc cycling is required for cell 
viability, then disruption of the enzyme that removes O-GlcNAc, OGA, should also impede cell 
division.  However, unlike Ogt knockout mice, Oga knockout mice have a limited capacity to 
develop.  They have stunted growth and die within a day of birth, but their cells nevertheless retain 
the ability to divide [435].  Furthermore, treatment of cells with an uncleavable UDP-GlcNAc 
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analog, Ac4-5SGlcNAc, significantly decreases O-GlcNAcylation, but does not affect the 
proliferation of CHO cells, suggesting that these cells do not require O-GlcNAcylation for cell 
division [436].  In contrast to these data, there is also some evidence that O-GlcNAcylation is 
required for the essential functions of OGT.  Decreasing intracellular UDP-GlcNAc levels by 
knocking out glucosamine-6-phosphate (EMeg32), which is required for UDP-GlcNAc synthesis, 
reduces proliferation in MEF cells [437].  Interestingly, EMeg32 knockout cells still retain 2 – 
33% of the normal intracellular UDP-GlcNAc concentration [437].  This observation may explain 
why proliferation is reduced and not completely inhibited in these cells and suggests there is a 
redundant pathway for UDP-GlcNAc synthesis .  Finally, inhibition of OGT O-GlcNAcylation 
activity with the small molecule OSMI-1 decreases CHO cell viability to 50% within 24 hours, 
supporting the requirement of O-GlcNAcylation activity for cellular viability [438].  However, a 
small molecule structurally related to OSMI-1 that did not inhibit OGT O-GlcNAcylation activity 
affected cell viability to the same extent as OSMI-1, suggesting that OSMI-1 functions through an 
OGT-1 independent pathway to regulate cell viability [438].  The mechanism of OSMI-1 inhibition 
has not been determined and it thus cannot be ruled out that OSMI-1 inhibits other OGT functions, 
such as its proteolytic and non-catalytic functions.  Therefore, whether or not O-GlcNAcylation is 
required for cellular viability remains an open question.  
Proteolysis of HCF-1 by OGT is likely not the essential function of OGT in mammalian 
cells.  Cleavage of HCF-1 by OGT is not required for cell cycle progression in mammalian cells 
[400].  Furthermore, HCF-1 depleted cells have impaired cytokinesis, which results in a 
binucleation phenotype that is not seen in Ogt knockout cells [400].  Therefore, cells lacking HCF-
1 do not display the same phenotypes as cells lacking OGT, suggesting that inhibited HCF-1 
cleavage is not what leads Ogt knockout cells to die.  Finally, as with O-GlcNAcylation activity, 
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treatment of cells with the UDP-GlcNAc analog Ac4-5SGlcNAc inhibits the proteolytic activity of 
OGT, but does not affect the proliferation of CHO cells [404, 436].  These data in combination 
suggest that the proteolytic activity of OGT is not required for cellular viability. 
Since neither the O-GlcNAcylation nor the proteolytic activity of OGT appear to be 
required for cell proliferation, this suggests that OGT may function via a non-catalytic mechanism 
to facilitate cell survival.  The details of this non-catalytic mechanism remain uncharacterized, but 
may involve protein interactions via the TPR domain of OGT.  It is also not understood why, in 
contrast to other metazoans, ogt-1 knockout C. elegans appear grossly WT.  My thesis project 
begins to address these question because we discovered that, while ogt-1 is not essential in C. 
elegans under normal isotonic laboratory conditions, it is essential for C. elegans survival in 
hypertonic environments.  Since the HTS and cell division both affect cell volume, this suggests 
that OGT may more broadly be required for cell volume regulation in all metazoans.  
1.6.5 Conclusions 
OGT was first discovered because of its catalytic O-GlcNAcylation activity, but it clearly 
has other non-enzymatic functions.  The rapid nature of this PTM, in combination with its 
sensitivity to the nutrient status of the cells, implicates it in numerous cellular pathways including 
stress responses and insulin signaling.  While the nature of OGT’s involvement in these cellular 
pathways has benefitted greatly from the availability of Ogt knockout cells/organisms and tagged 
OGT proteins, many questions still remain about how OGT is regulated and how OGT achieves 
substrate specificity.  Importantly, O-GlcNAcylation is not the only function of OGT.  OGT also 
proteolytically cleaves one target protein, HCF-1, and has largely uncharacterized non-catalytic 
roles in cells.  Furthermore, Ogt is essential in all metazoans except for C. elegans.  The required 
 
  84 
function(s) of OGT in these organisms are not well understood, but several pieces of evidence 
suggest that the catalytic activities of OGT are dispensable for cell viability.   
In my thesis project I demonstrate that OGT is essential in the HTSR.   My findings not 
only add to the growing list of cellular pathways OGT plays a role in, but they also describe a 
novel non-catalytic function of OGT that requires the TPR domain.  Furthermore, the requirement 
for OGT during HTS in C. elegans and during cell division in mammalian cells supports the 
hypothesis that OGT is generally required for cell volume regulation because both cell division 
and HTS impact cell volume.  However, significant work is still required to understand the precise 
role OGT may play in cell volume regulation. 
1.7 The 3’mRNA cleavage and polyadenylation complex 
In my genetic screen for regulators of the C. elegans HTSR, I identified mutations in two 
interacting components of the 3’ mRNA cleavage and polyadenylation complex (cpf-2 and symk-
1) that blocked hypertonic induction of gpdh-1 and prevented adaptation to hypertonic 
environments.  This was a surprising discovery because it implicates a protein complex that is 
required for most types of gene expression in the specific upregulation of ORGs.  The unbiased  
forward genetic screens I performed in C. elegans was essential for this discovery because the null 
phenotype for the genes in this complex is lethal.  Therefore, the role of these genes in the HTSR 
was only revealed due to the discovery of unique LOF missense alleles that did not completely 
ablate their essential functions. 
Adenine nucleotide repeat sequences (poly(A) sequences) on the 3’ end of mRNA 
transcripts were first discovered in the mid twentieth century through analysis of thymus extract 
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[439].  The nuclear and cytoplasmic localization of these poly(A) mRNA 3’ tails led to the 
hypothesis that eukaryotic precursor mRNA molecules are co-transcriptionally cleaved and 
polyadenylated to create the mature mRNA species [440, 441].  This 3’ mRNA cleavage and 
polyadenylation of transcripts is required to promote the transcriptional termination, nuclear 
export, protection from degradation by 3’ exonucleases, and translation of mRNA in the cytoplasm 
[442-445].  
More than 80 proteins in mammals make up the 3’ mRNA cleavage and polyadenylation 
complex and facilitate its two enzymatic activities, cleavage and polyadenylation [446, 447].  The 
mammalian 3’ mRNA cleavage and polyadenylation complex contains eight major subcomplexes 
each made up of multiple proteins: the cleavage and polyadenylation specificity factor (CPSF), the 
cleavage stimulation factor (CstF), cleavage factor I (CF Im), cleavage factor II (CF IIm), poly(A) 
polymerase (PAP), poly(A) binding protein (PABP), symplekin (SYMPK), and RNAP II [447].  
The CPSF complex recognizes the polyadenylation signal sequence (PAS) at the 3’ end of mRNA, 
recruits the other components of the larger 3’ mRNA cleavage and polyadenylation complex to 
the PAS, and catalyzes 3’ cleavage of the mRNA [448].  Once recruited by the CPSF complex, the 
CstF complex binds the mRNA via  its N-terminal RNA-recognition motif (RRM) [449] and the 
two CF complexes (CF Im and CF IIm) stabilize these RNA interactions while SYMPK stabilizes 
the entire structure [442, 450, 451].  PAP is a template independent polymerase that poly-
adenylates the 3’ end of mRNAs [452].  The entire 3’ mRNA cleavage and polyadenylation 
complex is assembled on the CTD of RNAP II [453, 454].  The association of any one of these 
subcomplexes with RNA is weak, but together they form a stable and high affinity interaction 
[448].   
 
  86 
1.7.1 Mechanism of 3’ mRNA cleavage and polyadenylation 
The first step in 3’ mRNA cleavage and polyadenylation is recognition of the 3’ 
untranslated region (3’ UTR).  This is most frequently done via the presence of a PAS in the 3’ 
UTR.  The PAS is highly conserved and 10-30 nucleotides upstream of the mRNA cleavage site 
[455].  The canonical PAS sequence in mammalian cells is AAUAAA, although some variation in 
this sequence is tolerated [442, 447, 456].  The 3’ UTR is also defined by the downstream element 
sequence (DSE), which is located about 30 nucleotides downstream of the cleavage site [457].  
The DSE is less well conserved than the PAS, but it is generally a GU or U rich sequence [457].  
Finally, there is the actual cleavage site which is located between the PAS and DSE in the 3’ UTR 
and this is where the poly(A) tail is added onto the mRNA.  While the cleavage site is not very 
well conserved, the most optimal cleavage occurs between adjacent C and A nucleotides [455]. 
The assembly of the large 3’ mRNA cleavage and polyadenylation complex begins when 
the CPSF complex co-transcriptionally binds the PAS in the 3’ UTR [458] .  The CPSF subunits 
CPSF160 and FIP1 alone are able to bind the PAS sequence on the mRNA, but they require the 
other components of the CPSF complex to bind with full affinity and specificity [459, 460].  Once 
bound to the PAS, the CPSF complex recruits the rest of the 3’ mRNA processing complex in a 
SYMPK dependent manner [461].  SYMPK is an adaptor protein that interacts with several 
components of the 3’ mRNA cleavage and polyadenylation complex to facilitate its assembly.  
SYMPK is required for both the cleavage and polyadenylation of the mRNA [461].  The interaction 
between the CPSF complex and the transcript is further enhanced by the recruitment and 
subsequent interaction of the CstF complex with the DSE [462].  Among the proteins recruited to 
the PAS are the CF Im and CF IIm complexes, which stabilize the CPSF-CstF interaction, bind the 
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mRNA, and are required for mRNA cleavage [450].  Additionally, the CTD of RNAP II interacts 
with CPSF and CstF to stabilize formation of the entire complex [454]. 
Once the 3’ mRNA cleavage and polyadenylation complex has been fully assembled, the 
endonuclease CPSF-73 cleaves the mRNA at the cleavage site [463].  CPSF-73 contains metallo-
beta-lactamase and beta-CASP domains that are known endonucleases and CPSF-73 alone is 
therefore sufficient to cleave mRNA in vitro [463].  After the mRNA is successfully cleaved, the 
CPSF complex remains bound to the PAS and recruits PAP [460].  CPSF anchors PAP to the 
mRNA so that it can use ATP to add 150-250 adenosines to the 3’ end of the transcript in a 
template-independent manner [448, 464].  Without CPSF, PAP has no specificity for mRNA 
substrates [458, 464].  PABP functions with PAP to regulate the length of the poly(A) tail and 
increase the efficiency with which PAP lengthens the poly(A) tail [465].  
Before the newly polyadenylated transcript can be exported from the nucleus, the 3’ mRNA 
cleavage and polyadenylation complex must be disassembled.  Disassembly is poorly understood 
in mammalian cells.  However, data from yeast suggest that CF IIm (PcfII in yeast) binds the RNAP 
II CTD to initiate disassembly of the complex and transcriptional termination [466].  Additionally, 
there is evidence that the entire 3’ mRNA cleavage and polyadenylation complex does not 
dissociate from the mRNA [467].  At least a few cleavage and polyadenylation factors, such as CF 
Im 68, remain associated with the mRNA and act as adaptors for the mRNA export receptor 
NXF1/TAP to promote export of the processed mRNA [467]. 
1.7.2 Alternative polyadenylation  
Virtually all eukaryotic mRNAs are processed by the 3’ mRNA cleavage and 
polyadenylation complex, with histone encoding mRNAs representing an important exception 
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[468].  Interestingly, many mRNA transcripts contain more than one PAS [469, 470].  This allows 
for modulation of the polyadenylation site, a phenomenon called alternative polyadenylation 
(APA).  APA is carried out by the 3’ mRNA cleavage and polyadenylation complex, which has 
led the field to refer to it as the APA complex [471].  At least 79% of transcripts in mammals [469] 
and 40% of transcripts in C. elegans undergo APA  [470].  APA functions to regulate gene 
expression and/or increase the diversity of transcripts made from a single gene. 
APA can occur in two distinct ways.  First, genes can have multiple PAS sites in the 3’ 
UTR (3’ UTR APA) [472, 473].  This creates mRNA isoforms with the same coding sequence but 
short or long 3’ UTRs.  Long 3’ UTRs contain sequences that are subject to post-transcriptional 
regulation by miRNA, RNA binding proteins, and long non-coding RNAs that may be lacking in 
short mRNAs [474].  Additionally, long 3’ UTRs can alter several aspects of mRNA biology, 
including stability, translation, localization, and nuclear export [471, 475].  Since short 3’ UTRs 
can escape these additional layers of regulation, they are often more stable and are therefore present 
under conditions necessitating rapid translation, such as in stress responses and proliferation [474, 
476]. 
A second type of APA is termed Upstream Region APA (UR-APA).  This type of APA 
differentially utilizes PAS sequences upstream of coding exons [472].  This results in mRNA 
isoforms that encode different protein sequences, as well as different 3’ UTRs.  UR-APA proteins 
can carry out different cellular functions, including activation or inhibition of cellular signaling or 
even auto-regulation of APA itself [477, 478].  Therefore, both 3’ UTR APA and UR-APA can 
have major consequences for cellular and organismal biology. 
APA is regulated primarily in two ways.  First, expression of the APA complex can be 
modulated to affect PAS usage.  In general, decreased expression of the APA complex promotes 
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distal PAS usage and increased expression of the APA complex promotes proximal PAS usage 
[479, 480].  This trend can be explained by the observation that the APA complex generally has a 
higher affinity for the distal PAS than the proximal PAS [473, 481].  Therefore, when the cleavage 
and polyadenylation machinery is not the limiting factor, the first (most proximal) PAS 
encountered by the machinery is used.  However, in actuality the relationship between expression 
of the APA complex and PAS usage is much more complicated than these general trends imply.  
For example, knockdown of specific subunits of the CF Im subcomplex decreases expression of 
the APA complex [482, 483].  This should lead to increased utilization of distal PAS sites and 
longer mRNAs.  However, the opposite is observed, i.e. CF Im knockdown leads to increased usage 
of proximal PAS sites and thus to global shortening of 3’ UTRs [482, 483].  This is hypothesized 
to be due to the recognition of specific sequences enriched near the distal PAS by the CF Im 
subunits.  Therefore, when these subunits are expressed, global use of distal PAS sequences is 
promoted [482, 483]. 
APA is also regulated through auxiliary factors, in particular RNA binding proteins 
(RBPs).  RBPs can both inhibit APA complex formation at canonical PAS sites [484] and promote 
3’ mRNA processing complex formation at alternative PAS sites [485].  RBPs that regulate 
splicing also regulate APA because there is often interplay between splicing and APA, particularly 
in the case of UR-APA.  Intronic PAS usage increases in genes with weak intronic 5’ splice sites 
and when splicing is inhibited by knockdown of RBPs that promote splicing [486, 487].  This 
increase in UR-APA when splicing is inhibited may represent redundancy to ensure proper protein 
expression [486, 487].   In addition to splicing RBPs, other RBPs such as SR proteins [488] and 
embryonic lethal abnormal vision (ELAV) proteins [489], also regulate APA in a context 
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dependent manner.  The exact mechanisms by which these RBPs regulate APA are largely 
unknown. 
The APA complex is able to modulate gene expression through APA.  For example, the 
CstF subunit CstF-64 regulates the expression of membrane-bound and secreted immunoglobulin 
M heavy chain (IgM H-chain) through APA [490].  Low CstF-64 levels promote the expression 
of membrane-bound IgM H-chain from a distal higher affinity PAS [490].  In contrast, during B 
cell activation, the expression of CstF-64 is increased and this promotes the expression of secreted 
IgM H-chain from a proximal lower affinity PAS because it is the first encountered PAS [490].  In 
this way, the APA complex is able to directly influence IgM H-chain isoform expression.  
Surprisingly, despite being required for general gene expression, knockdown of CstF-64 by 10% 
specifically affects IgM H-chain expression in B cells, without affecting the expression of other 
genes [490].  One hypothesis that may explain this specific effect is that CstF-64 has a lower 
affinity for the PAS sites in the IgM H-chain transcript than it does for other transcripts and 
therefore IgM H-chain PAS sites are more drastically affected by CstF-64 knockdown [490]. 
APA also affects expression of the cytoskeletal protein ankyrin in C. elegans [491].  There 
are three isoforms of ankyrin expressed via different PAS site usage.  Expression of the longest 
ankyrin isoform, giant ankyrin, in neurons facilitates stabilization of the mature C. elegans nervous 
system by preventing neuronal growth cone growth [491].  Casein kinase 1δ (CK1δ) promotes the 
formation of giant ankyrin by inhibiting usage of the most proximal and middle PAS in the ankyrin 
transcript [491].  Therefore, ck1δ mutants exhibit paralysis and disordered nervous system 
phenotypes [491].  However, missense mutations in several APA complex components or in 
ankyrin’s proximal PAS sites themselves suppress the ck1δ mutant phenotypes because they allow 
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read through of the most proximal PAS sites, which leads to expression of the giant ankyrin 
isoform [491].   
APA is also utilized by cells to change gene expression during cellular stress responses 
[492].  For example, arsenic induced oxidative stress causes global shortening of 3’ UTRs via APA 
[476].  Transcripts with shorter 3’ UTRs are generally more stable than transcripts with longer 
3’UTRs [474].  Therefore by biasing towards short 3’ UTRs via APA, cells preserve transcripts 
crucial for the oxidative stress recovery process [476].  Following a similar theme, APA allows 
for the increased expression of Hsp70.3 during ischemia and heat shock [493].  These cellular 
stresses promote the usage of a proximal PAS to create Hsp70.3 transcripts with short 3’ UTRs 
[493].  These shortened 3’ UTRs make the Hsp70.3 transcripts more stable because they do not 
contain the miRNA targeting sites and other cis elements found in the longer 3’ UTR [493].  
Interestingly, the transcription factor that regulates Hsp70.3 transcription, HSF1, interacts with the 
APA complex components SYMPK, CstF-64, and CPSF during heat shock [493].  This supports 
the hypothesis that the 3’ mRNA cleavage and polyadenylation complex is recruited to the Hsp70.3 
transcript by HSF1 [493]. 
1.7.3 Conclusions 
The APA complex is required for the addition of 3’ poly(A) tails onto mRNA transcripts 
prior to their export form the nucleus.  Despite the general requirement for this complex in the 
modification of all transcripts exiting the nucleus, knockdown of components of the 3’ APA 
complex affects the expression of specific genes via APA.  Therefore, modulation of the 3’ APA 
complex is a way for cells to post-transcriptionally regulate gene expression.  However, the 
mechanisms through which this occurs are still largely undefined. 
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Intriguingly, I identified unique LOF missense alleles of two conserved components of the 
APA complex, SYMPK (SYMK-1 in C. elegans) and CstF-64 (CPF-2 in C. elegans), in a forward 
genetic screen for genes required for ORG induction in C. elegans.  These components of the APA 
complex are also required for C. elegans to adapt to HTS.  We do not know how these missense 
alleles affect the functions of SYMK-1 and CPF-2 or their interactions with other members of the 
3’ mRNA processing complex.  Additionally, we do not know if they function in the same pathway 
as OGT in the HTSR.  However, the identification of these proteins as critical to the HTSR 
suggests that, as with other cellular stress responses, APA may be involved in the regulation of 
ORGs during HTS. 
1.8 Conclusions 
The HTSR is a conserved and essential way in which cells counter the decreased cell 
volume and increased intracellular ionic strength that occur when extracellular solute 
concentration is increased.  A conserved physiological component of the HTSR is the intracellular 
accumulation of compatible osmolytes.  These small organic solutes are accumulated to molar 
concentrations within cells without affecting general cellular functions and are required for long 
term adaptation to HTS.  Importantly, these compatible osmolytes are universally accumulated via 
the transcriptional upregulation of either osmolyte transport proteins or biosynthetic enzymes.  
Osmolyte accumulation genes are among hundreds of genes differentially regulated by HTS.  
Therefore upon sensing increases in extracellular osmolarity, cells transmit signals to the nucleus 
to modulate gene expression.   
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Many of the signaling proteins and transcription factors that make up osmosensitive 
signaling pathways have been characterized in single celled organisms and plants.  However these 
pathways are less well understood in multicellular organisms.  In mammals, a master 
transcriptional regulator of the HTSR, NFAT5, has been identified.  However, not all genes are 
upregulated during HTS in a NFAT5 dependent manner in mammals and not all multicellular 
organisms express rel family transcription factors like NFAT5.  Therefore, other mechanisms to 
modulate gene expression during HTS must exist.  Furthermore, even in the case of NFAT5 
dependent osmosensitive gene expression, the proteins and mechanisms cells use to sense 
increases in extracellular osmolarity and how these signals are integrated to activate NFAT5 are 
poorly understood. 
In my thesis project I identified three novel proteins regulating both ORG induction and 
physiological adaptation during HTS in C. elegans.  These proteins include the O-GlcNAc 
transferase OGT-1 and two interacting components of the APA complex: CPF-2 and SYMK-1.  
OGT is a highly conserved enzyme that O-GlcNAcylates serine and threonine residues of hundreds 
of intracellular proteins, proteolytically cleaves the cell cycle regulator HCF-1, and functions non-
catalytically as a putative scaffolding protein.  Through these functions OGT regulates diverse 
cellular processes including metabolism, gene expression, and cellular stress responses.  
Importantly, OGT function is required in mammalian cells for cell division.  While research in the 
field has largely focused on the catalytic activities of OGT, its non-catalytic functions are less well 
understood.  In particular, it is unknown how widespread the non-catalytic activity of OGT is, 
which protein domains are required for its non-catalytic function, and if the non-catalytic function 
of OGT is essential for mammalian cell division.  My thesis project begins to address these 
questions.  I found that OGT is required for the post-transcriptional induction of the 
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osmoprotective gene GPDH-1 and the long term viability of C. elegans in hypertonic conditions.  
Surprisingly, this function of OGT in the HTSR is independent of its O-GlcNAcylation and 
proteolytic catalytic activities.  However, it requires the protein interacting TPR domain of OGT.  
These discoveries were only possible in C. elegans because, unlike other organisms, ogt null 
mutants are uniquely viable under control conditions.  Furthermore, the conditional requirement 
for ogt expression during HTS in C. elegans provides a valuable platform from which to investigate 
the conserved essential functions of OGT. 
The other two proteins I identified as being required for the HTSR, the cleavage stimulation 
factor subunit 2 homolog CPF-2 and the symplekin homolog SYMK-1, are part of the conserved 
APA complex.  This complex is required for the cleavage and polyadenylation of most mRNAs 
prior to their export from the nucleus.  Because many transcripts have multiple PAS sites in their 
3’ UTR and/or coding sequence, the APA complex can regulate gene expression by altering 3’ 
UTR length and protein isoform expression.  Additionally, despite the general requirement for the 
APA complex in mRNA processing, mutations in components of the APA complex have been 
shown to  preferentially change the expression of particular genes.  Changes in PAS site usage by 
the APA complex can be induced by cellular stress to modulate gene expression.  Therefore, the 
APA complex is a highly dynamic multi-faceted complex with functions that extend beyond 
general mRNA processing.  However, the mechanisms through which this complex regulates 
inducible gene expression are not well understood.  In my thesis project, I describe two novel 
missense alleles of cpf-2 and symk-1 that impair ORG induction and physiological adaptation to 
HTS.  These two missense alleles will not only allow us to characterize a potential role of APA in 
the HTSR, but they will also provide clues to how the APA complex modulates the expression of 
specific genes despite being required for general mRNA processing. 
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2.0 Results 
We employed unbiased genetic methods in C. elegans to characterize the metazoan HTSR.  
In response to HTS, C. elegans induces the robust upregulation of the osmolyte accumulation gene 
gpdh-1.  To characterize the cellular pathways required for gpdh-1 upregulation, we designed a 
forward genetic screen to identify mutants with impaired hypertonic induction of gpdh-1.  I 
focused on three mutants from this screen because they not only had impaired hypertonic induction 
of gpdh-1p::GFP, but they were also unable to acutely adapt to HTS.  Upon further 
characterization of these three mutants I identified novel and unexpected HTSR regulatory 
pathways. 
2.1 Identification of mutant C. elegans with impaired induction of the hypertonic stress 
response through an unbiased, fluorescence based, forward genetic screen 
In C. elegans, HTS rapidly and specifically upregulates expression of the osmolyte 
biosynthesis gene gpdh-1, which we visualized with a gpdh-1p::GFP transcriptional reporter.  To 
optimize this reporter for genetic screening, we added a col-12p::dsRed reporter, whose expression 
is not affected by HTS and serves as an internal control for non-specific effects on gene expression.  
This dual reporter strain (drIs4) expresses only dsRed under isotonic conditions and both dsRed 
and GFP under hypertonic conditions, with very few animals exhibiting an intermediate phenotype 
(Fig 2.1.1A, 2.1.1B, and 2.1.1C).  A gpdh-1p::GPDH-1-GFP translational reporter (kbIs6) is also 
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upregulated by HTS, but exhibits more variability than the drIs4 transcriptional reporter (Fig 
2.1.1D, 2.1.1E, and 2.1.1F).  
 
Figure 2.1.1 gpdh-1 transcriptional and translational reporters are upregulated by HTS  
(A) Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 (col-12p::dsRed;gpdh-1p::GFP) 
exposed to 50 or 250 mM NaCl for 18 hours.  Images depict merged GFP and RFP channels.  Scale bar = 100 microns. 
(B) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 50 or 
250 mM NaCl NGM plates for 18 hours.  Each point represents the quantified signal from a single animal.  N ≥ 276 
for each group.  (C) Population mean of the normalized GFP/RFP ratio from data in B.  Data are expressed as mean 
± S.D. with individual points shown.  **** - p < 0.0001 (Mann-Whitney test). (D) Wide-field fluorescence microscopy 
of day 2 adult animals expressing kbIs6 (gpdh-1p::GPDH-1-GFP) translational fusion protein exposed to 50 or 250 
mM NaCl NGM plates for 18 hours.  Scale bar = 100 microns.  (E) COPAS Biosort quantification of GFP and time 
of flight (TOF) signal in day 2 adult animals expressing the kbIs6 translational fusion protein exposed to 50 or 250 
mM NaCl NGM plates for 18 hours. N ≥ 276 for each group.  (F) Population mean of the normalized GFP/TOF ratio 
from data in E.  Data are expressed as mean ± S.D. **** - p < 0.0001 (Mann-Whitney test). 
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Taking advantage of the binary nature of GFP activation by HTS in the drIs4 strain, we 
designed an unbiased F2 forward genetic screen for mutants that fail to activate GFP expression 
during HTS, but still express RFP (No induction of osmolyte biosynthesis gene expression or Nio 
mutants).  Briefly, I mutagenized hermaphrodite animals with N-ethyl-N-nitrosourea (ENU) and 
screened the F2 generation as day one adults exposed to 250 mM NaCl agar plates for ~18 hours 
(Fig 2.1.2A).  From this screen of ~120,000 haploid genomes, I identified ten mutants that failed 
to activate gpdh-1p::GFP during HTS, but that still expressed col-12p::dsRed (Fig 2.1.2B and 
2.1.2C).  I determined that these ten mutants contained recessive single-gene mutations by crossing 
each mutant back to WT males and testing the gpdh-1p::GFP phenotypes of their cross-progeny 
and the self progeny of those cross progeny during HTS.  If an individual Nio mutant is a recessive 
allele of a single gene, then the number of Nio (impaired gpdh-1p::GFP induction on 250 mM 
NaCl NGM plates) males from a cross of nio x WT (i.e nio/+) should be 0% and the number of 
Nio animals among self progeny of nio/+ hermaphrodites should be about 25% (Table 2.1.1).  
After determining that these ten mutants had recessive single gene phenotype-causing mutations, 
I used genetic complementation testing to demonstrate that they represented seven genes, nio-1 
through nio-7 (Table 2.1.2).  To do this genetic complementation testing, I crossed each Nio mutant 
to each other Nio mutant two times, once as a hermaphrodite and once as a heterozygous male.  
Mutant crosses complemented (i.e. phenotype causing mutations are in different genes) when 0% 
of progeny were Nio and failed to complement (i.e. phenotype causing mutations are in the same 
gene) when ~50% of progeny were Nio (Table 2.1.2). 
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Figure 2.1.2 Seven nio genes are required for the upregulation of the gpdh-1 transcriptional reporter by HTS  
(A) ENU-based forward genetic screening strategy and mutant identification workflow.  (B) Wide-field fluorescence 
microscopy of day 2 adult drIs4 and nio;drIs4 mutant animals exposed to 50 or 250 mM NaCl NGM plates for 18 
hours.  Images depict merged GFP and RFP channels.  Scale bar = 100 microns.  (C) COPAS Biosort quantification 
of GFP and RFP signal in day 2 adult animals expressing drIs4 or nio;drIs4 exposed to 250 mM NaCl NGM plates 
for 18 hours.  Data are represented as the relative fold induction of normalized GFP/RFP ratio on 250 mM NaCl plates 
versus 50 mM NaCl NGM plates.  Each point represents the quantified signal from a single animal.  Data are expressed 
as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test). N ≥ 38 for each group. 
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Table 2.1.1 The genetics of the nio genes are consistent with recessive single gene alleles 











from a cross 





* Data not collected
0/7 (0%)
0/34 (0%) 16/40 (40%)
0/15  (0%) 17/70 (24%)
0/20  (0%) 15/70 (21%)
0/12 (0%) 13/65 (20%)
0/20  (0%) 8/35 (23%)
0/6 (0%) 9/45 (20%)
nio-7(dr23) [ENU4 7c#2]
#1 0/9 (0%) 6/50 (12%)
#2 0/20  (0%) 8/50 (16%
#3 0/9 (0)%) 8/45 (18%)
nio-5(dr22) [ENU4 5a#1]
#1 0/12 (0%) 5/21 (24%)
#2 0/20  (0%) 5/15 (33%)
#3
nio-2(dr20) [ENU3 2c#2]
#1 0/20  (0%) 3/17 (18%)
#2 * 7/34 (21%)
#3
nio-6(dr19) [ENU3 3d#2]
#1 0/18 (0%) 4/18 (22%)
#2 * 4/16 (25%)
#3
nio-5(dr18) [ENU2 7a#2]
#1 0/10 (0%) 16/41 (39%)
#2 0/15  (0%) 6/23 (26%)
#3
nio-4(dr17) [ENU2 6a#5]
#1 0/9 (0%) 9/56 (16%)
#2 0/6 (0%) 6/30 (20%)
#3
0/15  (0%) 13/65 (20%)
nio-3(dr16) [ENU1 2c#4]






#1 0/30 (0%) 8/27 (30%)







#3 0/20  (0%) 9/50 (18%)
nio-5(dr13) [ENU2 9a#1]
0/30 (0%) 6/29 (21%)
0/20  (0%) 9/36 (25%)
0/25 (0%) 12/40 (30%)
1/20 (5%) 5/27 (19%)
#2 0/15  (0%) 6/37 (16%)
 
  100 
Table 2.1.2 Genetic complemention of the nio alleles 
Fractions represent the number of animals with a Nio phenotype (impaired gpdh-1p::GFP induction on 250 mM NaCl 
NGM plates) over the total number of animals observed.  Males were heterozygous for the nio mutation.  Mutant 




Since the nio genes were required for induction of the gpdh-1p::GFP transcriptional 
reporter by HTS, we hypothesized that they were also required for induction of endogenous gpdh-
1 mRNA by HTS.  To test this, I used qPCR to measure the amount of gpdh-1 mRNA in each Nio 
mutant.  Surprisingly, I found that gpdh-1 mRNA was still upregulated by HTS in the majority of 
the Nio mutants (Fig 2.1.3A).  nio-3(dr16) and nio-7(dr23) were the only two Nio mutants that 
appeared to have reduced gpdh-1 mRNA during HTS, however neither reduction was statistically 
significant compared to WT animals (mean ± S.D. of fold change in gpdh-1 mRNA on high salt – 
Genetic complementation of nio alleles
dr14 dr15 dr16 dr13 dr17
dr14 17/36 (47%) 0/35 (0%) 0/36 (0%) 0/24 (0%) *
dr15 0/36 (0%) 13/29 (45%) 0/37 (0%) 0/33 (0%) 0/10 (0%)
dr16 0/30 (0%) 0/33 (0%) 16/34 (47%) 0/35 (0%) 0/7 (0%)
dr13 0/24 (0%) 0/23 (0%) 0/28 (0%) 14/30 (47%) 0/7 (0%)
dr17 0/34 (0%) 0/38 (0%) 0/31 (0%) 0/34 (0%) 8/18 (44%)
dr18 0/35 (0%) 0/31 (0%) 0/21 (0%) 15/29 (52%) 2/8 (25%)
dr19 1/36 (3%) 0/32 (0%) 0/18 (0%) 1/30 (3%) 0/8 (0%)
dr20 0/22 (0%) 13/31 (42%) 0/18 (0%) 0/22 (0%) 0/20 (0%)
dr22** (~0%) (~0%) (~0%) (~50%) (~0%)
dr23** (~0%) (~0%) (~0%) (~0%) (~0%)
dr18 dr19 dr20 dr22** dr23**
dr14 0/23 (0%) 0/37 (0%) 0/26 (0%) (~0%) (~0%)
dr15 0/36 (0%) 0/32 (0%) 7/38 (18%) (~0%) (~0%)
dr16 0/36 (0%) 0/32 (0%) 0/36 (0%) (~0%) (~0%)
dr13 9/32 (28%) 0/35 (0%) 0/32 (0%) (~50%) (~0%)
dr17 1/27 (4%) 0/35 (0%) 0/36 (0%) (~0%) (~0%)
dr18 13/27 (48%) 1/33 (3%) 0/23 (0%) (~50%) (~0%)
dr19 0/38 (0%) 6/21 (29%) 0/35 (0%) (~0%) (~0%)
dr20 0/30 (0%) 0/26 (0%) 13/30 (43%) (~0%) (~0%)
dr22** (~50%) (~0%) (~0%) (~50%) (~0%)
dr23** (~0%) (~0%) (~0%) (~0%) (~50%)
Complemented = 0%
Failed to complement = ~50%
* mate did not work
** did not rec rd numbers 
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WT 17.8 ± 4.3, nio-3(dr16) 7.9 ± 0.2, nio-7(dr23)  2.5 ± 0.3).  Consistent with endogenous gpdh-
1 mRNA levels, I also observed that GFP mRNA derived from the overexpressed gpdh-1p::GFP 
reporter drIs4 was upregulated by HTS in nio-1 through nio-7, even though GFP fluorescence in 
these strains was strongly reduced (Fig 2.1.2B, 2.1.2C and 2.1.3B).  As was the case with gpdh-1 
mRNA, nio-3(dr16) and nio-7(dr23) were the only two Nio mutants with reduced (albeit not a 
statistically significant reduction compared to WT animals) GFP mRNA during HTS (mean ± S.D. 
of fold change in GFP mRNA on high salt – WT 12.9 ± 2.8, nio-3(dr16) 10.7 ± 1.3, nio-7(dr23) 
3.5 ± 3.3).  These data unexpectedly suggest that the majority of the nio genes are required for 
hypertonic induction of gpdh-1p::GFP reporter protein expression, but not endogenous gpdh-1 or 
HTS reporter derived GFP mRNA. 
   To further understand the requirements of the nio genes in the HTSR, I examined the 
physiological phenotypes of each Nio mutant in response to HTS.  C. elegans upregulates 
osmosensitive genes, including gpdh-1, to survive and adapt to hypertonic challenges.  Survival 
and adaptation can be measured in several ways.  Survival measures the ability of animals grown 
under standard laboratory isotonic conditions to survive a 24 hour exposure to an indicated level 
of HTS [318].  Acute adaptation measures the ability of animals to activate adaptive responses that 
permit survival under normally lethal hypertonic conditions using a pre-conditioning stimulus 
[318].  Chronic adaptation measures the ability of animals to develop under non-lethal hypertonic 
conditions [319]. 
I found that loss of the nio genes had no effect on the survival of C. elegans during 
increasing levels of HTS.  nio-4(dr17) mutants did have reduced survival during HTS, but they 
also had reduced survival under isotonic conditions (Fig 2.1.3C).  This results suggests that the 
health of nio-4(dr17) mutants is generally compromised regardless of the tonicity of their 
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environment.  In contrast to the survival assay, five out of the seven nio genes were implicated in 
acute adaptation to HTS.  nio-4 and nio-6 had a moderate acute adaptation phenotype, whereas 
nio-2, nio-3, and nio-7 mutants were almost completely unable to maintain movement on normally 
lethal levels of HTS even though they received a pre-conditioning stimulus (Fig 2.1.3D).  The 
severe acute adaptation phenotype of nio-2, nio-3, and nio-7, in combination with the gpdh-
1p::GFP phenotype, suggests that these three Nio mutants contain mutations in genes required for 
both osmoprotective gene expression and physiological adaptation to HTS. 
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Figure 2.1.3 The majority of Nio mutants upregulate osmosensitive mRNAs, exhibit normal survival, and are 
able to acutely adapt to HTS 
(A) qPCR of gpdh-1 mRNA from WT and nio mutant day 2 adult animals expressing drIs4 exposed to 250 mM NaCl 
NGM plates for 24 hours.  Data are represented as fold induction of mRNA on 250 mM NaCl relative to 50 mM NaCl.  
Data are expressed as mean ± S.D. **** - p < 0.0001, ns = nonsignificant (One-way ANOVA with post hoc Tukey’s 
test).  N ≥ 3 biological replicates of 35 animals for each group.  (B) qPCR of GFP mRNA from WT and nio mutant 
day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 24 hours.  Data are represented as 
fold induction of mRNA on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D. * - p < 0.05, 
n.s. = nonsignificant (One-way ANOVA with post hoc Tukey’s test).  N ≥ 3 biological replicates of 35 animals for 
each group.  (C) Percent survival of day 2 adult animals expressing drIs4 exposed to 100 – 600 mM NaCl NGM plates 
for 24 hours.  Strains include WT and the nio mutants expressing drIs4.  Data are expressed as mean ± S.D.  N = 5 
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replicates of 20 animals for each salt concentration.  (D) Percent of moving unadapted and adapted day 3 adult animals 
exposed to 600 mM NaCl NGM plates for 24 hours.  Strains include WT and the nio mutants expressing drIs4.  Data 
are expressed as mean ± S.D. **** - p < 0.0001, ** - p < 0.01, ns = nonsignificant.  N = 5 replicates of 20 animals for 
each strain.     
 
In order to identify the phenotype-causing mutations in the Nio mutants, we had the 
genome of each mutant sequenced.  Using bioinformatics, I compared the single nucleotide 
polymorphisms (SNPs) in each Nio mutant to the SNPs in the drIs4 starting strain to find genes 
with homozygous mutations not present in the drIs4 starting strain. My bioinformatic analysis 
identified hundreds of homozygous SNPs in each mutant that were not in the starting drIs4 strain 
(Table 2.1.3).  A common practice in forward genetic screens is to cross isolated mutants back to 
WT animals (backcrossing) several times to decrease background mutations.  Each Nio mutant 
was therefore backcrossed three times prior to sequencing.  However, the sequencing results 
suggest that at least for nio-1(dr14) and nio-2(dr20) mutants, backcrossing did not have a large 
effect on mutant SNP number (Table 2.1.3).     
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Table 2.1.3 Number of unique homozygous SNPS in each Nio mutant 
SNPs in the drIs4 strain were subtracted from SNPs in the WT strain (N2) to identify SNPs unique to drIs4.  These 
SNPs in drIs4 were then subtracted from the SNPs in each Nio mutant to identify SNPs unique to each Nio mutant. 
 
 
To simplify analysis of the whole genome sequencing data, I mapped the nio genes to 
specific chromosomes using C. elegans balancer strains harboring chromosomal translocations or 
inversions.  Using the mIn1 strain, which carries an inversion of a region of chromosome II, I 
determined that nio-6(dr19) was the only nio gene located on chromosome II.  Using the nT1 
(chromosome IV/V translocation) strain and the hT2 (chromosome I/III translocation) strains I 
mapped nio-3(dr16) to chromosome III and nio-7(dr23) to chromosome V.   Furthermore, since 
each Nio mutant segregated with traditional Mendelian genetics, I was able to rule out gene 
candidates on chromosome X, as hemizygous X/null males did not exhibit a Nio phenotype.  
Finally, I used the results from the genetic complementation testing to further narrow down the 
phenotype-causing nio gene candidates.  A list of phenotype-causing nio gene candidates for each 
strain can be found in Table 2.1.4.  Since the nio-2, nio-3, and nio-7 mutants had both impaired 
hypertonic induction of the gpdh-1p::GFP reporter and acute adaptation to HTS, we chose to focus 
on these three mutants to further characterize the HTSR.   
Number of relevant homozygous SNPs *
Mutant # of SNPs
drIs4 359
nio-1(dr14) 311
nio-1(dr14) no backcross 329
nio-2(dr15) 259
nio-2(dr20) 340








*drIs4 SNPs subtracted from N2 SNAPs 
and Nio mutant SNPs subtracted from 
drIs4 SNPs
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Table 2.1.4 nio gene candidates (SNPs) 
Genes in each strain with homozygous missense, nonsense, or splicing mutations that are predicted to be LOF.  Bolded genes have mutations that are found in 
multiple strains that complement (i.e. strains that have different phenotype causing mutations).  Underlined genes have mutations that are found in multiple strains 
that fail to complement (i.e. strains that have the same phenotype-causing mutations).  * - The C01B10.3 genes is adjacent to the drh-2 pseudogene. 
 
nio gene candidates (SNPs)
Mutant nio-1(dr14) nio-2(dr15) nio-2(dr20) nio-3(dr16) nio-4(dr17) nio-5(dr13) nio-5(dr18) nio-5(dr22 ) nio-6(dr19) nio-7(dr23)
Y54E10A.23 cpt-3 ubr-1 ZK1025.1 C36F7.5 nono-1 dig-1 gcy-35 kpc-1 gls-1
rcq-5 ogt-1 stam-1 cpf-2 Y54E5B.5 Y47D3B.14 srv-19 fkh-7 F33E2.10 C39B5.6
C01G12.16 T07C4.3 let-607 srv-19 Y55B1BR.2 srv-19 drh-2* srv-19 hinf-1 dig-1
C28A5.6 Y41C4A.11 sec-8 clx-1 pef-1 C01B10.3* str-219 drh-2* sdz-3 ZK370.8
C27F2.8 Y111B2A.24 Y47H9C.9 Y105C5B.1420 Y47D3B.23 T05A12.3 F35H10.10 F42A9.6 Y57A10A.27 Y55F3C.17
adr-2 srv-19 F08A8.4 srx-9 srv-19 catp-7 K09B11.5 C33A12.16 usp-14 srv-19
gsp-2 Y80D3A.8 Y53G8AR.6 srbc-9 sss-1 Y80D3A.8 C52D10.10 F13B12.2 dig-1 hcf-1
alh-12 amx-1 21ur-1385 alh-2 T12G3.4 srv-19 Y105C5B.1420
C07H6.4 dex-1 alh-2 ZC178.2 Y57G11C.36 pqn-79 srw-7
cdc-25.3 nono-1 Y40B10A.9 Y80D3A.8 alh-2 alh-2 C49G7.1
R10E11.9 ogt-1 srt-13 Y80D3A.8 nhr-181
srv-19 Y69A2AR.25 C14C11.2 mut-14
H24K24.2 C55C3.72 ZC178.2 alh-4
ZC178.2 srv-19 sup-37  C50E3.5
F40F9.11 sss-1 srt-18 ncx-10
unc-41 Y57G11C.1143 pqn-63 symk-1
F28H7.2 Y105C5B.1420 C08B6.14 tag-196
nas-17 alh-2 T04F3.1 R03H4.8
C55A6.3 srx-86 K01D12.5 ptr-1









Bolded genes are found in multiple strains that complement.
Underlined genes are found in multiple strains that fail to complement.
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2.2 The O-GlcNAc transferase OGT-1 is required post-transcriptionally for the hypertonic 
induction of GPDH-1 and physiological adaptation to hypertonic stress 
In the forward genetic screen for Nio mutants, I identified two recessive alleles, dr15 and 
dr20, that genetically failed to complement (Tables 2.1.1 and 2.1.2).  Whole genome sequencing 
and bioinformatics revealed that dr15 and dr20 contained distinct nonsense mutations (R267STOP 
and Q600STOP respectively) in the gene encoding the O-GlcNAc transferase ogt-1 (Table 2.1.4, 
Fig 2.2.1A).  Two independently isolated ogt-1 deletion alleles, ok430 and ok1474, as well as WT 
worms exposed to ogt-1(RNAi), also exhibited a Nio phenotype (Fig 2.2.1A, 2.2.1B, 2.2.1C, 
2.2.1D).  The ok430 and ok1474 alleles failed to complement the dr15 and dr20 alleles, supporting 
the hypothesis that the loss of ogt-1 function is the basis for the Nio phenotype (Table 2.2.1).  
Consistent with this hypothesis, transgenic overexpression of ogt-1 in the ogt-1(dr20) mutant led 
to supra-physiological rescue of hypertonic gpdh-1p::GFP induction (Fig 2.2.1E).  Finally, 
CRISPR reversion of the dr20 Q600STOP mutation back to WT was sufficient to rescue the ogt-
1 Nio phenotype, indicating that ENU induced mutations in the background of these animals do 
not contribute to the Nio phenotype (Fig 2.2.1F).  In combinations, these results support the 
hypothesis that ogt-1 is required for hypertonic induction of gpdh-1p::GFP.  
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Figure 2.2.1 The conserved O-GlcNAc transferase OGT-1 is required for the upregulation of the gpdh-1p::GFP 
transcriptional reporter by HTS. 
(A) C. elegans and Homo sapians OGT protein domain diagrams detailing the positions of the two LOF ogt-1 alleles 
identified in the screen (dr15 and dr20), two independently isolated ogt-1 deletion mutations (ok430 and ok1474), and 
the two mutations that disrupt catalytic activity of the enzyme (H612A and K957M).  The precise breakpoints of 
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ok1474 have not been determined.  (B) Wide-field fluorescence microscopy of day 2 adult drIs4 and ogt-1;drIs4 
mutant animals exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  Images depict merged GFP and RFP 
channels.  Scale bar = 100 microns.  (C) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals 
expressing drIs4 or ogt-1;drIs4 exposed to 250 mM NaCl NGM plates for 18 hours.  Data are represented as the 
relative fold induction of normalized GFP/RFP ratio on 250 mM NaCl NGM plates versus 50 mM NaCl NGM plates, 
with WT induction set to 1.  Each point represents the quantified signal from a single animal.  Data are expressed as 
mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 62 for each group.  (D) COPAS 
Biosort quantification of GFP and RFP signal in day 2 adult WT animals expressing drIs4 exposed to 250 mM NaCl 
NGM plates for 18 hours.  Animals were grown on empty vector (RNAi) (ev(RNAi)) or ogt-1(RNAi) plates for multiple 
generations.  Data are represented as fold induction of normalized GFP/RFP ratio on 250 mM NaCl NGM plates 
relative to on 50 mM NaCl NGM plates.  Each point represents the quanitfied signal from a single animal.  Data are 
expressed as mean ± S.D.  **** - p < 0.0001 (Mann-Whitney test).  N ≥ 334 for each group.  Inset: Wide-field 
fluorescence microscopy of day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 18 hours.  
Animals were grown on ev(RNAi) or ogt-1(RNAi) plates for multiple generations.  Images depict merged GFP and 
RFP channels.  Scale bar = 100 microns.  (E) COPAS Biosort quanitification of GFP and RFP signal in day 2 adult 
animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 18 hours in the indicated genetic background.  
drEx465 is an extrachromosomal array expressing a 10.3 Kb ogt-1 genomic DNA fragment containing ~2 Kb upstream 
and ~1 Kb domnstream of the ogt-1 coding sequence.  Data are represented as fold induction of normalized GFP/RFP 
ratio on 250 mM NaCl NGM plates relative to on 50 mM NaCl NGM plates.  Each point represents the quantified 
signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001, * - p  < 0.05 (Kruskal-Wallis test 
with post hoc Dunn’s test).  N ≥ 37 for each group.  (F) COPAS Biosort quanitification of GFP and RFP signal in day 
2 adult animals expressing drIs4 or drIs4;ogt-1(dr20) exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  ogt-
1(dr20 dr36) is a strain in which the dr20 mutation is converted back to WT using CRISPR/Cas9 genome editing.  
Data are represented as relative fold induction of normalized GFP/RFP ratio on 250 mM NaCl NGM plates versus 50 
mM NaCl NGM plates, with WT fold induction set to 1.  Each point represents the quantified signal from a single 
animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 
170 for each group.  Inset: Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 in the WT or 
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indicated ogt-1 mutant background exposed to 250 mM NaCl NGM plates for 18 hours.  Images depict merged GFP 
and RFP channels.  Scale bar = 100 microns. 
 
Table 2.2.1 Genetic complementation of the ogt alleles 
Fractions represent the number of animals with a Nio phenotype (impaired gpdh-1p::GFP induction on 250 mM NaCl 
NGM plates) over the total number of animals counted.  Males were heterozygous for the nio mutation.  Mutant 
crosses complemented (i.e. phenotype causing mutations are in different genes) when 0% of progeny were Nio and 
failed to complement (i.e. phenotype causing mutations are in the same gene) when ~50% of progeny were Nio. 
 
 
To determine if ogt-1 is required specifically for HTSR induced reporter expression or 
more generally for stress-inducible reporter expression, I examined the requirement for ogt-1 in 
the heat shock and ER stress responses.  ogt-1 was not required for activation of other stress 
inducible reporters since inhibition of ogt-1 resulted in a small but significant increase in the heat 
shock inducible GFP reporter and had no effect on the ER stress inducible GFP reporter (Fig 
2.2.2A, 2.2.2B, 2.2.2C, and 2.2.2D).  Additionally, I used a GFP reporter for the expression of the 
antimicrobial peptide nlp-29 (frIs7) to examine if ogt-1 is required for the induction of other 
osmotically induced reporters.  nlp-29p::GFP is induced by several stressors including HTS.  ogt-
1(RNAi) did not prevent nlp-29p::GFP upregulation by HTS and in some cases led to a small but 
significant increase in the hypertonic induction of this reporter.  In conclusion, these results suggest 
that ogt-1 is required specifically for the upregulation of gpdh-1p::GFP reporter expression during 
HTS. 
Genetic complementation of ogt-1 alleles
dr15 dr20 ok430 ok1474
dr15 8/18 (44%) 13/31 (42%) 6/12 (67%) 8/20 (40%)
dr20 11/28 (39%) 9/32 (28%) 12/33 (36%)
ok430 3/10 (30%) 13/27 (48%)
ok1474 14/22 (64%)
Complemented = 0%




Number of of animals with a Nio phenotype (no gfp induction on 
250 mM NaCl) in the cross progeny of a ogt-1/+ male to an ogt-
1/ogt-1 hermaphrodite
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Figure 2.2.2 ogt-1 is not required for the upregulation of transcriptional reporters by heat shock or ER stress 
or for the upregulation of the nlp-29p::GFP reporter by HTS. 
(A) Wild-field fluorescence microscopy of day 2 adult animals expressing hsp-16.2p::GFP (gpIs1) grown on 
ev(RNAi), ogt-1(RNAi), or hsf-1(RNAi) plates and exposed to control or heat shock conditions (35˚C for 3 hours, 18 
hour recovery at 20˚C).  Images depict the GFP channel, since there is not a normalizing RFP reporter in these strains.  
Scale bar = 100 microns.  (B) COPAS Biosort quantification of GFP and TOF signal from animals in (A).  Data are 
represented as fold induction of normalized GFP/TOF ratio of animals exposed to heat shock conditions relative to 
animals exposed to control conditions.  Each point represents the quantified signal from a single animal.  Data are 
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expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 158 for each group.  
(C) Wide-field fluorescence microscopy of day 2 adult animals expressing hsp-4p::GFP (zcIs4) exposed to DTT plates 
for 18 hours.  The ogt-1(dr50) allele carries the same homozygous Q600STOP mutation as the ogt-1(dr20) allele and 
was introduced using CRISPR/Cas9.  Images depict the GFP channel.  Scale bar = 100 microns.  (D) COPAS Biosort 
quantification of GFP and TOF signal from animals in (C).  Data are represented as fold induction of normalized 
GFP/TOF ratio of animals exposed to DTT plates relative to animals exposed to control plates.  Each point represents 
the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001, ns = nonsignificant 
(Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 48 for each group.  (E) COPAS Biosort quantification of GFP 
and RFP signal from day 2 animals expressing gpdh-1p::GFP (drIs4) or nlp-29p::GFP (frIs7) exposed to 250 mM 
NaCl for 18 and 24 hours respectively [349].  Data are represented as fold induction of normalized GFP/RFP ratio of 
animals exposed to 250 mM NaCl plates relative to animals exposed to 50 mM NaCl plates.  Each point represents 
the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test 
with post hoc Dunn’s test).  N ≥ 173 for each group. 
2.2.1 OGT-1 is required for osmosensitive GPDH-1-GFP protein expression, but not 
osmosensitive transcription in a sequence-independent manner  
Since ogt-1 is required for induction of the gpdh-1p::GFP transgenic reporter by HTS, I 
hypothesized that endogenous osmosensitive mRNAs would not be upregulated in ogt-1 mutants.  
To test this, I used qPCR to measure the expression levels of several previously described mRNAs 
that are induced by HTS.  Surprisingly, I found that gpdh-1 was still upregulated by HTS in all 
four ogt-1 mutants following 24 hours of HTS (Fig 2.2.3A).  In fact, ogt-1 mutants upregulated 
gpdh-1 mRNA levels to a greater extent than WT animals during HTS.  Consistent with this, I also 
observed that GFP mRNA derived from the overexpressed gpdh-1p::GFP reporter drIs4 was 
upregulated by HTS in all four ogt-1 mutants even though GFP protein levels were strongly 
reduced (Fig 2.2.3B, 2.2.1B, and 2.2.1C).  Furthermore, gpdh-1 mRNA was upregulated in ogt-
 
  113 
1(dr20) mutants after only three hours of HTS (Fig 2.2.3C).  Therefore, ogt-1 mutant animals, like 
WT animals, likely activate the cellular pathways required for gpdh-1 mRNA induction soon after 
exposure to HTS and they maintain high gpdh-1 mRNA levels for an extended period of time.  
Finally, osmotically induced mRNA expression of nlp-29 and hmit-1.1 mRNA was also increased 
in ogt-1(dr20) mutants (Fig 2.2.3D and 2.2.3E), suggesting that osmosensitive mRNAs are 
upregulated in ogt-1 mutants despite the reduction in gpdh-1p::GFP protein levels. 
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Figure 2.2.3 ogt-1 is not required for the upregulation of ORG mRNA transcripts by HTS 
(A) qPCR of gpdh-1 mRNA from WT and ogt-1 mutant day 2 adult animals expressing drIs4 exposed to 250 mM 
NaCl NGM plates for 24 hours.  Data are represented as fold induction of RNA on 250 mM NaCl relative to 50 mM 
NaCl.  Data are expressed as mean ± S.D.  *** - p < 0.001, ** - p < 0.01, * < 0.05 (One-way ANOVA with post hoc 
Tukey’s test).  N ≥ 3 biological replicates of 35 animals for each group.  (B) qPCR of GFP mRNA from WT and ogt-
1 mutant day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 24 hours.  Data are 
represented as fold induction of RNA on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D. 
* p < 0.05, ns = nonsignificant (One-way ANOVA with post hoc Tukey’s test).  N ≥ 3 biological replicates of 35 
animals for each group.  (C) qPCR of gpdh-1 mRNA from WT and ogt-1 mutant day 2 adult animals expressing drIs4 
exposed to 250 mM NaCl NGM plates for 3 hours.  Data are represented as fold induction of RNA on 250 mM NaCl 
relative to 50 mM NaCl.  Data are expressed as mean ± S.D. ** - p < 0.01 (Student’s two-tailed t-test).  N ≥ 3 biological 
replicates of 35 animals for each group.  (D) qPCR of hmit-1.1 mRNA from WT and ogt-1 mutant day 2 adult animals 
expressing drIs4 exposed to 250 mM NaCl NGM plates for 24 hours.  Data are represented as fold induction of RNA 
on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D.  ns  = nonsignificant (Student’s two-
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tailed t-test).  N ≥ 3 biological replicates of 35 animals for each group.  (E) qPCR of nlp-29 mRNA from WT and ogt-
1 mutant day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 24 hours.  Data are 
represented as fold induction of RNA on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D.  
ns  = nonsignificant (Student’s two-tailed t-test).  N ≥ 3 biological replicates of 35 animals for each group.     
     
To further examine how OGT-1 affects the coupling between HTS induced mRNA and 
protein expression, I measured GFP protein levels in an ogt-1 mutant (dr34; CRISPR/Cas9 knock-
in of the dr20(Q600STOP mutation)) expressing a GPDH-1 translational reporter (GPDH-
1::GFP).  As I observed for the gpdh-1p::GFP transcriptional reporter, ogt-1(dr34) mutants failed 
to induce the GPDH-1::GFP protein in response to HTS (Fig 2.2.4A).  However, the mRNA from 
this translational reporter was still induced to WT levels (Fig 2.2.4B).  mRNA induction of the 
translational reporter did not exceed WT levels like I saw for the transcriptional reporter for 
unknown reasons.  Importantly, the requirement for ogt-1 in the HTS is not transgene dependent 
because ogt-1 is also required for the hypertonic induction of a CRISPR/Cas9 engineered 
endogenously expressed GPDH-1::GFP fusion protein, which I confirmed to be functional based 
on its ability to exhibit acute adaptation to HTS (Fig 2.2.4C and 2.2.6E).  Like in the transcriptional 
and translational reporters, gpdh-1::GFP mRNA levels of the gpdh-1::GFP CRISPR allele were 
induced to WT levels or higher during HTS (Fig 2.2.4D and 2.2.4E).  In conclusion, these results 
suggest that ogt-1 functions downstream of osmosensitive mRNA upregulation to regulate 
hypertonic GPDH-1 protein induction.  
One possibility to explain these results is that ogt-1 mutants aberrantly activate protein 
degradation pathways that decrease GPDH-1 protein levels.  To test this possibility, I inhibited 
proteasomal degradation and autophagy in ogt-1 mutants with rpn-8(RNAi) and lgg-1(RNAi) 
respectively [423, 494].  I hypothesized that if these degradation pathways decreased GPDH-1 
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protein levels in the ogt-1 mutants, then inhibiting these pathways would rescue gpdh-1p::GFP 
expression in ogt-1 mutants.  However, rpn-8(RNAi) and lgg-1(RNAi) did not increase gpdh-
1p::GFP expression in ogt-1 mutants, suggesting that these pathways are not regulated by OGT-1 
during the HTSR (Fig 2.2.4F and 2.2.4G).  Therefore, OGT-1 functions downstream of 
osmosensitive mRNA upregulation, but upstream of osmosensitive GPDH-1-GFP protein 
expression during the HTSR. 
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Figure 2.2.4 OGT-1 functions post-transcriptionally to regulate osmosensitive GPDH-1 protein expression 
(A) COPAS Biosort quantification of GFP and TOF signal in day 2 adult animals expressing the kbIs6 GPDH-1 
translational fusion exposed to 250 mM NaCl NGM plates for 18 hours.  The ogt-1(dr34) allele carries the same 
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homozygous Q600STOP mutation as the ogt-1(dr20) allele and was introduced using CRISPR/Cas9.  Data are 
represented as relative fold induction of normalized GFP/TOF ratio on 250 mM NaCl NGM plates versus 50 mM 
NaCl NGM plates.  Each point represents the quantified signal from a single animal.  Data are expressed as mean ± 
S.D.  **** - p < 0.0001 (Mann-Whitney test).  N ≥ 84 for each group.  Inset: Wide-field fluorescence microscopy of 
day 2 adult animals expressing the kbIs6 translational fusion protein exposed to 250 mM NaCl NGM plates for 18 
hours.  Scale bar = 100 microns.  (B) qPCR of gpdh-1 mRNA from day 2 adult animals expressing the kbIs6 
translational fusion exposed to 250 mM NaCl NGM plates for 24 hours.  Strains include WT and ogt-1(dr34).  The 
ogt-1(dr34) allele is the dr20 point mutation introduced using CRISPR/Cas9.  Data are represented as fold induction 
of RNA on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D.  ns = nonsignificant (Student’s 
two-tailed t-test).  N = 3 biological replicates of 35 animals for each group.  (C) Immunoblot of GFP and β-actin in 
lysates from day 2 adult animals exposed to 50 mM or 250 mM NaCl for 18 hours.  The animals express a 
CRISPR/Cas9 edited knock-in of GFP into the endogenous gpdh-1 gene (gpdh-1(dr81)).  ogt-1 carries the dr83 allele, 
which is the same homozygous Q600STOP mutation as the ogt-1(dr20) allele and was introduced using 
CRISPR/Cas9.  Top: Normalized quantification of immunoblots.  * - p < 0.05 (Two-way ANOVA with post hoc 
Tukey’s test).  Bottom: Representative immunoblot.  N = 3 biological replicates.  (D) qPCR of gpdh-1 mRNA in day 
2 adult animals exposed to 250 mM NaCl NGM plates for 24 hours.  The animals express a CRISPR/Cas9 edited 
knock-in of GFP into the endogenous gpdh-1 gene (gpdh-1(dr81)).  ogt-1 carries the dr83 allele, which is the same 
homozygous Q600STOP mutation as the ogt-1(dr20) allele and was introduced using CRISPR/Cas9.  Data are 
represented as fold induction of RNA on 250 mM NaCl relative to 50 mM NaCl.  Data are expressed as mean ± S.D.  
ns = nonsignificant (Student’s two-tailed t-test).  N ≥ 3 biological replicates of 35 animals for each group.  (E) qPCR 
of GFP mRNA in day 2 adult animals exposed to 250 mM NaCl NGM plates for 24 hours.  The animals express a 
CRISPR/Cas9 edited knock-in of GFP into the endogenous gpdh-1 gene (gpdh-1(dr81)).  ogt-1 carries the dr83 allele, 
which is the same homozygous Q600STOP mutation as the ogt-1(dr20) allele and was introduced using 
CRISPR/Cas9.  Data are represented as fold induction of RNA on 250 mM NaCl relative to 50 mM NaCl.  Data are 
expressed as mean ± S.D.  ns = nonsignificant (Student’s two-tailed t-test).  N ≥ 3 biological replicates of 35 animals 
for each group.  (F) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 
exposed to 50 and 250 mM NaCl NGM plates for 18 hours.  Animals were placed on ev(RNAi) or rpn-8(RNAi) plates 
as L1s.  Data are represented as normalized fold induction of GFP/RFP ratio on 250 mM or 50 mM NaCl RNAi plates 
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relative to on 50 mM NaCl RNAi plates.  Each point represents the quantified signal from a single animal.  Data are 
expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 14 for each group.  
(G) COPAS Biosort quanitification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 50 and 
250 mM NaCl NGM plates for 18 hours.  Animals were placed on ev(RNAi) or lgg-1(RNAi) plates as L1s.  Data are 
represented as normalized fold induction of GFP/RFP ratio on 250 mM or 50mM NaCl RNAi places relative to on 50 
mM NaCl RNAi plates.  Each point represents the quantified signal from a single animal.  Data are expressed as mean 
± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 47 for each group. 
 
Since our evidence thus far suggested that ogt-1 is required for translation of the gpdh-
1p::GFP transcript into protein, I next considered which portion of the gpdh-1p::GFP transcript 
was required for ogt-1 regulation during HTS.  The gpdh-1p::GFP reporter (drIs4) that was the 
basis for my forward genetic screen contained the gpdh-1 5’ UTR, start ATG codon, and a small 
portion of the gpdh-1 coding sequence fused to GFP (Fig 2.2.5).  This gpdh-1p::GFP reporter is 
referred to as the WT gpdh-1p::GFP reporter here.  As previously shown, hypertonic induction of 
GFP was reduced in animals expressing this WT gpdh-1p::GFP reporter upon knock down of ogt-
1 with RNAi (Fig 2.2.1D and Fig 2.2.5).  Similarly, animals expressing truncated gpdh-1p::GFP 
reporters missing the gpdh-1 coding sequence (∆CDS gpdh-1p::GFP reporter) or both the gpdh-1 
coding sequence and 5’ UTR (∆5’ UTR gpdh-1p::GFP reporter) also had decreased GFP induction 
when ogt-1 was knocked down with RNAi (Fig 2.2.5).  Since transcripts derived from the ∆5’ 
UTR gpdh-1p::GFP reporter contained no mRNA sequence unique to the gpdh-1 transcript, this 
result surprisingly indicates that OGT-1 requires no part of the gpdh-1 mRNA sequence to regulate 
gpdh-1 protein expression.  Therefore OGT-1 may regulate the hypertonic induced translation of 
the GPDH-1 protein through an indirect mechanism. 
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Figure 2.2.5 OGT-1 regulates hypertonic induction of the gpdh-1 transcriptional reporter in a sequence 
independent manner 
Wide-field fluorescence microscopy of day 2 adult animals expressing the indicated gpdh-1p::GFP transcriptional 
reporters (extrachromosomal arrays) exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  Animals also express 
a the myo2p::mCherry extrachromosomal array as a co-injection marker.  All images are exposure matched.  Scale 
bar = 100 microns. In the diagrams P = promoter, E = exon, and I = intron. 
 
2.2.2 Physiological and genetic adaptation to hypertonic stress requires ogt-1 
C. elegans upregulates osmosensitive genes, including gpdh-1, to survive and adapt to 
hypertonic challenges.  As mentioned previously (Section 2.1), survival, acute adaptation, and 
chronic adaptation all measure the physiological phenotypes of C. elegans during HTS.  I found 
that loss of ogt-1/nio-2 had no effect on survival during HTS (Fig 2.1.3C).  In contrast, loss of ogt-
1 blocked both acute and chronic adaptation to HTS (Fig 2.2.6A and 2.2.6B).  Chronic HTS did 
not alter ogt-1(dr20) egg laying under hypertonic conditions compared to WT animals (Fig 
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2.2.6C).  However, embryo development during HTS, but not in isotonic conditions, was inhibited 
in ogt-1(dr20) animals (Fig 2.2.6D).  Therefore, the chronic adaptation phenotype of ogt-1(dr20) 
mutants is likely caused by the inability of ogt-1 mutants to develop during chronic HTS.  The 
acute adaptation phenotype was rescued by CRISPR reversion of the dr20 Q600STOP mutation 
to WT (Fig 2.2.6E).  Interestingly, the acute adaptation phenotype of ogt-1 mutants must extend 
beyond its effects on gpdh-1, since the acute adaptation phenotype of a gpdh-1 presumptive null 
mutant was not as severe as that observed in an ogt-1 mutant (Fig 2.2.6A). 
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Figure 2.2.6 ogt-1 is required for physiological acute and chronic adaptation to HTS 
(A) Percent of moving unadapted and adapted day 3 adult animals exposed to 600 mM NaCl NGM plates for 24 hours.  
Strains expressing drIs4 are on the left of the dashed orange line and those not expressing drIs4 are on the right.  
ok1558 is an out-of-frame deletion allele that generates a premature stop codon in exon 2 of gpdh-1 and is therefore a 
likely null allele.  Data are expressed as mean ± S.D. **** - p < 0.0001 (Two-way ANOVA with post hoc Tukey’s 
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test.). N = 5 replicates of 20 animals for each strain.  (B) Brightfield microscopy images of animals grown on 50 mM 
or 250 mM NaCl for 5 and 10 days respectively.  Strains include WT (drIs4) and ogt-1(dr20);drIs4.  Scale bar = 100 
microns.  (C) Percent of progeny laid.  L4 animals were placed on 50 or 250 mM NaCl and the total number of eggs 
laid were counted each day as described in the ‘Methods’.  Data are expressed as mean ± S.D.  **** - p < 0.0001, ns 
= nonsignificant (Two-way ANOVA with post hoc Tukey’s test).  N = 10 independent broods for each strain.  (D) 
Percent of progeny that developed into L4s.  L4 animals were placed on 50 or 250 mM NaCl and the total number of 
eggs laid and progeny that developed into L4s were counted each day as described in the ‘Methods’.  Data are 
expressed as mean ± S.D. **** - p <0.0001, ns = nonsignificant (Two-way ANOVA with post hoc Tukey’s test).  N 
= 10 independent broods for each strain.  (E) Percent of moving unadapted and adapted day 3 adult animals exposed 
to 600 mM NaCl NGM plates for 24 hours.  ogt-1(dr20 dr36) is a strain in which the dr20 mutation was converted 
back to WT using CRISPR/Cas9 genome editing.  The gpdh-1(dr81) allele is a CRISPR/Cas9 edited C-terminal knock-
in of GFP into the endogenous gpdh-1.  The ogt-1(dr84) allele is a CRISPR/Cas9 edited C-terminal knock-in of GFP 
into the endogenous ogt-1.  Data are expressed as mean ± S.D. *** - p < 0.001, ns = nonsignificant (Two-way ANOVA 
with post hoc Tukey’s test).  N = 5 replicates of 20 animals for each strain. 
 
In addition to physiological exposures, adaptation to HTS can also be induced genetically 
via LOF mutations in several hypodermis expressed secreted extracellular proteins.  These mutants 
exhibit maximal induction of gpdh-1 mRNA and accumulation of glycerol [324, 329].  As a result, 
these mutants are constitutively adapted to survive normally lethal levels of HTS.  To test if ogt-1 
is required for genetic adaptation to HTS, I introduced the ogt-1(dr20) mutation into osm-8(dr9) 
or osm-11(n1604) mutants.  Both osm-8 and osm-11 mutants exhibit constitutively elevated gpdh-
1p::GFP expression under isotonic conditions [324, 329].  However, gpdh-1p::GFP levels were 
significantly reduced in osm-8;ogt-1 and osm-11;ogt-1 double mutants (Fig 2.2.7A and 2.2.7B).  
Consistent with this observation, the ability of osm-8 mutants to survive a lethal HTS was 
suppressed in the osm-8;ogt-1 double mutants (Fig 2.2.7C).  These data suggest that ogt-1 is 
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required for both physiological adaptation to HTS and genetic adaptation to HTS caused by loss 
of the extracellular proteins OSM-8 and OSM-11. 
 
Figure 2.2.7 ogt-1 is required for genetic adaptation to HTS 
(A) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 50 mM 
NaCl NGM plates.  Data are represented as the fold induction of normalized GFP/RFP ratio on 50 mM NaCl NGM 
plates with osm-8(dr9) set to 1.  osm-8(dr9) was isolated in a previous genetic screen for new osm-8 alleles but encodes 
the same mutation as the n1518 reference allele.  Each point represents the quantified signal from a single animal.  
Data are expressed as mean ± S.D.  **** p < 0.0001 (Mann-Whitney test).  N ≥ 109 for each group.  Inset: Wide-field 
fluorescence microscopy of day 2 adult animals expressing drIs4 exposed to 50 mM NaCl NGM plates.  Images depict 
merged GFP and RFP channels.  Scale bar = 100 microns.  (B) COPAS Biosort quantification of GFP and RFP signal 
in day 2 adult animals expressing drIs4 exposed to 50 mM NaCl NGM plates.  Data are represented as the fold 
induction of normalized GFP/RFP ratio on 50 mM NaCl NGM plates with osm-11(n1604) set to 1.  The ogt-1(dr52) 
allele carries the same homozygous Q600STOP mutation as the ogt-1(dr20) allele, which was introduced using 
CRISPR/Cas9.  Each point represents the quantified signal from a single animal.  Data are expressed as mean ± S.D.  
**** p < 0.0001 (Mann-Whitney test).  N ≥ 163 for each group.  Inset: Wide-field fluorescence microscopy of day 2 
adult animals expressing drIs4 exposed to 50 mM NaCl NGM plates.  Images depict merged GFP and RFP channels.  
Scale bar = 100 microns.  (C) Percent of moving (OSR) day 1 animals after exposure to 500 mM NaCl or 700 mM 
NaCl for 10 minutes.  Data are represented as mean ± S.D. **** p – 0.0001 (Two-way ANOVA with post hoc Tukey’s 
test).  N = 5 replicates of 10 animals for each strain. 
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2.2.3 Non-canonical activity of ogt-1 in the hypodermis regulates gpdh-1 induction by 
hypertonic stress through a functionally conserved mechanism 
I next investigated the functional requirements of OGT-1 in the HTSR.  First, knock down 
of ogt-1 during post-developmental stages with ogt-1(RNAi) was sufficient to cause a Nio 
phenotype.  This result suggests that OGT-1 is not required for the establishment of developmental 
structures necessary for responding to HTS and that it is instead required acutely in the HTSR (Fig 
2.2.8A). 
In C. elegans, a CRISPR generated OGT-1-GFP allele is functional and is ubiquitously 
expressed throughout somatic cells in the nucleus, consistent with previous observations [362] 
(Fig 2.2.10B and 2.2.6E).  Therefore, I used tissue specific promoters to test which tissues require 
ogt-1 expression for gpdh-1 induction by HTS.  The expression of ogt-1 from either its native 
promoter or a hypodermal specific promoter was sufficient to rescue gpdh-1 induction by HTS in 
ogt-1 LOF mutants (Fig 2.2.8B and 2.2.8C).  Expression of ogt-1 from an intestinal specific 
promoter or a muscle specific promoter caused weak but statistically significant rescue (Fig 
2.2.8C).  Expression of ogt-1 in the neurons did not rescue.  Since gpdh-1 is induced by HTS in 
the hypodermis, these results suggest that ogt-1 primarily acts cell autonomously in the hypoderm 
to regulate osmosenstive protein expression. 
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Figure 2.2.8 ogt-1 expression is required acutely in the hypodermis for hypertonic induction of gpdh-1p::GFP  
(A) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 50 or 
250 mM NaCl NGM plates for 18 hours.  Animals were placed on ev(RNAi) or ogt-1(RNAi) plates at the indicated 
stage.  Data are represented as normalized fold induction of GFP/RFP ratio on 250 mM NaCl RNAi plates relative to 
on 50 mM NaCl RNAi plates, with ev(RNAi) set to 1 for each RNAi timepoint.  Each point represents the quantified 
signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Mann-Whitney test).  N ≥ 144 for 
each group.  (B) Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 exposed to 50 or 250 
mM NaCl NGM plates for 18 hours.  Strains express ogt-1 cDNA from the indicated tissue-specific promoter.  Images 
depict the GFP channel only for clarity.  The RFP signal was unaffected in these rescue strains (not shown).  Scale 
bar = 100 microns.  (C) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 
exposed to 250 mM NaCl NGM plates for 18 hours.  Data are represented as normalized fold induction of GFP/RFP 
ratio on 250 mM NaCl NGM plates relative to 50 mM NaCl NGM plates.  Each point represents the quantified signal 
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from a single animal.  Data are expressed as mean ± S.D.  *** - p < 0.001, **** < 0.0001, ns = nonsignificant (Kruskal-
Wallis test with post hoc Dunn’s test).  N ≥ 110 for each group.  
 
Given that C. elegans OGT-1 is highly conserved with human OGT (Fig 2.2.1A), I asked 
if human OGT could functionally replace C. elegans OGT-1 (ceOGT-1) in the HTSR.  
Overexpression of a human Ogt cDNA (hsOGT) from the native C. elegans ogt-1 promoter 
exhibited weak but statistically significant rescue of gpdh-1p::GFP induction by HTS in an ogt-1 
LOF mutant (Fig 2.2.9A and 2.2.9B).  Unexpectantly, catalytically inhibited human OGT (OGT 
H498A) rescued gpdh-1p::GFP induction by HTS in an ogt-1(dr20) LOF mutant to the same 
extent as WT human OGT (Fig 2.2.9A and 2.2.9B).  To further test the requirement for OGT-1 O-
GlcNAcylation in the HTSR, I CRISPR engineered catalytically inactive mutations into the 
endogenous C. elegans ogt-1 locus (H612A and K957M, equivalent to human H498A and K842M 
respectively).  Surprisingly, only the K957M mutation completely suppressed O-GlcNAcylation 
activity (Fig 2.2.10A).  The H612A mutation reduced O-GlcNAcylation but did not eliminate it 
(Fig 2.2.10A).  However, neither the K957M nor the H612A mutation altered OGT-1 protein levels 
or nuclear localization (Fig 2.2.10B).  In agreement with the results from the catalytically inhibited 
human OGT rescue experiments, C. elegans expressing catalytically impaired alleles of 
endogenous ogt-1 induced gpdh-1p::GFP during HTS and had normal acute adaptation during 
HTS (Fig 2.2.10C, 2.2.10D, and 2.2.10E).  In conclusion, a non-catalytic function of OGT-1 in the 
hypodermis is required for osmosensitive protein induction by HTS and this function may be 
conserved from C. elegans to humans. 
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Figure 2.2.9 Overexpression of human Ogt partially rescues hypertonic induction of gpdh-1p::GFP 
(A) Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 exposed to 50 or 250 mM NaCl 
NGM plates for 18 hours.  For the WT and catalytically inactive human rescue strains, we expressed a human cDNA 
(hsOGT) corresponding to isoform 1 of OGT using an extrachromosomal array.  Images depict the GFP channel only 
for clarity.  The RFP signal was unaffected in these rescue strains (not shown).  Scale bar = 100 microns.  (B) COPAS 
Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM 
plates for 18 hours.  Data are represented as normalized fold induction of GFP/RFP ratio on 250 mM NaCl NGM 
plates relative to 50 mM NaCl NGM plates.  Each point represents the quantified signal from a single animal.  Data 
are expressed as mean ± S.D. **** - p < 0.0001, *** - p < 0.001, ** - p < 0.01 (Kruskal-Wallis test with post hoc 
Dunn’s test).  N ≥ 40 for each group. 
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Figure 2.2.10 OGT-1 functions through a non-catalytic mechanism to regulate hypertonic induction of gpdh-
1p::GFP and adaptation to HTS 
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(A) Wide-field fluorescence microscopy of fixed and stained embryos.  RL2 was used to stain for nuclear pore O-
GlcNAc modifications and Hoechst 33258 was used to visualize the DNA.  Images are exposure matched.  White 
arrowheads indicate RL2 staining in OGT-1H612A embryos.  Scale bar = 10 microns.  (B) Wide-field fluorescence 
microscopy of day 1 adult animals expressing endogenously CRISPR/Cas9 GFP tagged OGT-1 exposed to 50 mM 
NaCl NGM plates.  Scale bar = 100 microns.  Images are exposure matched.  Inset: Zoomed in images of the boxed 
area.  Scale bar = 10 microns.  (C) Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 
exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  Images depict the GFP channel only for clarity.  The RFP 
signal was unaffected in these rescue strains (not shown).  Scale bar = 100 microns.   (D) COPAS Biosort 
quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates 
for 18 hours.  Data are represented as the fold induction of normalized GFP/RFP ratio on 250 mM NaCl NGM plates 
relative to 50 mM NaCl NGM plates, with WT induction set to 1.  Each point represents the quantified signal from a 
single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  
N ≥ 81 for each group.  (E) Percent of moving unadapted and adapted day 3 adult animals expressing drIs4 exposed 
to 600 mM NaCl NGM plates for 24 hours.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Two-way ANOVA 
with post hoc Tukey’s test).  N = 5 replicates of 20 animals for each strain. 
 
In addition to the catalytic domain of OGT, another functionally important domain in OGT 
is the tetratricopeptide repeat (TPR) domain [366].  This domain mediates protein-protein 
interactions thought to be important for the binding of O-GlcNAcylation substrates.  To determine 
if the TPR domain is also required for the HTSR in C. elegans, I used CRISPR to engineer a 
complete deletion of the TPR domain in the ogt-1 locus (∆TPR (128aa-583aa)).  The ∆TPR 
mutation suppressed O-GlcNAcylation completely (Fig 2.2.11A).  However, it did not alter OGT-
1-GFP protein levels or localization (Fig 2.2.11B).  C. elegans expressing the ogt ∆TPR allele 
(ogt-1(dr93)) had impaired gpdh-1p::GFP induction during HTS and impaired adaptation during 
HTS (Fig 2.2.11C, 2.2.11D and 2.2.11E).  Therefore, a TPR-dependent, O-GlcNAcylation-
independent function of OGT-1 is required in the HTSR. 
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Figure 2.2.11 The tetratricorepeat domain of OGT-1 is required for hypertonic induction of gpdh-1p::GFP and 
adaptation to HTS 
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(A) Wide-field fluorescence microscopy of fixed and stained embryos.  RL2 was used to stain for nuclear pore O-
GlcNAc modifications and Hoechst 33258 was used to visualize the DNA.  Images are exposure matched.  Scale bar 
= 10 microns.  (B) Wide-field fluorescence microscopy of day 1 adult animals expressing endogenously CRISPR/Cas9 
GFP tagged OGT-1 exposed to 50 mM NaCl NGM plates.  Scale bar = 100 microns.  Images are exposure matched.  
Inset: Zoomed in images of the boxed area.  Scale bar = 10 microns.  (C) Wide-field fluorescence microscopy of day 
2 adult animals expressing drIs4 exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  Images depict the GFP 
channel only for clarity.  The RFP channel was unaffected in these rescue strains (not shown).  Scale bar = 100 
microns.  (D) COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed 
to 250 mM NaCl NGM plates for 18 hours.  Data are represented as the fold induction of normalized GFP/RFP ratio 
on 250 mM NaCl relative to on 50 mM NaCl NGM plates, with WT induction set to 1.  Each point represents the 
quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test 
with post hoc Dunn’s test).  N ≥ 92 for each group.  (E) Percent of moving unadapted and adapted day 3 adult animals 
expressing drIs4 exposed to 600 mM NaCl NGM plates for 24 hours.  Data are expressed an mean ± S.D.  **** - p < 
0.0001, ns = nonsignificant (Two-way ANOVA with post hoc Tukey’s test).  N = 5 replicates of 20 animals for each 
strain. 
2.3 Interacting components of the 3’ mRNA cleavage and polyadenylation complex are 
required for the hypertonic induction of GPDH-1 and physiological adaptation to 
hypertonic stress 
In our forward genetic screen for Nio mutants I identified two recessive mutants, nio-
3(dr16) and nio-7(dr23), that exhibited impaired hypertonic induction of gpdh-1p::GFP and 
adaptation to HTS (Fig 2.1.2C and 2.1.3D).  Through whole genome sequencing, bioinformatics, 
and RNAi screening of nio gene candidates, I found that the phenotype causing mutations in nio-
3(dr16) and nio-7(dr23) were both missense mutations in interacting components of the conserved 
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3’ mRNA cleavage and polyadenylation complex (APA complex).  Our analysis revealed that a 
G42E mutation in the mammalian cleavage stimulation factor subunit 2 (CSTF2/CstF-64) 
homolog CPF-2 and a R580W mutation in the mammalian symplekin (SYMPK) homolog SYMK-
1 caused nio-3(dr16) and nio-7(dr23) mutants respectively to have an impaired HTSR (Fig 2.3.1, 
2.1.2B, 2.1.2C, 2.1.3D,  Table 2.1.1, 2.1.2, 2.1.3, and 2.1.4).  Consistent with the hypothesis that 
these missense alleles cause a LOF phenotype, RNAi knockdown of cpf-2 and symk-1, which 
produces genetic LOF, also inhibited the hypertonic induction of gpdh-1p::GFP (Fig 2.3.2A and 
2.3.2B).  Furthermore, transgenic overexpression of a cpf-2 DNA fragment in nio-3(dr16) mutants 
and a symk-1-containing fosmid in nio-7(dr23) mutants rescued hypertonic induction of gpdh-
1p::GFP (Fig 2.3.2C, 2.3.2D, and 2.3.2E). 
 
Figure 2.3.1 The nio-3(dr16) and nio-7(dr23) mutants contain distinct LOF mutations in the CstF-64 homolog 
cpf-2 and the symplekin homolog symk-1 respectively that impair the HTSR 
C. elegans CPF-2 and SYMK-1 protein domain diagrams detailing the positions of the two LOF alleles identified in 
the screen (dr16 and dr23).  
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Figure 2.3.2 cpf-2 and symk-1 are required for hypertonic induction of gpdh-1p::GFP 
(A) Wild-field fluorescence microscopy of day 2 adult WT animals expressing drIs4 grown on ev(RNAi) or ogt-
1(RNAi) plates and exposed to 50 or 250 mM NaCl.  Images depict the GFP channel only for clarity.  Scale bar = 100 
microns.  (B) COPAS Biosort quantification of GFP and RFP signal in day 2 adult WT animals expressing drIs4 
grown on ev(RNAi) or ogt-1(RNAi) plates and exposed to 250 mM NaCl NGM plates for 18 hours.  Data are 
represented as fold induction of normalized GFP/RFP ratio on 250 mM NaCl RNAi plates relative to on 50 mM NaCl 
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RNAi plates, with WT fold induction on ev(RNAi) and 250 mM NaCl set to 1.  Each point represents the quantified 
signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc 
Dunn’s test).  N ≥ 99 for each group.  (C) Wide-field fluorescence microscopy of day 2 adult WT, nio-3(dr16) and 
nio-7(dr23) mutant animals exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  The cpf-2 rescue animals 
express an extrachromosomal array with a cpf-2 genomic DNA fragment containing ~2 Kb upstream and ~1 Kb 
domnstream of the coding sequence.  The symk-1 rescue animals express a fosmid containing the symk-1 genomic 
sequence.  All strains express drIs4.  Images depict merged GFP and RFP channels.  Scale bar = 100 microns.  (D) 
COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 250 mM 
NaCl NGM plates for 18 hours.  The cpf-2 rescue animals express an extrachromosomal array with a cpf-2 genomic 
DNA fragment containing ~2 Kb upstream and ~1 Kb domnstream of the coding sequence.  Data are represented as 
the fold induction of normalized GFP/RFP ratio on 250 mM NaCl relative to on 50 mM NaCl NGM plates.  Each 
point represents the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 
(Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 49 for each group.  (E) COPAS Biosort quantification of GFP 
and RFP signal in day 2 adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 18 hours.  The 
symk-1 rescue animals express a fosmid containing the symk-1 genomic sequence.  Data are represented as the fold 
induction of normalized GFP/RFP ratio on 250 mM NaCl relative to on 50 mM NaCl NGM plates.  Each point 
represents the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001, ns = 
nonsignificant (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 35 for each group.   
 
Similarly to ogt-1, cpf-2 and symk-1 are required for hypertonic induction of the gpdh-
1p::GPDH-1-GFP translational reporter (kbIs6) (Fig 2.3.3).  Additionally, since nio-3(dr16) and 
nio-7(dr23) mutants have an acute HTS adaptation phenotype, this suggests that cpf-2 and symk-
1, like ogt-1, are required physiologically during HTS (Fig 2.1.3D).  However, unlike ogt-1 
mutants, nio-3/cpf-2(dr16) and nio-7/symk-1(dr23) mutants have slightly reduced hypertonic 
induction of endogenous gpdh-1 RNA and GFP RNA derived from the gpdh-1p::GFP reporter 
compared to WT animals (mean ± S.D. of fold change in gpdh-1 RNA on high salt – WT 17.8 ± 
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4.3, cpf2/nio-3(dr16) 7.9 ± 0.2, symk-1/nio-7(dr23) 2.5 ± 0.3, mean ± S.D. of fold change in GFP 
RNA on high salt – WT 12.9 ± 2.8, cpf-2/nio-3(dr16) 10.7 ± 1.3, symk-1/nio-7(dr23) 3.5 ± 3.3) 
(Fig 2.1.3A and 2.1.3B).  However, these reductions were not statistically significant when 
compared with all the nio mutants (Fig 2.1.3A and 2.1.3B).  These results in combination suggest 
that in contrast to ogt-1, cpf-2 and symk-1 may function to regulate the mRNA induction of gpdh-
1 during HTS.   
 
Figure 2.3.3 cpf-2 and symk-1 are required for hypertonic induction of gpdh-1p::GPDH-1-GFP 
COPAS Biosort quantification of GFP and TOF signal in day 2 adult animals expressing the kbIs6 GPDH-1 
translational fusion grown on ev(RNAi) or ogt-1(RNAi) and exposed to 250 mM NaCl NGM plates for 18 hours.  Data 
are represented as relative fold induction of normalized GFP/TOF ratio on 250 mM NaCl NGM plates versus 50 mM 
NaCl NGM plates, with WT induction on ev(RNAi) and 250 mM NaCl set to 1.  Each point represents the quantified 
signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc 
Dunn’s test).  N ≥ 54 for each group. 
 
To begin investigating the dynamics and interplay of the APA complex and OGT-1 in the 
HTSR, I studied the localization of CPF-2 and OGT-1 during isotonic and hypertonic conditions.  
In isotonic conditions a functional endogenously CRISPR/Cas9 tagged tagRFP-CPF-2 allele had 
a diffuse nuclear localization in the hypodermis, intestine and germline (Fig 2.3.4A, 2.3.4B, and 
2.3.4C).  In the same strain in isotonic conditions, an endogenously CRISPR/Cas9 tagged OGT-
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1-GFP allele had a similar nuclear localization as tagRFP-CPF-2, except that it was not detectably 
expressed in the germline (Fig 2.3.4A, 2.3.4B, and 2.3.4C).  In response to HTS of 600 mM NaCl 
for 24h, both tagRFP-CPF-2 and OGT-1-GFP formed nuclear puncta.  Puncta formation of both 
these proteins was most robust in the hypodermis, but it also occurred in intestinal cells (Fig 2.3.4A 
and 2.3.4B).  Neither tagRFP-CPF-2 nor OGT-1-GFP formed puncta in the germline in response 
to HTS (Fig 2.3.4C).  Interestingly, the tagRFP-CPF-2 and OGT-1-GFP puncta that formed in the 
hypodermis did not co-localize with one another (Fig 2.3.4A).  These results suggest that HTS 
causes the redistribution of both CPF-2 and OGT-1 into distinct nuclear compartments in the 
hypodermis.  However, the specific characteristics and functional significance of these nuclear 
puncta remain unknown. 
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Figure 2.3.4 CPF-2 and OGT-1 form puncta during HTS that do not colocalize 
(A) Wide-field fluorescence microscopy of hypodermal cells from day 2 adult animals exposed to 600 mM NGM 
NaCl plates for 24 hours.  Animals express functional endogenously CRISPR/Cas9 GFP tagged OGT-1 and tagRFP 
tagged CPF-2.  Images are exposure matched.  Images depict GFP, RFP, and merged channels.  Scale bar = 10 microns.  
(B) Wide-field fluorescence microscopy of intestinal cells from day 2 adult animals exposed to 600 mM NGM NaCl 
plates for 24 hours.  Animals express functional endogenously CRISPR/Cas9 GFP tagged OGT-1 and tagRFP tagged 
CPF-2.  Images are exposure matched.  Images depict GFP, RFP, and merged channels.  Scale bar = 10 microns. (C) 
Wide-field fluorescence microscopy of germline cells from day 2 adult animals exposed to 600 mM NGM NaCl plates 
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for 24 hours.  Animals express functional endogenously CRISPR/Cas9 GFP tagged OGT-1 and tagRFP tagged CPF-
2.  Images are exposure matched.  Images depict GFP, RFP, and merged channels.  Scale bar = 10 microns.      
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3.0 Discussion 
The maintenance of  cell volume is critical to cellular function because it directly influences 
protein folding [2], enzymatic activity [3, 4], membrane potential [5] and cytoskeletal architecture 
[6].  Therefore, virtually all cells have evolved protective mechanisms to counteract changes in 
cell volume.  These mechanisms are mostly conserved across cell types and organisms and have 
been extensively characterized over the last several decades.  However, the cellular pathways that 
regulate these protective mechanisms remain poorly understood.  In my thesis project, I employed 
unbiased genetic methods in the small metazoan C. elegans to identify the cellular pathways 
regulating the response to cell volume changes, specifically those induced by HTS.  
3.1 Identification of mutant C. elegans with impaired induction of the hypertonic stress 
response through an unbiased fluorescence based forward genetic screen 
To characterize the metazoan HTSR, I conducted an unbiased forward genetic screen in C. 
elegans to identify mutants with impaired induction of osmosensitive gene expression.  I identified 
ten single gene recessive mutants with decreased induction of the osmolyte accumulation gene 
reporter gpdh-1p::GFP during HTS.  I refer to this phenotype as the Nio (no induction of osmolyte 
accumulation) phenotype.  Genetic complementation analysis revealed that these ten Nio mutants 
represented seven nio genes and there were two alleles of nio-2 and three alleles of nio-5.  
Surprisingly, hypertonic induction of endogenous gpdh-1 mRNA and GFP mRNA derived from 
the gpdh-1p::GFP reporter continued to be upregulated in the majority of the Nio mutants.  
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Additionally, none of the Nio mutants had a survival phenotype and only three Nio mutants had a 
severe acute adaptation phenotype during HTS.  The identification of several mutants with both 
impaired genetic and physiological induction of the HTSR highlights the feasibility of our genetic 
screening strategy. 
However, there are likely additional nio genes that remain to be identified because our 
genetic screen did not reach saturation.  A forward genetic screen is saturated when several alleles 
of the same genes are identified instead of alleles of new genes.  Saturation indicates that all the 
genes in a pathway, at least all the genes that can be isolated through genetic screening methods, 
have been found.  For example, in my genetic screen I did not identify predicted members of the 
HTSR pathway such as genes that encode transcription factors or extracellular proteins.  Continued 
Nio screening may uncover these predicted HSTR factors and provide a more detailed 
understanding of the HTSR pathway. 
Forward genetic screening methods in C. elegans have been used for decades to understand 
genetic pathways [311-314].  The beauty of the forward genetic screen is that it is an unbiased 
approach to let the organism and/or cells reveal what genes are important for a phenotype.  
Therefore, it is common to uncover unanticipated cellular pathways and mechanisms of gene 
regulation through forward genetic screens.  Despite not reaching saturation, my Nio screen was 
no exception as it provided me with unexpected results.  We designed the Nio screen with the 
expectation that we would identify genes, such as transcription factors, required for the 
transcriptional upregulation of gpdh-1 during HTS.  However, to our surprise the majority of the 
nio genes I identified were not required for hypertonic upregulation of gpdh-1 mRNA, despite 
being required for induction of gpdh-1p::GFP reporter fluorescence.  nio-3 and nio-7 were the 
only two nio genes that were likely required for induction of gpdh-1 mRNA, as both these mutants 
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had a slightly decreased fold induction of gpdh-1 mRNA during HTS, although not statistically 
significant when compared with all the Nio mutants.  Therefore, instead of isolating the expected 
candidates, our genetic screen revealed that the HTSR pathway is more nuanced than we 
anticipated.     
The results from our Nio screen unexpectedly suggest that in the majority of Nio mutants, 
regulation of the overexpressed gpdh-1p::GFP reporter protein is distinct from regulation of gpdh-
1 mRNA during HTS.  One possible explanation for this phenomenon is that the Nio mutants 
contain transgene suppressor mutations.  Although forward genetic screens can provide an 
unbiased lens into cellular pathways, they are limited by the screening method, i.e. you get what 
you screen for.  Transgene suppressor mutations inhibit the expression of overexpressed 
transgenes, such as the gpdh-1p::GFP reporter, without affecting endogenous gene expression.  
However, three pieces of evidence suggest that the Nio mutants do not contain transgene 
suppressor mutations.  First, transgene suppressor mutations would also inhibit expression of the 
col-12p::dsRed2 reporter, which was not the case in the Nio mutants.  Second, transgene 
suppressor mutations would inhibit hypertonic induction of GFP mRNA derived from the gpdh-
1p::GFP reporter.  However, the Nio mutants upregulated GFP mRNA during HTS.  Finally, 
although we did not examine this in all of the Nio mutants, nio-2 mutants expressed GFP reporters 
other than the gpdh-1p::GFP reporter at WT levels or higher, supporting the conclusion that 
fluorescent reporter expression is not generally affected in the Nio mutants.  Therefore, it is 
unlikely that the Nio mutants contain transgene suppressor mutations.   
Since our evidence indicates that reporter fluorescence is not generally inhibited in the Nio 
mutants because they do not contain transgene suppressor mutations, this suggests that the majority 
of the nio genes may be required post-transcriptionally for hypertonic GPDH-1 protein expression 
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(Table 3.1.1).  While we provide evidence that nio-2/ogt-1 mutants have decreased GPDH-1 
protein expression during HTS, this still needs to be explicitly tested in the remaining Nio mutants.  
If all the Nio mutants have decreased hypertonic induction of GPDH-1 like nio-2 mutants, this 
would surprisingly suggest that the HTSR is under strong post-transcriptional regulation.  
Although evidence exists that other cellular stress responses, such as the heat shock and ER stress 
response, are regulated post-transcriptionally via modulation of translation initiation factors [426, 
495], this is the first evidence that the HTSR is also under post-transcriptional control. 
C. elegans upregulates osmosensitive genes, including gpdh-1, to survive and adapt to HTS 
[317, 318].  Survival is the ability of animals grown in isotonic conditions to survive a 24 hour 
exposure to HTS [318].  Adaptation is measured as either acute or chronic adaptation.  Acute 
adaptation is the ability of animals to upregulate adaptative responses that facilitate survival under 
normally lethal HTS after a pre-conditioning stimulus [318].  Chronic adaptation is the ability of 
animals to develop under continuous non-lethal HTS [319].   
The survival of all seven Nio mutants did not depend on environmental hypertonicity 
(Table 3.1.1).  This result was not surprising since gpdh-1 null mutants also do not have a survival 
phenotype [317].  However, despite their WT survival during HTS, five out of the seven Nio 
mutants and gpdh-1 null mutants had an acute adaptation phenotype (Table 3.1.1).  nio-2, -3, and 
-7 mutants had the most severe phenotype, with virtually no ability to adapt to HTS, suggesting 
that these genes regulate more than just gpdh-1 to facilitate adaptation to HTS.  Interestingly, nio-
1 and nio-5 mutants did not have an impaired ability to adapt to HTS, despite having impaired 
hypertonic gpdh-1p::GFP reporter induction.  This lack of an acute adaptation phenotype suggests 
that nio-1 and nio-5 mutants retain enough GPDH-1 activity to accumulate sufficient glycerol over 
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a 24 hour period to facilitate acute adaptation to HTS.  Therefore, nio-1 and nio-5 are likely only 
partially required for GPDH-1 induction during HTS. 
 
Table 3.1.1 Summary of the Nio mutant phenotypes  
The genetic and physiological phenotypes of each Nio mutant are summarized. 
 
 
In conclusion, our Nio screen revealed that gpdh-1 induction during HTS is under post-
transcriptional regulation by several nio genes.  Although we are still in the preliminary stages of 
characterizing many of these Nio mutants, the results from this screen represent the first indication 
that the HTSR is under post-transcriptional control.  Post-transcriptional regulation of cellular 
stress responses is a relatively new and growing field of study and it will be interesting to determine 
the post-transcriptional mechanisms at play in the HTSR.  Further characterization of nio-2/ogt-1 
mutants has provided us with a platform from which to start answering these questions. 
3.1.1 Future directions 
Since our Nio screen did not reach saturation, continued Nio screening will likely reveal 
additional genes and/or cellular pathways that regulate the HTSR.  In our initial iteration of the 





















nio-1(dr14) No Yes Yes No No Unknown
nio-2(dr15/dr20) No Yes Yes No Yes Yes
nio-3(dr16) No Reduced Reduced No Yes Unknown
nio-4(dr17) No Yes Yes No Yes Unknown
nio-5(dr13/dr18/dr22) No Yes Yes No No Unknown
nio-6(dr19) No Yes Yes No Yes Unknown
nio-7(dr23) No Reduced Reduced No Yes Unknown
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in future Nio screens it will be useful to screen animals for both decreased gpdh-1p::GFP 
expression and impaired adaptation during HTS in order to identify nio genes that are required for 
both the genetic and physiological components of the HTSR.  This modification to the genetic 
screen should enrich for bona fide components of the HTSR pathway.  Through this type of screen 
I expect the newly identified nio genes to fall into one of two categories: those that are required 
for both the mRNA and protein induction of gpdh-1 during HTS (like cpf-2 and symk-1) and those 
that are required for only the protein induction of gpdh-1 during HTS (like ogt-1).  By carrying the 
Nio screen out to saturation we will identify genes that function with ogt-1, the APA complex, or 
in different pathways to regulate the HTSR. 
3.2 The O-GlcNAc transferase OGT-1 is required post-transcriptionally for the hypertonic 
induction of GPDH-1 and physiological adaptation to hypertonic stress  
In our unbiased forward genetic screen for mutants that disrupt osmosensitive expression 
of a gpdh-1p::GFP reporter in C. elegans (Nio mutants), I identified multiple alleles of the O-
GlcNAc transferase OGT-1 .  ogt-1 likely functions as a key signaling component of the HTSR, 
since post-developmental knockdown of ogt-1 was sufficient to cause the Nio phenotype.  
Furthermore, ogt-1-dependent signaling in the HTSR is required in the hypodermis, a known 
osmosensitive tissues in C. elegans [317, 329].  The mechanism by which ogt-1 regulates 
hypertonicity induced gene expression was unexpected.  ogt-1 mutants exhibited hypertonicity 
induced upregulation of stress response mRNAs.  However, the level of at least one reporter 
protein, GPDH-1::GFP, was significantly reduced, suggesting ogt-1 acts via a post-transcriptional 
mechanism(s).  Interestingly, ogt-1 was not required for hypertonic induction of the nlp-29::GFP 
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reporter, suggesting that the effect of ogt-1 is linked to gpdh-1 and not GFP.  Additionally, ogt-1 
mutants were completely unable to adapt and develop in hypertonic environments and this 
correlated with an inability of ogt-1 mutants to properly upregulate the translation of 
osmoprotective proteins such as GPDH-1-GFP.  Intriguingly, I demonstrated that the function of 
ogt-1 in the HTSR did not require O-GlcNAcylation catalytic activity.  This non-catalytic function 
of OGT-1 may be conserved with humans as both WT and catalytically inactive human OGT 
partially rescued the C. elegans ogt-1 Nio phenotype.  However, C. elegans expressing OGT-1 
without the TPR domain were Nio, suggesting that unlike the catalytic activity, the TPR domain 
is required for the HTSR (Figure 3.2.1). 
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Figure 3.2.1 A non-catalytic function of ogt-1 is required to couple HTS induced transcription and translation 
to enable physiological adaptation to HTS. 
WT animals exposed to HTS induce the transcription of osmosensitive mRNAs, such as gpdh-1.  These mRNAs are 
rapidly translated into protein by the ribosome, facilitating adaptation to HTS.  Loss of ogt-1 does not interfere with 
HTS induced transcription.  Rather, loss of ogt-1 decreases HTS induced protein levels.  ogt-1 may facilitate stress-
induced translation via several potential mechanisms, including regulation of mRNA cleavage and 3’ UTR usage, 
mRNA export, intiation factor interactions, or ribosomal elongation of the transcript.  Importantly, the TPR domain, 
but not the O-GlcNAcylation function of OGT-1 is required in the HTSR.  
 
C. elegans is the primary genetic model system for studies of ogt-1 because it is the only 
known organism in which loss of ogt-1 is viable [413, 433].  This has allowed many previous 
studies to parse the roles of ogt-1 in lifespan [370, 496, 497], metabolism [413], innate immunity 
[430], behavior [419], neuron function [408, 418], stress responses [424, 498, 499], cell fate [362, 
500], and autophagy [423].  Importantly, most of these studies utilized global ogt-1 knockdown, 
which eliminates both O-GlcNAcylation-dependent and -independent functions of ogt-1.  The 
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missense alleles generated here will provide powerful tools for differentiating between catalytic 
and non-catalytic functions.  Further structure-function studies are needed to determine if the 
hypertonic functions of ogt-1 can be molecularly separated from its O-GlcNAcylation-dependent 
functions.  If these non-catalytic regions are conserved, such mutations could provide important 
new insights into the physiological role of non-catalytic OGT functions in humans.   
My studies revealed a critical and previously unappreciated condition-specific role of 
OGT-1 in adaptation to HTS.  This phenotype is completely penetrant and one of the strongest 
ogt-1 phenotypes described to date.  Although their ability to survive acute HTS is unaffected, ogt-
1 mutants are unable to adapt and develop following extremely mild shifts in extracellular 
osmolarity (250 mM NaCl).  Such conditions have minimal effects on the ability of WT animals 
to adapt and develop [317].  This suggest a critical physiological role of ogt-1 in the ability of C. 
elegans to survive in the wild, since C. elegans are continuously exposed to fluctuating 
environmental salinity in its native ecosystems [501].  Given that both C. elegans and human OGT 
are able to rescue the Nio phenotype of ogt-1 mutants in C. elegans, we speculate that OGT plays 
an ancient and conserved biological function in response to environmental and physiological 
perturbations in osmotic homeostasis. 
In mammals, OGT is essential to cell division, a physiological process that involves tight 
regulation of cell volume [11, 433, 502, 503].  Therefore, we speculate that OGT may be required 
for mammalian cell division for the same reason it is essential for adaptation to HTS in C. elegans: 
it plays a critical role in cell volume regulation.  One reason mammalian cells may be unable to 
divide without OGT is because they cannot properly regulate cell volume during cell division.  In 
C. elegans, unlike in mammals, ogt-1 is not an essential gene [413, 433].  I hypothesize that the 
osmotic homogeneity of standard C. elegans lab culture conditions allows ogt-1 mutants to survive 
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and propagate normally.  However, under hypertonic conditions, ogt-1 becomes an essential gene 
in C. elegans, like it is in humans.  It will be interesting to explore the roles and requirements of 
OGT in cell volume regulation in mammalian cells and tissues. 
Knockout of OGT in mammalian cells leads to a rapid loss of cellular viability [433].  This 
phenotype is largely thought to be due to loss of O-GlcNAcylation activity.  However, data from 
human cells suggest that O-GlcNAcylation activity may not be the essential function of OGT.  For 
example, exposure of mammalian cells to the O-GlcNAc inhibitor Ac4-5SGlcNAc largely blocks 
O-GlcNAcylation, but cellular viability and division are unaffected [436].  Additionally, cells and 
humans carrying inherited catalytic point mutations in OGT associated with intellectual disability 
are viable [504].  My data show that the role of OGT-1 in the C. elegans HTSR is also independent 
of catalytic activity.  Such catalytically-independent roles of OGT-1 have also been described in 
the context of synaptic regulation [408], cell adhesion [407], and transcriptional repression [371].  
If the evolutionarily critical role of OGT in mammalian cells is related to its ability to regulate cell 
volume, my data suggest that such functions are independent of O-GlcNAcylation activity.  These 
non-catalytic functions of OGT and the protein domains that regulate these functions are largely 
unexplored.  The C. elegans Nio phenotype may provide a powerful genetic system for identifying 
new domains important for OGT function via targeted and unbiased genetic screening strategies. 
Cell volume regulation during environmental stress requires upregulation of 
osmoprotective proteins, including those that regulate osmolyte accumulation.  In almost all cases, 
these genes are upregulated at the transcriptional level [324].  My findings are the first evidence 
that this pathway is also under post-transcriptional control.  OGT-1 is required for the 
accumulation of a GFP tagged GPDH-1 protein during HTS, but not for the upregulation of gpdh-
1 mRNA.  Interestingly, this is not a complete elimination of GPDH-1-GFP protein induction and 
 
  150 
even if it were, gpdh-1 null mutants retain significant hypertonic adaptation potential, whereas ogt-
1 mutants are completely adaptation deficient.  Alternatively, OGT-1 may in fact regulate gpdh-1 
mRNA at the transcriptional level but only in specific tissues, such as the hypodermis.  
Upregulation of gpdh-1 in other tissues, like the intestine, may mask such tissues specific 
regulation.  Nevertheless, my results suggest that OGT-1 regulation of the HTSR is likely to extend 
beyond its effects on GPDH-1 induction.  The nature of these additional targets and/or mechanisms 
is currently unknown. 
The regulation of stress responsive gene expression by OGT is not a new paradigm.  
Previous data has shown that it plays both a transcriptional and post-transcriptional role in stress 
response gene expression.  For example, OGT-1 O-GlcNAcylates the oxidative stress responsive 
transcription factor SKN-1 to facilitate upregulation of antioxidant gene transcription [424].  On 
the other hand, OGT regulates ER stress response [495] and heat shock response [426] gene 
expression post-transcriptionally by O-GlcNAcylating translation initiation factors to selectively 
facilitate translation of stress induced mRNAs.  Importantly, all of the previously described roles 
of OGT in stress responses require O-GlcNAcylation.  While our data suggests that OGT-1 also 
functions in the HTSR through a post-transcriptional mechanism, this mechanism is fundamentally 
different from that of the oxidative, heat shock, and ER stress responses because it does not require 
O-GlcNAcylation activity.  Further mechanistic studies are needed to define the O-
GlcNAcylation-independent downstream targets of OGT-1 and cellular mechanisms required for 
osmoprotective protein expression. 
Since the discovery of OGT, C. elegans have been an important tool for characterizing the 
role of OGT in cell signaling because it is the only known organism in which genetic loss of OGT 
generates viable cells and organisms [360, 413].  However, it is still unknown why ogt-1 null C. 
 
  151 
elegans, in contrast to every other metazoan, is viable [505].  One possibility is that the 
evolutionarily conserved role of ogt-1 in cell volume regulation during HTS contributes to the 
essential role of OGT in all metazoans, including C. elegans.  However, several key questions 
about the osmoprotective nature of OGT still remain.  First, while canonical OGT-1-dependent O-
GlcNAcylation is dispensable for the HTSR, it remains unclear which functions of OGT-1 are 
important to this physiological process.  Although OGT-1 can catalyze a unique type of proteolysis 
event, this activity is not thought to occur in C. elegans [403].  Regardless, the K957M mutation 
eliminates the known proteolytic activity of OGT-1 [404], but does not exhibit a Nio phenotype, 
suggesting that OGT-1 proteolysis is also not required in the HTSR.  Future studies, utilizing both 
targeted ogt-1 deletion alleles and unbiased genetic screens for new ogt-1 missense mutations with 
a Nio phenotype, should help to define the structural requirements of OGT-1 in the HTSR.  Second 
the precise post-transcriptional mechanism(s) that OGT-1 regulates to control GPDH-1 protein 
expression remains unknown.  Such mechanisms could include mRNA cleavage and 
polyadenylation site usage, mRNA nuclear export, selective interactions between ribosomes and 
stress-induced mRNAs, or regulated proteolysis of stress-induced proteins such as GPDH-1.  
While most of these potential mechanisms await testing, we found that autophagic or proteasome-
mediated proteolysis did not appear to be involved.  Finally, it remains unclear which genes ogt-1 
coordinates with to regulate HTS signaling.  Future studies analyzing new Nio mutants should 
shed light on these interactions. 
In conclusion, our unbiased genetic screening approaches in C. elegans have revealed a 
previously unappreciated requirement for non-canonical OGT signaling in a critical and conserved 
aspect of cell physiology.  The primary function of OGT has long been assumed to be due to it 
catalytic O-GlcNAcylation activity.  However, as I and others have shown, OGT also has critical 
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and conserved non-catalytic functions that warrant further study [371, 407, 408].  It is vital that 
future studies involving OGT utilize point mutants that differentiate canonical from non-canonical 
functions rather than OGT knockouts, which ablate both.  As my studies have shown, such 
approaches could reveal new roles for this key protein in unexpected aspects of cell physiology. 
3.2.1 Future directions 
While I was the first to discover and characterize the role of OGT-1 in the HTSR, the 
mechanism through which OGT-1 operates to regulate this cellular stress response are still 
unknown.  Defining the function(s) of OGT-1 that is required in the HTSR, characterizing the 
OGT-1-dependent osmosensitive cellular pathway(s), and identifying the post-transcriptional 
step(s) of osmosensitive gene expression that requires ogt-1 will shed mechanistic insights into the 
role of this protein in the HTSR. 
The most obvious first step in identifying the non-catalytic function(s) of OGT-1 required 
in the HTSR is to better delineate the OGT-1 structure-function relationships with respect to the 
Nio phenotype.  In particular, mutations that are Nio, but preserve the catalytic activity of OGT-1 
are of interest, because these will be the first known mutations that uncouple the catalytic and non-
catalytic functions of OGT-1.  I demonstrated that a complete deletion of the OGT-1 TPR domain 
inhibits the HTSR pathway and OGT-1 catalytic activity.  However, it will be interesting to use 
CRISPR/Cas9 to determine what portion of the TPR domain is required in the HTSR and if smaller 
TPR deletions also affect the catalytic activity of OGT-1.  One hypothesis is that OGT-1 regulates 
the HTSR via only a portion of its TPR domain, similarly to mSin3A-dependent transcriptional 
repression, which only requires the first six TPRs of OGT.  Additionally, it will be important to 
mutate the NLS with CRISPR/Cas9 to test if the nuclear localization of OGT-1 is required in the 
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HTSR.  Finally, although I demonstrated that the catalytic activity of OGT-1 is not required in the 
HTSR pathway, it is unknown if other functions of the catalytic domain, such as its substrate 
binding functions, are required in this response.  Using CRISPR/Cas9 to test the effect of a catalytic 
domain deletions on the HTSR will address this unknown.  These structure-function experiments 
will provide valuable insights into the required functions of OGT-1 in the HTS. 
Another way to define which functions of OGT-1 are required in the HTSR is to examine 
OGT-1 localization during HTS more closely.  OGT-1 has a diffuse nuclear localization in somatic 
tissues during isotonic conditions.  In response to HTS, I observed the relocalization of OGT-1 
into nuclear puncta in the hypodermis.  Determining if these OGT-1 nuclear puncta are required 
for the HTSR will provide further insights into the functional requirements of OGT-1 in the HTSR.  
If the relocalization of OGT-1 into nuclear puncta is disrupted in ∆TPR mutants (which are Nio), 
but not catalytic mutants (which are not Nio), this suggests that OGT-1 nuclear puncta may be 
functionally required in the HTSR.  Such a finding would for the first time provide a means by 
which to monitor the precise kinetics of the HTSR via live-cell imaging of the nuclear puncta. 
In addition to the functional requirements of OGT-1 in the HTSR, the OGT-1-dependent 
cellular pathways that regulate the HTSR have not been characterized.  Identifying the proteins 
that OGT-1 interacts with directly or indirectly to regulate the HTSR is critical for understanding 
how OGT-1 facilitates osmosensitive protein expression and adaptation to HTS.  Co-
immunoprecipitation experiments in WT and ∆TPR OGT mutant animals can be used to determine 
if ogt-1 regulates the HTSR through stable interactions with other proteins.  Additionally, an ogt-
1 suppressor screen will reveal the dependence of the HTSR on weak or indirect interactions with 
OGT-1.  Mutants that suppress the ogt-1 adaptation phenotype could be bypass suppressors that 
activate compensatory pathways or epistatic suppressors that activate genes in the same pathway 
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downstream of ogt-1/increase levels of proteins to facilitate interactions normally driven by ogt-1.  
Identification of either of these types of mutants would be informative towards understanding the 
mechanistic nature of the ogt-1-dependent osmosensitive pathway. 
Finally, moving forward it will be important to characterize the post-transcriptional 
mechanism(s) under OGT-1 control.  Despite upregulating gpdh-1 mRNAs during HTS, ogt-1 
mutants have impaired hypertonic induction of GPDH-1 protein and this impaired protein 
induction is not dependent on proteosome or autophagy – mediated degradation pathways.  This 
suggests that ogt-1 is required for the translation of accumulated gpdh-1 mRNAs into protein.  
However, it remains unknown if ogt-1 is required for gpdh-1 mRNA processing, nuclear export, 
or ribosome/translation initiation factor – transcript interactions during HTS.  Previous reports 
have implicated OGT-1 in the regulation of stress-responsive protein expression during the heat 
shock and ER stress responses via O-GlcNAcylation of translation initiation factors.  My discovery 
of a non-catalytic role of OGT-1 in the HTSR is the first indication that OGT-1 also regulates 
stress responsive protein expression via an unknown O-GlcNAcylation-independent mechanism.   
To test if ogt-1 is required for osmosensitive mRNA processing, RT-PCR combined with 
3’ and 5’ rapid amplification of cDNA ends (RACE) can be used.  Sequencing of the 3’ and 5’ 
ends of transcripts in ogt-1 mutants during HTS through 3’ and 5’ RACE will determine if ogt-1 
is required for the 3’ polyadenylation or the 5’ methylguanosine capping of osmosensitive 
transcripts.  Additionally, to determine if ogt-1 is required for osmosensitive mRNA export, RNA 
FISH can be used.  RNA FISH allows for the visualization of mRNA transcripts in cells.  If ogt-1 
mutants have impaired nuclear export of gpdh-1 transcripts, these transcripts should be enriched 
in the nucleus.  Unfortunately, my early attempts to visualize mRNA using RNA FISH probes 
specific for gpdh-1 transcripts were not successful.   Alternatively, interactions between OGT-1 
 
  155 
and the translation machinery may be required for osmosensitive protein expression.  This 
possibility can be tested by examining the colocalization and co-immunoprecipitation of WT (non-
Nio) and ∆TPR OGT-1-GFP (Nio) with fluorescently tagged ribosomes and translation factors 
during HTS.  Colocalization and co-immunoprecipitation of WT OGT-1-GFP, but not ∆TPR 
OGT-1-GFP, with the translation machinery during HTS would suggest that OGT-1 may function 
through the translation complex to post-transcriptionally regulate gpdh-1 expression.  In 
conclusion, determining how OGT-1 regulates osmosensitive protein induction through a 
combination of structure-function studies, genetics, and cell imaging approaches could reveal a 
novel HTSR pathway and expand our understanding of the non-canonical functions of OGT-1. 
 
3.3 Interacting components of the 3’ mRNA cleavage and polyadenylation complex are 
required for the hypertonic induction of GPDH-1 and physiological adaptation to 
hypertonic stress 
In addition to ogt-1, our Nio screen identified mutations in two interacting components of 
the APA complex that impair hypertonic induction of the gpdh-1p::GFP reporter and acute 
adaptation to HTS.  Specifically, a G42E missense mutation in the cleavage stimulation factor 64 
kDa subunit (CstF-64) homolog CPF-2 and a R580W missense mutation in the symplekin homolog 
SYMK-1 led to decreased hypertonic induction of gpdh-1 transcriptional (gpdh-1p::GFP) and 
translational (gpdh-1p::GPDH-1::GFP) reporters in C. elegans.  Unlike ogt-1 mutants, which 
continued to upregulate gpdh-1 mRNA during HTS, the cpf-2 and symk-1 Nio mutants had a 
slightly reduced induction of gpdh-1 mRNA during HTS compared to WT animals.  While this 
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phenotype needs to be examined more thoroughly, it suggests that these APA complex proteins 
may be required transcriptionally for osmosensitive gene expression.  Additionally, endogenously 
tagged OGT-1-GFP and tagRFP-CPF-2 relocalized from a diffuse nuclear pattern into nuclear 
puncta in the hypodermis during HTS.  However, these puncta did not colocalize, suggesting that 
OGT-1 and CPF-2 do not interact during HTS.  In conclusion, the identification of the cpf-2 and 
symk-1 missense alleles in our Nio screen add the HTSR to the growing list of cellular stress 
responses regulated by the APA complex.  
The 3’ end processing of mRNA by the APA complex is required for the expression of 
most genes [468].  Additionally, the presence of multiple PAS sequences in the majority of 
transcripts [469, 470] allows the APA complex to fine tune and change gene expression in response 
to factors such as cell stress and metabolic state [474, 476].  In this way, cells use 3’ mRNA 
processing by the APA complex to diversify the transcripts expressed from a single gene.  
Alternative polyadenylation is therefore a ubiquitous and essential cellular process [442].  The 
composition, enzymatic activities, and global targets of the APA complex are the primary focus of 
APA research.  However, an understanding of how this complex alters APA usage in specific 
physiological contexts is largely lacking.  This is primarily because APA knockouts are lethal in 
every system, including C. elegans [442].  Our Nio screen identified unusual missense alleles in 
APA components that are viable, which will allow us to study the function-specific and tissue-
specific roles for APA.  They also provide a unique opportunity to identify specific APA targets 
and mechanistically test how APA events in specific target genes affect the physiological response 
to HTS in vivo. 
There are several hypotheses as to how the cpf-2 and symk-1 Nio mutations might disrupt 
alternative polyadenylation.  One possibility is that these mutations cause destabilization and 
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degradation of the APA complex.  This hypothesis can be tested by measuring the effect of the 
Nio mutations on protein abundance of endogenously tagged cpf-2 and symk-1 alleles.  Another 
hypothesis is that the cpf-2 and symk-1 Nio mutations disrupt APA complex subunit interactions.  
To test this, the endogenously tagged alleles can be used to measure co-localization between the 
Nio cpf-2/symk-1 alleles and the APA complex under basal and hypertonic conditions.  A final 
testable hypothesis is that the cpf-2 and symk-1 Nio mutations affect APA complex localization.  
During HTS, we observed the relocalization of tagRFP-CPF-2 into nuclear puncta.  Therefore, to 
test this hypothesis, we can measure the effect of the Nio mutations on the kinetics, reversibility, 
and diffusion characteristics of the hypertonicity induced tagRFP-CPF-2 foci.  These structure 
function studies are only possible due to the APA complex missense alleles that were isolated in 
our Nio screen and they will provide important information about the functional requirements of 
the APA complex in the HTSR.  
In addition to the functional requirements of the APA complex, the target(s) of the APA 
complex required for the HTSR also remains unknown.  Since the APA complex cleaves and 
polyadenylates the 3’ UTR of mRNA, it is conceivable that the cpf-2 and symk-1 Nio mutations 
prevent the proper 3’ processing of a transcript(s) required for the HTSR.  One possibility is that 
the processing of  gpdh-1 itself by the APA complex is required in the HTSR.  However, this is 
not the case because the 3’ UTR of the gpdh-1p::GFP reporter that was the basis for my Nio screen 
does not contain the gpdh-1 3’ UTR sequence.  Instead, it contains the unc-54 3’ UTR sequence.  
This generic unc-54 3’ UTR is commonly used in overexpressed reporter constructs because it 
simplifies the cloning process.  In fact, the control col-12p::dsRed reporter I used in the genetic 
screen also contains the generic unc-54 3’ UTR instead of the endogenous col-12 3’ UTR.  Because 
both the gpdh-1p::GFP and col-12p::dsRed reporters contain the unc-54 3’ UTR, but only 
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induction of the gpdh-1p::GFP reporter is decreased during HTS in the cpf-2 and symk-1 Nio 
mutants, this suggests that the generic unc-54 3’ UTR is not regulated by the APA complex.  These 
data suggest that the APA complex likely regulates a factor upstream of gpdh-1 (Factor X) instead 
of modulating the 3’ UTR of unc-54 or gpdh-1 itself. 
There are two main models by which the APA complex could regulate the HTSR.  In the 
first model, full expression of the APA complex facilitates the cleavage and polyadenylation of 
Factor X at the first PAS encountered on the transcript, a low affinity proximal PAS, and this 
produces a stable functional protein that can then go on to activate gpdh-1 induction.  This model 
assumes that the cpf-2 and symk-1 Nio mutations decrease expression of the APA complex as a 
whole and therefore promote its binding to the distal PAS of Factor X.  Since long 3’ UTRs are 
subject to greater regulation by miRNAs and RNA binding proteins and intrinsically less stable 
than short 3’ UTRs [474, 475], this model suggests that Factor X transcripts are less stable in the 
cpf-2 and symk-1 Nio mutants and thereby cause impaired induction of gpdh-1.  This model 
therefore hypothesizes that the cpf-2 and symk-1 Nio mutations influence the alternative 
polyadenylation of Factor X to a greater extent than the alternative polyadenylation of other 
transcripts.  A paradigm similar to this is seen with the 3’ mRNA processing of IgM H-chain in 
mammals (Section 1.7.2).  The second model to explain how the APA complex may regulate the 
HTSR is more general.  It hypothesizes that the cpf-2 and symk-1 Nio mutants reduce APA below 
a threshold that is insufficient for stress-induced APA but provides enough APA to avoid lethality.  
In this model the cpf-2 and symk-1 Nio mutants identified in our Nio screen are likely to exhibit 
other known APA reduction-of-function mutant phenotypes.  Testing for these phenotypes will 
help us characterize the mechanism(s) by which APA regulates the HTSR. 
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Genetic screens commonly identify genes in the same cellular pathways [313].  If ogt-1 
and the APA complex function in the same pathway, they should exhibit similar cellular and 
molecular phenotypes.  One possibility is that these proteins are in the same physical complex and 
co-localize in vivo.  Endogenously tagged OGT-1-GFP and tagRFP-CPF-2 are both nuclear 
localized and they form puncta during HTS.  Furthermore, these hypertonically induced puncta are 
most pronounced in the hypodermis, which is where OGT-1 functions to regulate the HTSR.  
However, OGT-1-GFP and tagRFP-CFP-2 puncta do not overlap in the hypodermis suggesting 
that OGT-1 and CPF-2 are not localized to the same complex during HTS.  Another prediction is 
that if ogt-1 and the APA complex work through the same pathway, they might exhibit similar 
molecular phenotypes.  In ogt-1 mutants, gpdh-1 mRNA continues to be upregulated during HTS 
even though GPDH-1 protein is not.  In contrast, in cpf-2 and symk-1 Nio mutants, the upregulation 
of gpdh-1 mRNA is slightly reduced compared to WT animals during HTS.  While the gpdh-1 
mRNA levels in APA complex mutants needs to be examined more closely, these divergent 
phenotypes suggest that OGT-1 and the APA complex may act in different genetic pathways to 
regulate the HTSR.  Testing the genetic interactions between ogt-1 and the APA complex through 
epistasis experiments will provide further insights into this hypothesis.   
In conclusion, through an unbiased approach, I identified two interacting components of 
the APA complex as regulators of the HTSR.  Missense mutations in the cleavage stimulation 
complex subunit CPF-2 and the adaptor protein SYMK-1 caused impaired hypertonic induction of 
gpdh-1 and adaptation to HTS.  Although we do not know how these missense mutations affect 
the APA complex, we hypothesize that they may affect APA complex protein abundance, subunit 
interactions, and/or localization.  The endogenously tagged tagRFP-CPF-2 allele that we made is 
an important tool for answering these questions.  We also do not know how the APA complex is 
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required for the HTSR.  However, the generic nature of the gpdh-1p::GFP reporter 3’ UTR 
suggests that the APA complex regulates a signaling protein upstream of gpdh-1 instead of 
modifying the 3’ UTR of gpdh-1 itself.  Furthermore, the absence of colocalization between 
tagRFP-CPF-2 and OGT-1-GFP during HTS and the different effects of cpf-2/symk-1 and ogt-1 
mutants on hypertonic gpdh-1 mRNA induction suggest that OGT-1 and the APA complex may 
function in distinct cellular pathways to regulate the HTSR.  Since complete knockout of APA 
complex genes is lethal in animals including C. elegans, it was only possible to discover the 
requirement of the APA complex in the HTSR because of the non-null missense mutations in cpf-
2 and symk-1 we identified in our screen.  These missense mutations therefore provide a unique 
tool that will not only be useful for further characterizing the role of the APA complex in the 
HTSR, but also for understanding the broader cell biological and physiological functions of the 
APA complex.   
3.3.1 Future directions 
Several key questions about the cpf-2 and symk-1 Nio alleles and the role of APA in the 
HTSR remain.  1. How do the cpf-2 and symk-1 Nio mutations affect the biochemical properties 
of the APA complex? 2. Are cpf-2 and symk-1, like ogt-1, required acutely in the hypodermis 
during HTS?  3. What is the target(s) of the APA complex required to facilitate the HTSR?  Each 
of these questions can be answered through well-established techniques in C. elegans.  The first 
question can be addressed using endogenous fluorescently tagged CPF-2 and SYMK-1 to 
determine the effect of the cpf-2 and symk-1 missense Nio alleles on the APA complex.  Several 
possibilities exist for how these missense alleles could impact the APA complex.  They may cause 
destabilization of the APA complex, affect APA subunit interactions, or affect APA localization.  
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Each of these possibilities is testable using a combination of imaging and biochemical approaches 
with endogenous fluorescently tagged CPF-2 and SYMK-1 alleles.   
Next, it is necessary to examine the temporal and spatial requirements of CPF-2 and 
SYMK-1 in the HTSR to more precisely define the requirement of these proteins and the APA 
complex in the HTSR.  ogt-1 and previously identified regulators of the HTSR function in the 
hypodermis to modulate osmosensitive signaling pathways [319, 324, 329].  If cpf-2 and symk-1 
expression are also required in the hypodermis to regulate HTSR pathways, this would support the 
hypothesis that the hypodermis is the primary site of osmosensitive signaling.  This hypothesis can 
be tested using tissue-specific rescue of cpf-2 and symk-1.  Additionally, characterizing the 
temporal requirements of cpf-2 and symk-1 expression during the HTSR is necessary to determine 
if the APA complex is required for cell signaling events immediatly following HTS or if it is 
required developmentally to facilitate later HTSRs.  An acute requirement for cpf-2 and symk-1 
expression during HTS suggests that the APA complex dynamically responds to HTS to modulate 
osmosensitive gene expression and physiological adaptation to HTS. 
Finally, the hypothesis that APA of unknown target(s) during HTS is required for 
osmosensitive gene expression and adaptation to HTS needs to be tested.  While our data suggests 
that gpdh-1 does not undergo APA during the HTSR, the stability of factor(s) upstream of gpdh-1 
may be modulated by APA.  Enrichment of transcripts for 3’ UTR polyA sequences followed by 
RNA sequencing in WT and APA complex Nio mutants in control and hypertonic conditions will 
allow for the quantification of shifts in APA utilization by HTS.  While unlikely, the identification 
of a single APA event with functional consequences during HTS would be a major breakthrough 
in both the osmotic stress and APA fields because it would suggest a novel mechanism for the 
regulation of the HTSR.  
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3.4 Conclusions 
Study of the HTSR in C. elegans, primarily through unbiased genetic screens, has revealed 
both post-transcriptional and transcriptional regulation of osmosensitive gene expression.   
Through my doctoral studies I discovered that the HTSR is post-transcriptionally regulated by a 
novel non-catalytic function of the O-GlcNAc transferase enzyme (OGT).  In addition, I found 
that the transcriptional induction of the HTSR requires the 3’ mRNA cleavage and polyadenylation 
complex (APA complex).  Previous studies from our lab also suggest that the HTSR is under strong 
negative transcriptional regulation.  Protein homeostasis genes, which oppose protein damage and 
new protein synthesis, negatively regulate the HTSR transcriptional response through a GCN-1/2 
and WNK-1/GCK-3-dependent pathway.  Additionally, ECM proteins inhibit gpdh-1 
transcriptional induction under isotonic conditions through a pathway involving a transmembrane 
protein and a GATA-type transcription factor.  Therefore, genetic screens performed to date have 
revealed the existence of at least four basic HTSR pathways in C. elegans (Fig 3.4.1). 
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Figure 3.4.1 HTSR pathways in C. elegans 
The induction of ORGs, such as gpdh-1, during HTS is regulated through both transcriptional and post-transcriptional 
mechanisms.  At least three pathways regulate the transcriptional induction of gpdh-1.  First, inhibition of proteins 
that maintain protein folding and new protein synthesis activate gpdh-1 expression.  HTS-induced decreases in protein 
translation lead to increased gpdh-1 transcription through a gcn-1/2 and wnk-1/gck-3 dependent pathway.  
Additionally, while significant work shows that HTS causes unique types of protein damage and inhibition of protein 
homeostasis genes activates the HTSR, the specific signaling mechanisms linking HTS-induced protein damage to 
gpdh-1 upregulation are not known.  Second, two interacting components of the APA complex, SYMK-1 and CPF-2, 
are required for transcriptional induction of the HTSR through an unknown mechanism.  The requirement of the APA 
complex in the HTSR needs to be examined more closely, but I speculate that a transcript(s) upstream of ORGs is 
alternatively polyadenylated to facilitate the HTSR.  Third, the HTSR transcriptional response is negatively regulated 
by extracellular proteins that function upstream of the transmembrane protein PTR-23/patched-related protein 23 and 
the GATA erythroid-like transcriptional factors ELT-2 and ELT-3.  However, ptr-23 is not required for all ORG 
expression and as such at least one ptr-23 independent pathway must exist.  It is unknown if this ptr-23 independent 
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pathway functions through the GATA transcription factors.  It also remains unknown if HTS itself can activate ELT-
2/3 through an extracellular protein and ptr-23 independent pathway.  Finally, the O-GlcNAc transferase OGT-1 
regulates GPDH-1 protein translation through a post-transcriptional pathway.  ogt-1 is required for osm-8 and osm-11 
phenotypes, suggesting there is some crosstalk between the extracellular protein transcriptional pathway and the ogt-
1 post-transcriptional pathway.  The TPR domain and not the catalytic domain of OGT-1 is required in this pathway.  
The precise mechanism by which ogt-1 induces GPDH-1 protein expression is unknown, but it could include 
regulation of mRNA processing, mRNA export, initiation factor interactions, or ribosomal elongation.  The output of 
both the transcriptional and post-transcriptional pathways is to mediate physiological adaptations that enable animals 
to survive and develop in hypertonic environments. 
  
One notable finding from these studies of the C. elegans HTSR is that the genes and 
mechanisms identified in this relatively simple organism are not ‘worm-specific’.  Rather, they are 
ancient and highly conserved cellular pathways that impinge on critical aspects of cell physiology 
such as protein synthesis and folding, extracellular matrices, 3’ mRNA processing, and novel 
functions of highly conserved proteins, such as OGT-1.  However, much remains unknown about 
these HTSR regulatory pathways.  The mechanisms by which cells sense HTS have yet to be 
described.  Furthermore, in the transcriptional pathways, a transcription factor specific to the 
HTSR has not been identified and the signaling mechanism(s) by which this transcription factor 
becomes activated is unknown.  One possibility is that HTS is sensed by the cell through the ECM.  
This paradigm occurs in the yeast Sho1 branch of the high osmolarity glycerol (HOG) pathway, 
where the OSM-8 – like, extracellular mucin domain – containing proteins, Msb2 and Hkr1 sense 
HTS to ultimately activate the master regulator of the yeast HTSR, Hog1 [115]. 
The post-transcriptional pathway through which OGT-1 functions to regulate the HTSR is 
also uncharacterized.  OGT-1 could regulate GPDH-1 protein expression through mRNA 
processing, mRNA export, initiation factor interactions or ribosomal elongation.  While the TPR 
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domain, and not catalytic activity, of OGT-1 is required to regulate GPDH-1 protein expression, 
the mechanism(s) by which this domain regulates the HTSR is currently unknown.  Continued 
unbiased genetic screens, complemented by targeted biochemical and cell biological studies, will 
be instrumental towards further defining the cellular pathways regulating the C. elegans HTSR.  
The success of the genetic screening approaches used to characterize the role of ECM proteins, 
PTR-23, protein homeostasis, 3’ mRNA processing, and OGT-1 in the HTSR indicate that such 
approaches are well suited to study this cellular stress response.  Capturing unique missense alleles, 
identifying new genes, and describing new loss of function phenotypes through forward genetic 
screens in C. elegans will not only provide insight into the protein functions and cellular pathways 
regulating the HTSR, but will also reveal novel cell signaling paradigms that can be applied to 
other aspects of cellular physiology.  
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4.0 Methods 
4.1 C. elegans strains and culture 
Strains were cultured on standard NGM media with E.coli OP50 bacteria at 20˚C unless 
otherwise noted.  The following strains were used; N2 Bristol WT, OG119 drIs4 [gpdh-1p::GFP; 
col-12p::dsRed2], VP223 kbIs6 [gpdh-1p::gpdh-1-GFP], OG971 ogt-1/nio-2(dr15);drIs4, OG969 
ogt-1/nio-2(dr20);drIs4, OG1034 ogt-1(ok430);drIs4, OG1035 ogt-1(ok1474);drIs4, OG968 nio-
5(dr13);drIs4, OG970 nio-6(dr19);drIs4, OG972 nio-1(dr14);drIs4, OG975 cpf-2/nio-
3(dr16);drIs4, OG976 nio-5(dr18);drIs4, OG978 nio-4(dr17);drIs4, OG995 nio-5(dr22);drIs4, 
OG996 symk-1/nio-7(dr23);drIs4, OG1066 ogt-1(dr20 dr36);drIs4, OG1064 ogt-1(dr34);unc-
119(ed3);kbIs6, OG1115 gpdh-1(dr81) [gpdh1::GFP], OG1123 gpdh-1(dr81);ogt-1(dr84), 
RB1373 gpdh-1(ok1558), OG1048 osm-8(dr9);unc-4(e120);drIs4, OG1049 osm-8(dr9);unc-
4(e120);ogt-1(dr20):drIs4, OG1111 ogt-1(dr20);drIs4;drEx468 [ogt-1p::ogt-1cDNA::ogt-1 
3’utr; rol-6(su1006)], OG1119 ogt-1(dr20);drIs4;drEx469 [dpy-7p::ogt-1cDNA::ogt-1 3’utr; rol-
6(su1006)], OG1120 ogt-1(dr20);drIs4;drEx470 [nhx-2p::ogt-1cDNA::ogt-1 3’utr; rol-
6(su1006)], OG1121 ogt-1(dr20);drIs4;drEx471 [myo-2p::ogt-1cDNA::ogt-1 3’utr; rol-
6(su1006)], OG1122 ogt-1(dr20);drIs4;drEx472 [rab-3p::ogt-1cDNA::ogt-1 3’utr; rol-
6(su1006)], OG1125 ogt-1(dr20);drIs4;drEx473 [ogt-1p::human OGT isoform 1cDNA::ogt-1 
3’utr; rol-6(su1006)], OG1126 ogt-1(dr20);drIs4;drEx474 [ogt-1p::human OGT isoform 1 
H498AcDNA::ogt-1 3’utr; rol-6(su1006)], OG1046 ogt-1(dr20);drIs4;drEx465 [ogt-1p::ogt-1 
genomic], TJ375 gpIs1 [hsp16.2p::GFP], SJ4005 zcIs4 [hsp4p::GFP] V, OG1081 ogt-
1(dr50);zcIs4, MT3643 osm-11(n1604), OG1083 ogt-1(dr52);osm-11(n1604), OG1135 ogt-
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1(dr86);drIs4, OG1140 ogt-1(dr90);drIs4, OG1124 ogt-1(dr84) [ogt-1::GFP], OG1139 ogt-
1(dr84 dr89), OG1141 ogt-1(dr84 dr91), OG1156 ogt-1(dr93);drIs4, OG1157 ogt-1(dr84 dr94), 
IG274 frIs7 [nlp-29p::GFP + col-12p::dsRed2], OG975 cpf-2(dr16);drIs4, OG996 symk-
1(dr23);drIs4.  To create mutant combinations, we used either standard genetic crossing 
approaches or CRISPR/Cas9 genetic engineering (see below for CRISPR methods).  The 
homozygous genotype of every strain was confirmed either by DNA sequencing of the mutant 
lesion, restriction digest, or a loss of function phenotype. 
4.2 Genetic methods 
4.2.1 ENU mutagenesis and mutant isolation 
L4 stage drIs4 animals (P0) were mutagenized in 0.6 mM ENU diluted in M9 for 4 hours 
at 20˚C.  One day after ENU mutagenesis, F1 mutagenized eggs were isolated by hypochlorite 
solution and hatched on NGM plates overnight. Starved ENU mutagenized F1 drIs4 L1 animals 
were washed twice in 1 x M9 and seeded onto 3–16 10 cm OP50 NGM plates. F2 synchronized 
larvae were obtained via hypochlorite synchronization and seeded onto OP50 NGM plates.  Day 
one adult F2 drIs4 animals were transferred to 250 mM NaCl OP50 NGM plates for 18 hours.  As 
controls, unmutagenized drIs4 day 1 adults were also transferred to 50 mM NaCl and 250 mM 
NaCl OP50 NGM plates for 18 hours.  After 18 hours, RFP and GFP fluorescence intensity, time 
of flight (TOF), and extinction (EXT) were acquired for each animal using a COPAS Biosort 
(Union Biometrica, Holliston, MA).  Using the unmutagenized 50 mM NaCl NGM data as a 
reference, gate and sort regions for animals exposed to 250 mM NaCl were defined that isolated 
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rare mutant animals with GFP and RFP levels similar to the population of unmutagenized drIs4 
animals on 50 mM NaCl.  These mutants were termed Nio mutants (no induction of osmolyte 
biosynthesis gene expression).  Individual Nio mutant hermaphrodites were selfed and their F3 and 
F4 progeny re-tested to confirm the Nio phenotype. 
4.2.2 Backcrossing and single gene recessive determination 
Each nio mutant was backcrossed to drIs4 males three times.  F1 progeny from these 
backcrosses were tested on 250 mM NaCl for 18 hours as day 1 adults.  As expected for a recessive 
mutant, 100% of the crossed progeny were WT (non-Nio). F1 heterozygous hermaphrodites from 
these crosses were selfed and their progeny (F2) were tested on 250 mM NaCl for 18 hours as day 
1 adults.  As expected for a single gene recessive mutation, ~25% of progeny exhibited the Nio 
phenotype. 
4.2.3 Complementation testing 
nio/+ males were crossed with hermaphrodites homozygous for the mutation being 
complementation tested.  The F1 progeny from this cross were put on 250 mM NaCl OP50 NGM 
plates for 18 hours and screened for complementation.  Crosses in which ~50% of these F1 progeny 
were WT failed to complement (i.e. phenotype-causing mutations were alleles of the same gene).  
Crosses in which 100% of these F1 progeny were WT complemented (i.e. phenotype-causing 
mutations were alleles of different genes).  Each mutant was complementation tested to every other 
mutant twice–as both a hermaphrodite and as a male. 
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4.2.4 Whole genome sequencing 
DNA was isolated from starved OP50 NGM plates with WT (drIs4) or mutant animals 
using the Qiagen Gentra Puregene Tissue Kit (Cat No 158667). The supplementary protocol for 
“Purification of archive-quality DNA from nematode suspensions using the Gentra Puregene 
Tissue Kit” available from Qiagen was used to isolate DNA.  DNA samples were sequenced by 
BGI Americas (Cambridge, MA) with 20X coverage and paired-end reads using the Illumina 
HiSeq X Ten System. 
4.2.5 SNP and INDEL identification in mutants 
A Galaxy workflow was used to analyze the FASTQ forward and reverse reads obtained 
from BGI.  The forward and reverse FASTQ reads from the animal of interest, C. elegans reference 
genome Fasta file (ce11m.fa), and SnpEff download gene annotation file (SnpEff4.3 
WBcel235.86) were input into the Galaxy workflow.  The forward and reverse FASTQ reads were 
mapped to the reference genome Fasta files with the Burrows-Wheeler Aligner (BWA) for 
Illumina. The resultant Sequence Alignment Map (SAM) dataset was filtered using bitwise flag 
and converted to the Binary Alignment Map (BAM) format [506].  Read groups were added or 
replaced in the BAM file to ensure proper sequence analysis by downstream tools.  To identify 
areas where the sequenced genome varied from the reference genome, the Genome Analysis 
Toolkit (GATK) Unified Genotyper was used.  The types of variants identified with GATK were 
Single Nucleotide Polymorphisms (SNPs) and Insertion and Deletions (INDELs).  The SnpEff4.3 
WBcel235.86 gene annotation file was used to annotate the non-synonymous SNPs and INDELs 
that were identified as variants by GATK.  The final list of all variants with annotated non-
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synonymous variants was exported as a Microsoft Excel table. To identify mutations in the 
sequenced mutants that were not in the parent strain (drIs4), the MATCH and VLOOKUP 
functions in Microsoft Excel were used. 
4.2.6 RNAi methods 
Gravid adult animals on RNAi plates (NGM + 1mM IPTG + 25ug/ml carbenicillin) were 
hypochlorite treated.  Synchronized L1s from the hypochlorite treatment were allowed to develop 
on RNAi plates until day one adult.  Day 1 adults were seeded onto either 50 mM or 250 mM 
RNAi or OP50 NaCl plates.  For the developmental timed RNAi experiment, hypochlorite 
synchronized L1 animals were seeded onto ev(RNAi) or ogt-1(RNAi). At the indicated stages, 
animals were manually transferred from ev(RNAi) to ogt-1(RNAi).  For the adult-specific RNAi, 
day 1 adult animals were transferred from ev(RNAi) to ogt-1(RNAi) plates containing either 50 
mM NaCl or 250 mM NaCl. The identity of all RNAi clones was confirmed by sequencing. 
4.3 COPAS biosort acquisition and analysis 
Day one adults from a synchronized egg lay or hypochlorite preparation were seeded on 
50 or 250 mM NaCl OP50 or the indicated RNAi NGM plates.  After 18 hours, the GFP and RFP 
fluorescence intensity, time of flight (TOF), and extinction (EXT) of each animal was acquired 
with the COPAS Biosort.  The TOF is directly proportional to worm size.  Events in which the 
RFP intensity of adult animals (TOF 400–1200) was <20 (dead worms or other objects) were 
excluded from the analysis.  The GFP fluorescence intensity of each animal was normalized to its 
 
  171 
RFP fluorescence intensity or TOF.  To determine the fold induction of GFP for each animal, each 
GFP/RFP or GFP/TOF was divided by the average GFP/RFP or GFP/TOF of that strain exposed 
to 50 mM NaCl.  The relative fold induction was determined by setting the fold induction of drIs4 
exposed to 250 mM NaCl to 1.  
4.4 Molecular biology and transgenics 
4.4.1 Reporter strains 
The drIs4 strain was made by injecting WT animals with gpdh-1p::GFP (20ng/μL) and 
col-12p::dsRed2 (100ng/μL) to generate the extrachromosomal array drEx73, which was 
integrated using UV bombardment, followed by isolation of animals exhibiting 100% RFP 
fluorescence.  The resulting strain was outcrossed five times to WT to generate the homozygous 
integrated transgene drIs4. kbIs6 was generated from a Gene Gun bombardment of unc-119(ed3) 
animals with a gpdh-1p::gpdh-1::GFP plasmid and an unc-119(+) rescue plasmid (pMM051).  
The resulting strain was outcrossed five times to generate kbIs6.  drIs4 is integrated on LGIV.  The 
integration site for kbIs6 is unmapped. 
The WT gpdh-1p::GFP, ∆CDS gpdh-1p::GFP, and ∆5’ UTR gpdh-1p::GFP 
extrachromosomal reporter strains were made by cloning each gpdh-1 promoter sequence into 
the pPD95.75 plasmid and injecting WT animals with 20 ng/µL of each construct.  Animals were 
also injected with 2.5 ng/µL of a myo2p::mCherry construct as a co-injection marker.  Animals 
expressing the gpdh-1 promoter extrachromosomal arrays were maintained by picking animals 
expressing pharyngeal myo2p::mCherry. 
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4.4.2 Transgene rescue 
The genomic ogt-1 rescue construct (used in the drEx465 extrachromosomal array) was 
made by amplifying ogt-1 with 2 kb of sequence upstream of the start codon and 1 kb of sequence 
downstream of the stop codon.  All other rescue constructs (used in extrachromosomal arrays 
drEx468 –drEx474) were made using Gibson Assembly.  The ogt-1 promoter, ogt-1 cDNA, and 
ogt-1 3’UTR were cloned into the pPD61.125 vector through a four component Gibson Assembly 
reaction.  This vector was used as the backbone for all other promoter and human OGT rescue 
constructs. All rescue constructs were confirmed by Sanger sequencing.  Extrachromosomal array 
lines were made by injecting day one adult animals with the rescue construct (20 ng/μL) and rol-
6(su1006) (100 ng/μL). 
4.4.3 CRISPR/Cas9 genomic editing 
CRISPR allele generation and TPR deletion was performed using the single-stranded 
oligodeoxynucleotide donors (ssODN) method [507, 508].  For identification of the dr20 allele, 
we performed RFLP (restriction fragment length polymorphism) analysis using the MboI 
restriction enzyme, which cuts the WT allele, but not dr20. For identification of the dr86, dr89, 
dr90, and dr91 alleles, we performed RFLP analysis using the DdeI restriction enzyme, which cuts 
the mutant alleles, but not WT.  To make the gpdh-1::GFP CRISPR strain, we used a previously 
described double stranded DNA (dsDNA) asymmetric-hybrid donor method [507, 508].  To make 
the ogt-1::GFP CRISPR strain, we used a dsDNA donor method using Sp9 modified primers 
[509].  Homozygous CRISPR/Cas9 generated alleles were isolated by selfing heterozygotes to 
ensure that complex alleles were not obtained. 
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4.4.4 mRNA isolation, cDNA synthesis, and qPCR 
Day one animals were plated on 50 mM or 250 mM NaCl OP50 NGM plates for 24 hours.  
Unless noted otherwise, after 24 hours, 35 animals were picked into 50 μL Trizol for mRNA 
isolation. RNA isolation followed a combined Trizol/RNeasy column purification method as 
previously described [324].  cDNA was synthesized from total RNA using the SuperScript VILO 
Master Mix.  SYBR Green master mix, 2.5 ng input RNA, and the appropriate primers were used 
for each qPCR reaction.  qPCR reactions were carried out using an Applied Biosystems 7300 Real 
Time PCR machine.  act-2 primers were used as a control for all qPCR reactions. At least three 
biological replicates of each qPCR reaction were performed with three technical replicates per 
biological replicate.  qPCR data was analyzed through ∆∆Ct analysis with all samples normalized 
to act-2.  Data are represented as fold induction of RNA on 250 mM NaCl relative to on 50 mM 
NaCl. 
4.4.5 Western blots 
Cell lysates were prepared from hypochlorite synchronized day 1 adult animals exposed to 
50 mM or 250 mM NaCl plates for 18 hours.  3–5 non-starved 10 cm plates were concentrated 
into a 100 μL mixture.  NuPage LDS Sample Buffer (4X) and NuPAGE Sample Reducing Agent 
(10X) were added and the sample was frozen and thawed three times at -80˚C and 37˚C.  Prior to 
gel loading, the sample was heated to 100˚C for 10 minutes and cleared by centrifugation at 4˚C, 
12,000 x g for 15 minutes.  The cleared supernatant was run on a 4–12% or 8% Bis-Tris Mini Plus 
gel and transferred to a nitrocellulose membrane using iBlot 2 NC Regular Stacks and the iBlot 2 
Dry Blotting System.  The membranes were placed on iBind cards and the iBind western device 
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was used for the antibody incubation and blocking.  The Flex Fluorescent Detection (FD) Solution 
Kit or the iBind Solution Kit was used to dilute the antibodies and block the membrane. The 
following antibody dilutions were used: 1:1000 α-GFP, 1:2000 α-ß-Actin, 1:2000 α-mouse HRP, 
and 1:4000 Goat α-Mouse IgG (H+L) Cross-Absorbed Secondary DyLight 800.  A C-DiGit Licor 
Blot Scanner (LI-COR Biosciences, Lincoln, NE) or an Odyssey CLx imaging System (LI-COR 
Biosciences, Lincoln, NE) were used to image membranes incubated with a chemiluminescent or 
fluorescent secondary antibody, respectively. 
4.5 Microscopy 
Worms were anesthetized (10mM levamisole) and mounted on either agar plates for low 
magnification stereo fluorescence microscopy or silicone greased slide chambers for high 
magnification wide-field microscopy.  Images were collected on either a Leica MZ16FA 
fluorescence stereo dissecting scope with a DFC345 FX camera or a Leica DMI4000B inverted 
compound microscope with a Leica DFC 340x digital camera using the Leica Advanced  
Fluorescence software (Leica Microsystems, Wetzlar, Germany).  Unless noted, images within an 
experiment were collected using the same exposure and zoom settings.  Unless noted, images 
depict merged GFP and RFP channels of age matched day 1 adult animals exposed to 50 or 250 
mM NaCl for 18 hours. 
 
  175 
4.6 Immunofluorescence 
Embryos from a hypochlorite preparation were freeze-cracked on a superfrost slide, fixed 
with 4% paraformaldehyde, blocked with bovine serum albumin (BSA), incubated with a 1:400 
dilution of α-O-GlcNAc monoclonal antibody (RL2) overnight, and incubated with 1:400 dilution 
of 1:400 goat α-mouse IgG, IgM (H+L) Secondary Antibody, Alexa Fluor 488 for 4–6 hours [510].  
Washes with PBS or antibody buffer were carried out between each incubation step.  DNA was 
stained with 1 μg/mL Hoechst 33258 diluted in PBS.  Exposure matched Z-stacks of images were 
processed using the following deconvolution parameters (Leica Application Suite Advanced 
Fluorescence, 2.1.0 build 4316): Method–blind, Total iterations– 10, Refractive index– 1.518, 
Resized to 16 bit depth. Images were scaled to the following intensities: RL2 maximum pixel 
intensity = 514, Hoechst 33258 maximum pixel intensity = 1028.  Final images are represented as 
maximum Z-stack projections. 
4.7 C. elegans assays 
4.7.1 Acute adaptation assay. 
Day one adult animals were transferred to five 50 mM NaCl OP50 NGM plates and five 
200 mM NaCl OP50 plates.  ~25 animals were transferred to each plate (i.e. ~125 animals total 
per condition per genotype).  After 24 hours, 20 animals from each 50 mM or 200 mM plate were 
transferred to 600 mM NaCl OP50 NGM plates.  Animals were scored for movement after 24 
hours on the 600 mM NaCl OP50 NGM plates.  The experimenter was blinded to genotype. To be 
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counted as moving, the animal had to move greater than half a body length.  Animals that were 
not moving were lightly tapped on the nose to confirm that they were paralyzed or dead. 
4.7.2 Chronic adaptation assay 
5 L4 animals were transferred to 50 or 250 mM NaCl OP50 NGM plates.  Plates were 
monitored over several days.  For the brood and development assays, a single L4 animal was 
transferred to a 50 or 250 mM NaCl OP50 NGM plate.  Embryos counts and transfer of the mother 
to a new plate were done daily until the mother stopped laying eggs.  Progeny from each animal 
were allowed to develop and the number of L4s was counted.  Percent of developed embryos was 
calculated by dividing the number of L4s on a plate by the number of embryos originally laid on 
that plate. 
4.7.3 Survival assays and OSR assays 
Survival and OSR assays were performed as previously described [324].  Briefly, for the 
survival assays, day 1 adults (24 hours post-L4) were placed on OP50 spotted NGM plates 
containing indicated concentrations of NaCl.  The survival of each animal was determined after 
24 hours at 20˚C.  Animals that failed to respond to prodding with a platinum wire were scored as 
dead.  For the OSR assay, animals were transferred from standard 50 mM NaCl OP50 spotted 
NGM plates to either 500 mM NaCl or 700 mM NaCl NGM plates without OP50.  The percentage 
of animals moving after 10 minutes was determined by prodding with a platinum wire.  Animals 
that failed to respond were scored as paralyzed. 
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4.8 Statistical analysis 
Comparisons of means were analyzed with either a two-tailed Students t-test (2 groups) or 
ANOVA (3 or more groups) using the Dunnett’s or Tukey’s post-test analysis as indicated in 
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA).  COPAS biosort data is nonparametric 
and was therefore analyzed using a Mann-Whitney test (2 groups) or Kruskal-Wallis test (3 or 
more groups) using the Dunn’s post-test analysis in GraphPad Prism 7 (GraphPad Software, Inc., 
La Jolla, CA).  p-values of <0.05 were considered significant. Data are expressed as mean ± S.D. 
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Appendix A Supplementary Data 
Appendix A.1 Investigating the role of the PQR/AQR/URX neurons in the physiological 
hypertonic stress response 
Gradual upshifts (between 200 mOsm and 1 Osm) in extracellular osmolarity cause C. 
elegans to increase their turning rate [511].  Expression of the cGMP-gated channel subunit tax-2 
in the PQR, AQR, and URX sensory neurons is required to mediate this aversive behavioral 
response [511].  Importantly, this behavior is genetically distinct from the acute reversal phenotype 
C. elegans exhibits when it encounters extracellular osmolarities > 1 Osm, which depends on the 
expression of the TRPV homolog osm-9 in the ASH sensory neurons [343].   
Since the C. elegans physiological HTSR (i.e. osmosensitive gene upregulation and 
glycerol accumulation in the hypodermis and intestine) occurs in the same range of tonicities as 
the behavioral increase in turning rate that depends on the PQR/AQR/URX neurons [318, 511], I 
investigated if these neurons also mediate the physiological HTSR.  Specifically, I hypothesized 
that if the PQR/AQR/URX neurons were required for the physiological HTSR, then tax-2 mutants 
would have reduced survival during 24 or 48 h of exposure to HTS (Fig A.1).  osm-8(n1518) 
mutants served as positive controls in these survival assays because they constitutively accumulate 
glycerol and therefore have increased survival during HTS compared to WT animals [329].  The 
initial 24 and 48 h survival curves suggested that tax-2 may be required for C. elegans survival on 
400 – 450 mM NaCl NGM plates (Fig A.1A).  Therefore, I tested the survival of three tax-2 LOF 
mutants and a tax-2(p694) mutant strain overexpressing tax-2 in the PQR/AQR/URX neurons at 
400 and 450 mM NaCl (Fig A.1B).  The survival results were highly variable among the different 
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tax-2 alleles, salt conditions, and between experiments.  Furthermore, the tax-2(p694) mutant 
strain overexpressing tax-2 in the PQR/AQR/URX neurons did not consistently rescue the survival 
of tax-2(p694) mutants (Fig A.1B).  Based on these results it is unlikely that the PQR/AQR/URX 
neurons regulate the physiological HTSR. 
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Figure A.1 tax-2 expression in the PQR/AQR/URX neurons is not required for survival during HTS 
(A) Percent survival of day 2 adult animals exposed to 100 – 600 or 700 mM NaCl NGM plates for 24 and 48 hours.  
Strains include WT, osm-8(n1518), and tax-2(p694).  Data are expressed as mean ± S.D.  N = 5 replicates of 20 
animals for each salt concentration. The number above each graph indicates the duration of HTS and experiment 
number.  (B) Percent survival of day 2 adult animals exposed to 400 or 450 mM NaCl for 24 and 48 hours.  The tax-
2(p694);lin-15A&lin-15B(n765);dbEx723 strain is a tax-2 rescue strain in which an extrachromosomal array 
containing the tax-2 genomic sequence is expressed specifically in the PQR/AQR/URX neurons of tax-2(p694) 
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mutants.  We included lin-15A&lin-15B(n765)qals2241x animals to test the background of this tax-2 rescue strain.  
Data are expressed as mean ± S.D.  N = 5 replicates of 20 animals for each salt concentration.  The number of above 
each graph indicates the duration of HTS and experiment number.  
Appendix A.2 Loss of gpdh-1 impairs growth during hypertonic stress 
I characterized the phenotype of the presumptive null gpdh-1(ok1558) mutant during HTS 
using a growth assay based on COPAS Biosort TOF measurements.  In this assay, I seeded WT 
and gpdh-1(ok1558) mutant L1s on isotonic (50 mM NaCl) and hypertonic (400 mM NaCl) NGM 
plates and measured their size as adults.  There was no difference in the size of WT and gpdh-
1(ok1558) mutant animals exposed to isotonic conditions (Fig A.2A).  However, when grown in 
hypertonic conditions for the same amount of time, gpdh-1(ok1558) mutants were significantly 
smaller than WT animals (Fig A.2B).  This result suggests that GPDH-1 facilitates C. elegans 
growth during HTS. 
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Figure A.2 gpdh-1 is required for growth in hypertonic conditions 
(A) COPAS Biosort quantification of the TOF of animals grown on 50 mM NaCl NGM plates.  Animals were seeded 
on 50 mM NaCl NGM plates as L1s and data was acquired 49.5 hours later when these animals reached adulthood.  
Strains include WT and the presumptive gpdh-1 null allele gpdh-1(ok1558).  ok1558 is an out-of-frame deletion allele 
that generates a premature stop codon in exon 2 of gpdh-1 and is therefore a likely null allele.  Data are expressed as 
mean ± S.D.  ns = nonsignificant (Mann-Whitney test).  N ≥  313 for each group.  (B) COPAS Biosort quantification 
of the TOF of animals grown on 400 mM NaCl NGM plates.  Animals were seeded on 400 mM NaCl NGM plates as 
L1s and data was acquired 98.5 hours later when these animals reached adulthood.  Strains include WT and the 
presumptive gpdh-1 null allele gpdh-1(ok1558).  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Mann-Whitney 
test).  N ≥  86 for each group.   
Appendix A.3 ogt-1 is required for full induction of the transcriptional gpdh-1p::GFP 
(drIs4) and translational gpdh-1p::GPDH-1-GFP (kbIs6) reporters during hypertonic stress 
A western blot using a GFP antibody showed that ogt-1(dr15) and ogt-1(dr20) mutants 
expressed reduced amounts of the gpdh-1p::GFP (drIs4) transcriptional reporter (Fig A.3A) 
during HTS.  Similarly, loss of ogt-1 also reduced the hypertonic induction of the gpdh-
1p::GPDH-1-GFP (kbIs6) translational reporter as measured by western blot (Fig A.3B).  These 
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western blots in combination support the gpdh-1p::GFP fluorescence data for ogt-1 mutants 
during HTS (Fig 2.2.1B, 2.2.1C, and 2.2.4A). 
 
Figure A.3 ogt-1 is required for full induction of the gpdh-1p::GFP (drIs4) and gpdh-1p::GPDH-1-GFP (kbIs6) 
reporters during HTS 
(A) Immunoblot of GFP and β-actin in lysates from WT and ogt-1 mutant animals expressing drIs4 exposed to 50 or 
250 mM NaCl NGM plates for 18 hours.  (B) Immunoblot of GFP and β-actin in lysates from WT and ogt-1(dr34) 
animals expressing the kbIs6 translational fusion exposed to 50 or 250 mM NaCl NGM plates for 18 hours.  The ogt-
1(dr34) allele carries the same homozygous Q600STOP mutation as the ogt-1(dr20) allele and was introduced using 
CRISPR/Cas9.  Numbers under the GFP bands represent GFP signal normalized to β-actin signal for each sample, 
with the WT 250 mM NaCl sample set to 1. 
Appendix A.4 Quantification of the hypertonic induction of gpdh-1p::GFP (drIs4) in a 
mixed age population of animals 
Our Nio screen was done in adult C. elegans (500-1000 TOF).  Here I tested if younger 
stage ogt-1 mutants also had a Nio phenotype.  ogt-1 mutants within the 40-100 TOF, 100-200 
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TOF, and 300-500 TOF sizes were Nio (Fig A.4A, A.4B, and A.4D).  However, ogt-1 mutants 
within the 200-300 TOF size induced the gpdh-1p::GFP (drIs4) reporter similarly to WT animals 
suggesting that they were not Nio.  Therefore, the Nio phenotype of ogt-1 mutants may depend on 
developmental stage.  However, this result has only been achieved once and thus this experiment 
needs to be repeated before robust conclusions can be made.  The next time this experiment is 
done, it may be useful to more directly test the effect of developmental stage on hypertonic gpdh-
1p::GFP induction instead of using COPAS Biosort size (TOF) as a proxy for developmental 
stage.  Although more laborious, this can be achieved by growing up synchronized C. elegans to 
each larval stage and individually testing each group of animals on high salt.  In this way, 
developmental stage can be directly linked to the ability to mount a HTSR in WT and ogt-1 mutant 
animals.  
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Figure A.4 The dependence of gpdh-1p::GFP expression on animal developmental stage 
(A) COPAS Biosort quantification of GFP and TOF signal from animals that had a TOF between 40 and 100.  Data 
are represented as the GFP/TOF ratio of animals exposed to 50 or 250 mM NaCl.  Each point represents the quantified 
signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc 
Dunn’s test).  N ≥ 567 for each group.  (B) COPAS Biosort quantification of GFP and TOF signal from animals that 
had a TOF between 100 and 200.  Data are represented as the GFP/TOF ratio of animals exposed to 50 or 250 mM 
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NaCl.  Each point represents the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p 
< 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 154 for each group.  (C) COPAS Biosort quantification 
of GFP and TOF signal from animals that had a TOF between 200 and 300.  Data are represented as the GFP/TOF 
ratio of animals exposed to 50 or 250 mM NaCl.  Each point represents the quantified signal from a single animal. 
Data are expressed as mean ± S.D.  ns = nonsignificant (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 53 for 
each group.  (D) COPAS Biosort quantification of GFP and TOF signal from animals that had a TOF between 300  
and 500.  Data are represented as the GFP/TOF ratio of animals exposed to 50 or 250 mM NaCl.  Each point represents 
the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-Wallis test 
with post hoc Dunn’s test).  N ≥ 45 for each group.  (E) COPAS Biosort quantification of GFP and TOF signal from 
animals that had a TOF between 500  and 1000.  Data are represented as the GFP/TOF ratio of animals exposed to 50 
or 250 mM NaCl.  Each point represents the quantified signal from a single animal. Data are expressed as mean ± 
S.D.  **** - p < 0.0001 (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 116 for each group. 
Appendix A.5 Intracellular glycerol measurements in ogt-1, cpf-2, and symk-1 mutants 
I measured whole worm glycerol concentration in ogt-1, cpf-2, and symk-1 Nio mutants 
using the  PicoProbe Free Glycerol Fluorometric Assay Kit (Biovision).  We decided to utilize this 
new glycerol detection assay because it theoretically would allow us to measure whole animal 
glycerol content using a smaller number of worms and in a quicker fashion than previously used 
methods [318].  I measured they glycerol content of about fifty C. elegans per genotype per sample 
and normalized the glycerol concentration to protein concentration (measured with a BCA assay).  
The fifty C. elegans were picked directly from plates into glycerol assay buffer.  In WT animals, 
I measured about a two-fold increase in glycerol levels during HTS (Fig A.5).  This increase in 
glycerol accumulation was considerably smaller than expected based on previous experiments in 
which glycerol accumulation was increased on the order of hundreds fold.  Glycerol accumulation 
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in the four Nio mutants was variable between experiments and I did not measure glycerol levels 
in these mutants in isotonic conditions (Fig A.5).   
It is hard to draw conclusions from the results of this experiment because the small increase 
in glycerol concentration during HTS in WT animals suggests that the assay parameters are not 
optimized for accurate glycerol quantification.  This smaller increase in glycerol concentration in 
WT animals could be due to the small number of animals or the sensitivity of the plate reader.  
Additionally, since the C. elegans were not washed prior to preparing the sample, bacterial 
contamination may have interfered with the fluorometric reaction, but there is currently no 
evidence that this was the case.    
 
Figure A.5 Intracellular glycerol accumulation in ogt-1, cpf-2, and symk-1 mutants 
Whole worm glycerol concentration normalized to total protein concentration in day 2 adult animals exposed to 50 or 
250 mM NaCl NGM plates for 18 hours.  The PicoProbe Free Glycerol Fluorometric Assay Kit (Biovision) was used 
to measure glycerol concentration and the Pierce BCA Protein Assay Kit was used to measure protein concentration.  
Data are expressed as mean ± S.D.  * - p < 0.05, ns = nonsignificant (One-way ANOVA with post hoc Tukey’s test).  
N = 3 biological replicates of 50 animals each and three technical replicates within each biological replicate.   
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Appendix A.6  empty vector(RNAi) and ogt-1(RNAi) impact the acute adaptation of wild 
type animals  
I performed an acute adaptation assay with WT drIs4 (gpdh-1p::GFP) and N2 Bristol C. 
elegans treated with either ev(RNAi) or ogt-1(RNAi).  The rationale behind this experiment was to 
determine if ogt-1(RNAi) phenocopied the ogt-1 LOF mutant adaptation phenotype.  Surprisingly, 
my results suggested that RNAi was not compatible with the adaptation assay (Fig A.6).  In both 
N2 and drIs4 animals, the movement of ogt-1(RNAi)-treated unadapted animals was not fully 
suppressed (Fig A.6).  Furthermore, a smaller percentage of adapted drIs4 animals treated with 
ev(RNAi) were moving than expected based on previous adaptation assays (Fig 2.2.6A and A.6).  
Since C. elegans in RNAi experiments are fed a different strain of E. coli (HT115 E. coli) than 
non-RNAi experiments (OP50 E.coli), the discrepancies between the RNAi and mutant adaptation 
assays may be due to the different food sources.  Alternatively, engagement of the RNAi 
machinery may desensitize C. elegans to HTS.  
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Figure A.6 Acute adaptation of WT animals treated with empty vector(RNAi) or ogt-1(RNAi) 
Percent of moving unadpated and adapted day 3 adult animals exposed to 600 mM NaCl NGM plates for 24 hours.  
Strains include WT (N2) animals and WT animals expressing drIs4.  Data are expressed an mean ± S.D.  *** - p < 
0.001, ** - p < 0.01, ns = nonsignificant (Two-way ANOVA with post hoc Tukey’s test).  N = 5 replicates of 20 
animals for each strain. 
Appendix A.7 ogt-1 mutant acute adaptation assays with overexpressed transgenes 
Since expression of an ogt-1 cDNA transgene in ogt-1 mutants rescued gpdh-1p::GFP 
reporter induction during HTS, I tested if it also rescued acute adaptation to HTS (Fig 2.2.1E, 
A.7A, and A.7B).  In my initial experiments, I injected the rescue transgenes with a rol-6(su1006) 
marker.  This marker causes a roller phenotype, which makes it possible to identify transgenic 
animals.  Interestingly, I found that use of the rol-6(su1006) injection marker interfered with rescue 
of the adaptation phenotype (Fig A.7A).  Expression rol-6(su1006) in C. elegans affects the cuticle 
to cause the roller phenotype.  Since the cuticle is a critical component of the HTSR, expression 
of rol-6(su1006) may also influence the HTSR.  In support of this hypothesis, when I injected the 
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rescue transgenes with a pharyngeal myo2p::GFP marker instead of the rol-6(su1006) marker, 
expression of an ogt-1 cDNA transgene in ogt-1 mutants rescued acute adaptation (Fig A.7B).   
I also examined if expression of WT or catalytically inhibited H498A human OGT (hOGT) 
with the pharyngeal myo2p::GFP marker in ogt-1 mutants rescued the acute adaptation phenotype 
(A.7C).  Since expression of both WT and H498A hOGT in ogt-1 mutants partially rescued 
hypertonic gpdh-1p:GFP induction, I hypothesized that these two constructs would also both 
partially rescue acute adaptation.  However, the expression of neither WT nor H489A hOGT in 
ogt-1 mutants rescued the acute adaptation phenotype (Fig A.7C).  This result suggests that the 
partial rescue of hypertonic gpdh-p::GFP induction by WT or H498A hOGT in ogt-1 mutants is 
not sufficient to facilitate acute adaptation to HTS.   
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Figure A.7 Acute adaptation assays with ogt-1 mutant rescue strains 
(A) Percent of moving unadapted and adapted day 3 adult animals exposed to 600 mM NaCl NGM plates for 24 hours.  
Strains express drIs4 and include WT, ogt-1(dr15) mutants expressing an extrachromosomal array with a roller marker 
( rol-6(su1006)) and a fosmid containing ogt-1 genomic sequence, and ogt-1(dr15) mutant siblings that do not express 
this extrachromosomal array.  Data are expressed an mean ± S.D.  **** - p < 0.0001, ns = nonsignificant (Two-way 
ANOVA with post hoc Tukey’s test).  N = 5 replicates of 20 animals for each strain.  (B) Percent of moving unadapted 
and adapted day 3 adult animals exposed to 600 mM NaCl NGM plates for 24 hours.  Strains express drIs4 and include 
WT, ogt-1(dr20), and two separate lines of ogt-1(dr20) mutants expressing an extrachromosomal array with the 
pharyngeal myo2p::GFP marker and a plasmid containing the ogt-1 cDNA sequence.  Data are expressed an mean ± 
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S.D.  **** - p < 0.0001, *** - p < 0.001 (Two-way ANOVA with post hoc Tukey’s test).  N = 5 replicates of 20 
animals for each strain.  (C) Percent of moving unadapted and adapted day 3 adult animals exposed to 600 mM NaCl 
NGM plates for 24 hours.  Strains express drIs4 and include WT, ogt-1(dr20), ogt-1(dr20) mutants expressing an 
extrachromosomal array with the myo2-GFP pharyngeal marker and ogt-1 cDNA (ogt-1(dr20);drEx478), and two 
separate lines each of ogt-1(dr20) mutants expressing an extrachromosomal array with the myo2-GFP pharyngeal 
marker and either WT h. sapians OGT cDNA or H498A h. sapians OGT cDNA.  Data are expressed as mean ± S.D.  
**** - p < 0.0001, *** - p < 0.001, ** - p < 0.05, ns = nonsignificant (Two-way ANOVA with post hoc Tukey’s test).  
N = 5 replicates of 20 animals for each strain.   
Appendix A.8 osm-8(dr9) mutants have reduced gpdh-1 RNA induction 
ogt-1 is required for the constitutive expression of the gpdh-1p::GFP reporter and survival 
of osm-8 LOF mutants during HTS (Fig 2.2.7A and 2.2.7C).  These results suggests that ogt-1 may 
function downstream of extracellular proteins such as OSM-8 during HTS to regulate gpdh-1 
expression.  During HTS, ogt-1 is not required for induction of osmosensitive mRNAs despite 
being required for osmosensitive protein expression.  Here, I measured gpdh-1 mRNA levels in 
osm-8(dr9);ogt-1(dr20) double mutants to test if osm-8 is required for the expression of 
endogenous gpdh-1 mRNA.  Surprisingly, unlike during HTS, ogt-1 is required for gpdh-1 mRNA 
induction in osm-8 mutants (Fig A.8A).  In support of this results, ogt-1 is also required for GFP 
mRNA induction from the gpdh-1p::GFP reporter in osm-8 mutants (Fig A.8B).  These results 
indicate that ogt-1 may function through distinct pathways in osm-8 mutants and during HTS. 
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Figure A.8 ogt-1 is required for constitutive upregulation of osmosensitive mRNAs in an osm-8 mutant 
(A) qPCR of gpdh-1 mRNA from osm-8(dr9) and osm-8(dr9);ogt-1(dr20) mutant day 1 adult animals expressing 
drIs4.  osm-8(dr9) was isolated in a previous genetic screen for new osm-8 alleles but encodes the same mutation as 
the n1518 reference allele.  Data are represented as fold induction of RNA in osm-8(dr9);ogt-1(dr20) mutants relative 
to osm-8(dr9) mutants.  Data are expressed as mean ± S.D.  *** - p < 0.001 (Student’s t-test).  N ≥ 3 biological 
replicates of 35 animals for each group.  (B) qPCR of GFP mRNA from osm-8(dr9) and osm-8(dr9);ogt-1(dr20) 
mutant day 1 adult animals expressing drIs4.  osm-8(dr9) was isolated in a previous genetic screen for new osm-8 
alleles but encodes the same mutation as the n1518 reference allele.  Data are represented as fold induction of RNA 
in osm-8(dr9);ogt-1(dr20) mutants relative to osm-8(dr9) mutants.  Data are expressed as mean ± S.D.  *** - p < 0.001 
(Student’s t-test).  N ≥ 3 biological replicates of 35 animals for each group.   
 
Appendix A.9 Expression of hOGT cDNA with the myo2p::GFP marker does not rescue 
gpdh-1p::GFP induction in ogt-1 mutants 
Here, I measured hypertonic gpdh-1p::GFP induction in ogt-1(dr20) mutants injected with 
hOGT cDNA constructs and the myo2p::GFP marker.  In contrast to the expression of hOGT 
cDNA with the rol-6(su1006) marker, which partially rescued hypertonic gpdh-1p::GFP induction 
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(Figure 2.2.9), expression of hOGT cDNA with the myo2p::GFP marker did not rescue hypertonic 
gpdh-1p::GFP induction in ogt-1 mutants (Fig 2.2.9A, 2.2.9B, and A.9).  Increasing the 
concentration of the injected hOGT cDNA construct from 20ng/µL to 100ng/µL also did not 
improve hypertonic gpdh-1p::GFP induction in ogt-1 mutants (Fig A.9).  These results suggest 
that increasing the injection concentration of the hOGT cDNA construct does not improve 
hypertonic gpdh-1p::GFP induction in ogt-1 mutants.  However, one important caveat in this 
experiment is that I only quantified the GFP/RFP signal for six ogt-1(dr20) mutants, which is a 
relatively small sample size, and the hypertonic gpdh-1p::GFP induction in these mutants was not 
significantly reduced compared to WT animals (Fig A.9).  Therefore, this experiment needs to be 
redone with a larger ogt-1(dr20) sample size.  If the results from this experiment stand, then they 
may explain why the hOGT constructs did not rescue the acute adaptation phenotype of ogt-
1(dr20) mutants (Figure A.7).  Additionally, this result would suggest that the myo2p::GFP marker 
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Figure A.9 Expression of hOGT cDNA with the pharyngeal myo2p::GFP marker does not rescue hypertonic 
gpdh-1p::GFP induction in ogt-1 mutants 
COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 250 mM 
NaCl NGM plates for 18 hours.  All strains express the pharyngeal myo2p::GFP marker.  Data are represented as 
normalized fold induction of GFP/RFP ratio on 250 mM NaCl NGM plates relative to 50 mM NaCl NGM plates.  
Each point represents the quantified signal from a single animal.  Data are expressed as mean ± S.D. ns = 
nonsignificant (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 6 for each group. 
Appendix A.10 HB101 E. coli impairs hypertonic gpdh-1p::GFP induction in wild type 
animals 
In addition to rpn-8(RNAi), proteasomal activity in C. elegans can be inhibited by feeding 
it HB101 E. coli (Fig 2.2.4F) [494].  We thus fed WT and ogt-1(dr20) C. elegans HB101 E. coli 
to test if ogt-1(dr20) mutants have decreased hypertonic induction of GPDH-1 due to aberrant 
activation of the proteasome (Fig A.10).  However, we found that HB101 bacteria impaired 
hypertonic gpdh-1p::GFP induction in WT animals (Fig A.10).  Therefore, the results from this 
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experiment cannot be interpreted.  We do not know why HB101 E. coli inhibits hypertonic gpdh-
1p::GFP induction, but this finding suggests that the bacterial strain may influence the Nio 
phenotype. 
 
Figure A.10 Hypertonic gpdh-1p::GFP induction is impaired in WT and ogt-1(dr20) mutant animals fed HB101 
E. coli  
COPAS Biosort quantification of GFP and RFP signal in day 2 adult animals expressing drIs4 exposed to 50 mM and 
250 mM NaCl NGM plates for 18 hours.  NGM plates were seeded with either the standard OP50 E. coli strain or the 
HB101 E.coli strain.  Data are represented as normalized fold induction of GFP/RFP ratio on 50 or 250 mM NaCl 
NGM plates relative to 50 mM NaCl NGM plates.  Each point represents the quantified signal from a single animal.  
Data are expressed as mean ± S.D. ns = nonsignificant (Kruskal-Wallis test with post hoc Dunn’s test).  N ≥ 81 for 
each group. 
Appendix A.11 TPRs 1-6 are required for hypertonic induction of gpdh-1p::GFP and acute 
adaptation to hypertonic stress 
I used CRISPR/Cas9 to delete the first six TPRs of the endogenous ogt-1 gene.  Sequencing 
of the isolated ∆TPR1-6 allele revealed that it contained an in-frame deletion of the first six TPRs.  
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However, it was not the exact deletion that I engineered with my primers.  Instead of a deletion 
spanning K127-E360 like I expected, the isolated ∆TPR1-6 allele had a E130-N357 deletion.  
Additionally, the ∆TPR1-6 allele contained a random eleven amino acid in-frame insertion 
sequence that did not introduce a stop codon.  Therefore, although the ∆TPR1-6 allele I isolated did 
not match the predicted sequence based on my CRISPR/Cas9 primers and a corrected allele needs 
to be made, it still appears to be a true TPR1-6 deletion.  We therefore carried out some preliminary 
experiments with this ∆TPR1-6 allele. 
Similarly to the full length ∆TPR allele (ogt-1(dr93)), the ∆TPR1-6 ogt-1 allele (ogt-
1(dr98)) completely suppressed the catalytic O-GlcNAcylation activity of OGT-1 (Fig 2.2.11A 
and A.11A).  While we have not explicitly examined the expression levels of the ogt-1(dr98)  
allele, we predict that the TPR1-6 deletion will not affect OGT-1 expression since the full length 
TPR deletion did not affect OGT-1 expression (Fig 2.2.11B)   Additionally, like ogt-1(dr93), ogt-
1(dr98) animals had impaired hypertonic induction of gpdh-1p::GFP and adaptation to HTS (Fig 
2.2.11C, 2.2.11D, 2.2.11E, A.11B, A.11C, and A.11D).  While a ∆TPR1-6 ogt-1 allele with the 
correct sequence deletion needs to be made, these results suggest that the first six TPRs of OGT-
1 are required for the HTSR.   
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Figure A.11 TPRs 1-6 are required for hypertonic induction of gpdh-1p::GFP and acute adaptation to HTS 
(A) Wide-field fluorescence microscopy of intestinal cells in fixed and stained day 1 adult animals.  RL2 was used to 
stain for nuclear pore O-GlcNAc modifications and Hoechst 33258 was used to visualize the DNA.  Images are 
exposure matched.  (B) Wide-field fluorescence microscopy of day 2 adult animals expressing drIs4 exposed to 50 or 
250 mM NaCl NGM plates for 18 hours.  Images depict the GFP channel only for clarity.  The RFP channel was 
unaffected in these rescue strains (not shown).  (C) COPAS Biosort quantification of GFP and RFP signal in day 2 
adult animals expressing drIs4 exposed to 250 mM NaCl NGM plates for 18 hours.  Data are represented as the fold 
induction of normalized GFP/RFP ratio on 250 mM NaCl relative to on 50 mM NaCl NGM plates.  Each point 
represents the quantified signal from a single animal.  Data are expressed as mean ± S.D.  **** - p < 0.0001 (Kruskal-
Wallis test with post hoc Dunn’s test).  N ≥ 91 for each group.  (D) Percent of moving unadapted and adapted day 3 
adult animals expressing drIs4 exposed to 600 mM NaCl NGM plates for 24 hours.  Data are expressed an mean ± 
S.D.  **** - p < 0.0001 (Two-way ANOVA with post hoc Tukey’s test).  N = 5 replicates of 20 animals for each 
strain. 
 
  199 
Appendix A.12 The protein expression of OGT-1 may increase in response to hypertonic 
stress 
Previous microarray data suggests that ogt-1 mRNA expression levels do not change 
during HTS [324].  However, preliminary data using a functional CRISPR/Cas9 GFP tagged ogt-
1 allele (OGT-1::GFP) indicates that the protein expression of OGT-1 may increase during HTS 
(Fig A12A and A12B).  Exposure matched images indicate that OGT-1::GFP expression is 
increased during HTS (Fig A.12A).  Furthermore, an anti-GFP western blot indicates this increase 
in OGT-1::GFP expression may be due to the formation of a new higher molecular weight OGT-
1::GFP species (Fig A.12B).  One possibility is that this higher molecular weight OGT-1::GFP 
species is due to the post-translational modification, such as the O-GlcNAcylation or 
phosphorylation, of OGT-1 during HTS.  To test if OGT-1 is itself O-GlcNAcylated during HTS 
this western blot can be redone with the catalytically dead K957M OGT-1 allele.  If the higher 
molecular weight OGT-1::GFP species goes away when the K957M mutation is introduced, this 
indicates that OGT-1 is O-GlcNAcylated during HTS.  Alternatively, to test if OGT-1 is 
phosphorylated during HTS, phosphatase can be added to the protein lysate before the western 
blot.  If the addition of phosphatase causes the higher molecular weight OGT-1::GFP species to 
disappear, this suggests that OGT-1 is phosphorylated during HTS.   
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Figure A.12 The protein expression of OGT-1-GFP changes during hypertonic stress 
(A) Wide-field fluorescence microscopy of WT day 2 adult animals expressing endogenously CRISPR/Cas9 GFP 
tagged OGT-1 exposed to 50 or 250 mM NaCl NGM plates.  Scale bar = 100 microns.  Images are exposure matched.  
Inset: Zoomed in images of the boxed area.  Scale bar = 10 microns.  (B) Immunoblot of GFP and β-actin in lysates 
from WT day 2 adult animals expressing endogenously CRISPR/Cas9 GFP tagged OGT-1 exposed to 50 or 250 mM 
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